cerebrovascular disorder: A disorder resulting from inadequate blood flow in the vessels that supply the brain. Representative examples include cerebrovascular ischemia, cerebral embolism, and cerebral infarction.
Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere
DOID EFO Endpoint Browser PheWeb
I9_CEREBDOTH
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
3058 |
4. Check minimum number of eventsNone |
3058 |
5. Include endpointsNone |
3058 |
6. Filter based on genotype QC (FinnGen only) |
2962 |
Control definitions (FinnGen only)
- Control exclude
- I9_CEREBVASC
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere
based on the number of shared cases.
Similar with more cases:
- Cerebrovascular diseases
- Neurological diseases, wide definition
- Cardiovascular diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 35100 | 17373 | 17089 |
| Only index persons | 20088 | 10110 | 9978 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.49 | 0.50 | 0.48 |
| Only index persons | 0.38 | 0.37 | 0.38 |
| Median age at first event (years) | |||
| Whole population | 72.53 | 75.26 | 69.77 |
| Only index persons | 69.92 | 72.84 | 66.95 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2962 | 1339 | 1623 |
| Unadjusted period prevalence (%) | 0.62 | 0.48 | 0.74 |
| Median age at first event (years) | 68.36 | 67.82 | 68.81 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3055
- Matched controls
- 30487
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B01AC04
ATC
clopidogrel; oral
4.5
317.0
1065
3245
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
993.5
307.7
429
5
G46.4*I67.9
ICD-10 Finland
Cerebellar stroke syndrome
+∞
307.7
680
*
G46.3*I67.9
ICD-10 Finland
Brain stem stroke syndrome (I60-I67+)
+∞
307.7
473
*
I67.8
ICD-10 Finland
Other specified cerebrovascular diseases
967.7
307.7
490
6
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
1413.1
307.7
1149
13
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
234.9
307.7
1072
70
AA1AD
NOMESCO Finland
CT of head and brain
4.6
307.7
1566
5703
K90
ICPC
Stroke/cerebrovascular accident
38.5
307.7
284
81
G46.8*I67.9
ICD-10 Finland
Other vascular syndromes of brain in cerebrovascular diseases
185.2
307.7
175
10
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
15.7
307.7
696
561
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
372.5
307.7
1174
51
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
11.5
287.6
311
297
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
5.8
272.4
571
1166
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
20.8
236.3
181
92
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.4
217.8
482
1024
XA800
NOMESCO Finland
Neuropsychological investigation
10.2
215.4
251
265
B01AC07
ATC
dipyridamole; systemic
5.8
210.0
424
828
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
2019.8
208.5
200
*
4360A
ICD-9 Finland
Acute but ill-defined cerebrovascular disease[MORBUS CEREBROVASCULARIS ACUTUS NON DEFINITUS]
+∞
171.4
163
*
R42
ICD-10 Finland
Dizziness and giddiness
2.9
166.0
1111
4954
K91
ICPC
Cerebrovascular disease
23.3
161.0
117
52
G46.7*I67.9
ICD-10 Finland
Other lacunar syndromes
+∞
159.7
152
*
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
17.9
139.7
114
66
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
+∞
133.2
127
*
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
7.2
132.8
205
303
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.7
132.2
955
4346
PA6AD
NOMESCO Finland
CT of neck arteries
6.8
122.6
199
310
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
5.4
120.3
250
495
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.1
115.5
350
939
I63
ICD-10 Finland
Cerebral infarction
64.2
113.8
63
10
R4120
NOMESCO Finland
Occupational therapy
4.6
112.0
281
652
N18
ICPC
Paralysis/weakness
10.9
111.2
121
115
R51.80
ICD-10 Finland
Headache
3.1
109.9
540
1977
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
373.0
109.0
109
*
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
55.5
105.6
60
11
C10AA05
ATC
atorvastatin; oral
2.3
104.0
1567
9693
G46.4
ICD-10 Finland
Cerebellar stroke syndrome
266.2
101.3
103
*
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
257.9
98.2
100
*
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
45.4
97.8
58
13
315
Kela drug reimbursment
Clopidogrel
11.7
97.5
101
89
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
5.3
95.7
199
393
I63.8
ICD-10 Finland
Other cerebral infarction
322.8
94.4
95
*
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
5.5
93.3
187
357
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
+∞
90.0
86
*
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.8
89.8
512
2020
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
105.2
84.3
92
9
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
37.7
83.8
52
14
I63.1
ICD-10 Finland
Cerebral infarction due to embolism of precerebral arteries
+∞
81.6
78
*
I69.8
ICD-10 Finland
Sequelae of other and unspecified cerebrovascular diseases
41.4
80.8
49
12
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
270.4
77.8
79
*
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
12.3
76.2
76
63
G81.9
ICD-10 Finland
Hemiplegia, unspecified
13.4
75.8
72
55
B01AA03
ATC
warfarin; systemic
2.2
75.6
928
5139
G46.3
ICD-10 Finland
Brain stem stroke syndrome
+∞
75.3
72
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
4.1
74.6
215
552
C10AA01
ATC
simvastatin; oral
2.0
72.8
1608
10961
I63.2
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
+∞
72.1
69
*
PA2AD
NOMESCO Finland
CT angiography of brain
16.5
71.0
60
37
43899
ICD-8 Finland
Other and ill-defined cerebrovascular disease, Without mention of hypertension
+∞
69.0
66
*
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
124.4
68.1
73
6
F01.9
ICD-10 Finland
Vascular dementia, unspecified
5.7
66.5
126
228
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
650.5
65.1
64
*
4380A
ICD-9 Finland
Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]
+∞
64.8
62
*
R53
ICD-10 Finland
Malaise and fatigue
2.0
64.4
894
5132
H53.4
ICD-10 Finland
Visual field defects
6.6
64.2
104
161
AA5PD
NOMESCO Finland
CT examination of brain pefusion
20.3
62.5
48
24
Z2445
NOMESCO Finland
Psychologist
5.4
62.4
125
238
R4150
NOMESCO Finland
Neuropsychological rehabilitation
26.5
60.7
42
16
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
12.0
57.4
58
49
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
+∞
56.4
54
*
I10
ICD-10 Finland
Essential (primary) hypertension
1.9
54.8
2101
16446
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.4
54.3
141
334
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.8
54.2
306
1186
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
50.7
629
3426
AAL10
NOMESCO Finland
Intracranial endovascular thrombolysis
505.1
50.5
50
*
N03AX14
ATC
levetiracetam; systemic
4.9
49.3
111
234
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.8
49.1
1133
7541
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.7
49.0
286
1126
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
+∞
48.0
46
*
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
47.9
591
3206
AAF00
NOMESCO Finland
Ventriculostomy
17.4
46.2
38
22
C09AA05
ATC
ramipril; oral
1.8
46.0
946
6058
R4130
NOMESCO Finland
Speech therapy
4.9
45.8
102
213
N03AF02
ATC
oxcarbazepine; oral
4.4
45.7
118
278
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.6
45.3
282
1145
G46.5*I67.9
ICD-10 Finland
Pure motor lacunar syndrome
453.4
45.3
45
*
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
8.9
44.8
56
64
TAB00
NOMESCO Finland
Lumbar puncture
3.5
44.0
154
451
C08CA01
ATC
amlodipine; oral
1.7
44.0
1342
9584
205
Kela drug reimbursment
Chronic hypertension
1.7
43.9
1093
7378
G44.2
ICD-10 Finland
Tension-type headache
2.3
43.8
383
1813
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
119.1
43.8
47
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
5.4
42.8
86
164
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
5.5
42.8
84
157
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
12.1
42.7
43
36
N03AG01
ATC
valproic acid; systemic, rectal
3.0
42.4
193
664
C10AX09
ATC
ezetimibe; oral
2.0
41.7
552
3056
F01.30
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without additional symptoms
12.6
40.9
40
32
G46.8
ICD-10 Finland
Other vascular syndromes of brain in cerebrovascular diseases
207.3
39.9
41
*
R1260
NOMESCO Finland
Evaluation of communicative skills
5.5
39.5
77
143
R20.2
ICD-10 Finland
Paraesthesia of skin
2.8
39.3
214
811
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.8
38.9
212
804
4378X
ICD-9 Finland
Other and ill-defined cerebrovascular disease, Other[MORBUS CERBROVASCULARIS ALIA DEFINITA]
+∞
38.6
37
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.1
38.5
163
537
PA7BD
NOMESCO Finland
CT angiography of neck and brain
6.2
37.8
65
107
I64
ICD-10 Finland
Stroke, not specified as haemorrhage or infarction
49.5
36.6
44
9
A28
ICPC
Limited function/disability NOS
1.8
36.3
746
4722
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
36.1
422
2227
N19
ICPC
Speech disorder
6.7
36.0
57
86
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.9
36.0
107
280
N06AB04
ATC
citalopram; systemic
1.8
35.6
617
3710
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.7
35.6
812
5290
Z3226
NOMESCO Finland
Physiotherapist
1.9
35.6
547
3169
H53.2
ICD-10 Finland
Diplopia
3.4
34.4
129
395
R47.0
ICD-10 Finland
Dysphasia and aphasia
8.0
34.0
46
58
WX892
NOMESCO Finland
Monitored bed care
2.3
33.4
261
1173
I67.0
ICD-10 Finland
Dissection of cerebral arteries, nonruptured
+∞
33.4
32
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
4.7
32.6
75
161
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.8
32.6
102
277
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
31.7
1491
11530
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
31.7
508
2973
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.0
31.6
390
2093
4019X
ICD-9 Finland
Essential hypertension, Unspecified
2.8
31.2
157
570
R4110
NOMESCO Finland
Physiotherapy
1.7
30.6
800
5368
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
5.1
30.3
64
128
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.3
29.8
238
1079
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
2.0
29.8
357
1895
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
6.1
29.7
52
87
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.5
29.6
203
860
N30.0
ICD-10 Finland
Acute cystitis
1.8
28.5
519
3147
P20
ICPC
Memory disturbance
1.7
28.4
587
3691
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
7.6
28.4
40
53
G46.6*I67.9
ICD-10 Finland
Pure sensory lacunar syndrome
+∞
28.1
27
*
N05AH04
ATC
quetiapine; oral
1.8
28.1
459
2695
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
28.0
547
3385
C03CA01
ATC
furosemide; systemic
1.5
27.7
1271
9677
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
6.4
27.7
46
73
S06.0
ICD-10 Finland
Concussion
2.0
27.5
332
1765
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
27.4
673
4426
N06AB10
ATC
escitalopram; oral
1.8
27.1
461
2736
I95.1
ICD-10 Finland
Orthostatic hypotension
2.5
27.0
183
771
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
26.5
502
3075
A10AE04
ATC
insulin glargine; parenteral
2.0
26.3
320
1705
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.4
26.2
196
863
N06AX11
ATC
mirtazapine; oral
1.6
26.2
943
6788
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
26.2
549
3458
R47.1
ICD-10 Finland
Dysarthria and anarthria
6.1
25.9
45
75
A10AB05
ATC
insulin aspart; parenteral
2.1
25.3
251
1240
A10AC01
ATC
insulin (human); parenteral
2.0
25.3
278
1428
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
25.2
512
3193
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
+∞
25.0
24
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
25.0
286
1491
H53.1
ICD-10 Finland
Subjective visual disturbances
2.3
24.7
197
892
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.8
24.7
390
2261
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.8
24.6
124
451
R41.0
ICD-10 Finland
Disorientation, unspecified
2.7
24.6
139
537
R55
ICD-10 Finland
Syncope and collapse
1.8
24.4
399
2336
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.5
24.1
901
6514
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.8
24.1
443
2684
N02BE01
ATC
paracetamol; systemic, rectal
1.7
24.1
2550
22895
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.6
24.1
145
578
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.5
23.2
867
6259
I69
ICD-10 Finland
Sequelae of cerebrovascular disease
54.3
23.0
27
5
N03AX12
ATC
[U] gabapentin; oral
1.7
22.5
455
2827
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
22.4
475
2989
C01DA14
ATC
isosorbide mononitrate; oral
1.6
22.4
702
4866
SPAT1216
SPAT
Assessment of functional ability
1.6
22.2
547
3579
SPAT1229
SPAT
Assessment of need for aid
1.9
21.9
276
1485
N02AX02
ATC
tramadol; systemic, rectal
1.5
21.9
1243
9740
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
21.8
593
3975
XCK00
NOMESCO Finland
Perimetry
2.1
21.7
210
1027
K89
ICPC
Transient cerebral ischaemia
4.9
21.5
47
97
N03AB02
ATC
phenytoin; systemic
4.8
21.4
48
101
G45
ICD-10 Finland
Transient cerebral ischaemic attacks and related syndromes
5.9
21.3
38
65
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
21.2
616
4189
N03AX16
ATC
[U] pregabalin
1.6
21.2
629
4300
R41.3
ICD-10 Finland
Other amnesia
2.6
20.9
122
479
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
20.9
844
6171
I67.2
ICD-10 Finland
Cerebral atherosclerosis
19.5
20.8
31
16
103
Kela drug reimbursment
Diabetes, insulin-treated
1.5
20.7
869
6399
J01MA02
ATC
ciprofloxacin; systemic
1.4
20.3
1176
9212
G43.9
ICD-10 Finland
Migraine, unspecified
2.7
20.2
112
429
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.8
20.0
318
1843
A02BC02
ATC
pantoprazole; systemic
1.4
20.0
1921
16480
C07AB07
ATC
bisoprolol; oral
1.4
20.0
1584
13125
TKC20
NOMESCO Finland
Catheterisation of bladder
2.0
19.9
240
1271
43399
ICD-8 Finland
Cerebral thrombosis, Without mention of hypertension
+∞
19.8
19
*
C10AA03
ATC
pravastatin; oral
1.9
19.7
254
1377
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.4
19.6
136
579
N03AX09
ATC
lamotrigine; oral
2.9
19.6
95
339
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
17.8
19.5
30
17
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.5
19.3
805
5909
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
3.0
19.0
85
290
SPAT1301
SPAT
No procedures
1.5
19.0
909
6850
X59
ICD-10 Finland
Exposure to unspecified factor
1.6
18.9
487
3210
C08CA05
ATC
nifedipine; systemic
2.0
18.9
223
1172
P29
ICPC
Psychological sympt/compl other
2.3
18.9
143
633
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
+∞
18.8
18
*
N05CF01
ATC
zopiclone; oral
1.4
18.7
987
7570
N28
ICPC
Limited function/disability (N)
3.4
18.7
66
195
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
7.0
18.6
28
40
N05AX08
ATC
risperidone; systemic
1.8
18.6
305
1783
PAN14
NOMESCO Finland
Plastic repair of arteries internal carotid artery
100.5
18.6
20
*
PA2AC
NOMESCO Finland
Cerebral angiography with X-ray
100.5
18.6
20
*
PA2VT
NOMESCO Finland
Intravascular evacuation of brain artery embolus
190.7
18.5
19
*
OAB41
NOMESCO Finland
Guidance and counselling related to ageing
5.7
18.5
34
60
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
18.4
1134
8940
PA6CG
NOMESCO Finland
Extensive MRI examination of neck vasculature with high intensity magnet
16.2
18.3
29
18
M03BX01
ATC
baclofen; systemic
3.6
18.2
59
165
SPAT1254
SPAT
Administration of medicine
1.6
18.1
474
3136
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.0
18.0
211
1107
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
18.0
829
6191
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.4
17.8
925
7059
C10AA07
ATC
rosuvastatin; oral
1.5
17.8
872
6584
2161
FHL
Neck ligation, big brain
+∞
17.7
17
*
PA2YT
NOMESCO Finland
Cerebral artery PTA with stent
+∞
17.7
17
*
N06AX21
ATC
duloxetine; oral
1.8
17.7
289
1686
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
2.9
17.7
83
291
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
2.8
17.7
87
313
SPAT1053
SPAT
Memory test
1.6
17.6
545
3744
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.3
17.5
136
609
TPH07
NOMESCO Finland
Cathetrisation of artery
1.7
17.5
343
2108
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
17.2
292
1722
280
Kela drug reimbursment
Clopidogrel
3.2
17.2
67
211
R11
ICD-10 Finland
Nausea and vomiting
1.8
17.1
258
1469
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
17.1
509
3467
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.4
17.0
816
6127
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
16.9
917
7039
J01DB01
ATC
cefalexin; oral
1.4
16.8
2214
19742
AXX01
NOMESCO Finland
Memory assessment
4.6
16.7
39
85
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
4.6
16.7
39
85
G46.7
ICD-10 Finland
Other lacunar syndromes
63.5
16.7
19
*
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
63.5
16.7
19
*
43800
ICD-8 Finland
Other and ill-defined cerebrovascular disease, With hypertension (benign)
+∞
16.7
16
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.7
16.7
335
2071
C07AB02
ATC
metoprolol; systemic
1.5
16.6
707
5184
J01DA01
ATC
[U] cefalexin
1.4
16.6
1685
14364
B01AB05
ATC
enoxaparin; parenteral
1.4
16.6
879
6718
N03AX18
ATC
lacosamide; systemic
6.7
16.5
26
39
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.2
16.5
148
704
R1250
NOMESCO Finland
Evaluation of functional capability
2.8
16.4
84
309
N06AA09
ATC
amitriptyline; systemic
1.8
16.4
281
1663
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
2.8
16.3
83
304
Z3231
NOMESCO Finland
Registered nurse
1.5
16.3
737
5465
R51
ICD-10 Finland
Headache
2.3
16.2
122
539
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
4.2
16.2
42
100
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
2.3
15.9
126
570
F06.7
ICD-10 Finland
Mild cognitive disorder
2.2
15.6
126
574
TPX22
NOMESCO Finland
Intravenous arterial thrombolysis
13.8
15.5
26
19
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.4
15.5
714
5309
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.4
15.4
734
5487
J01CA08
ATC
pivmecillinam; oral
1.4
15.4
996
7857
N03AF01
ATC
carbamazepine; oral, rectal
2.1
15.4
152
750
H81.4
ICD-10 Finland
Vertigo of central origin
4.4
15.4
38
87
G45.8
ICD-10 Finland
Other transient cerebral ischaemic attacks and related syndromes
5.4
15.4
30
56
J01FF01
ATC
clindamycin; systemic
1.4
15.3
697
5165
N01
ICPC
Headache
1.8
15.3
219
1227
N17
ICPC
Vertigo/dizziness
1.6
15.3
387
2535
J01EA01
ATC
trimethoprim; systemic
1.4
15.2
747
5614
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
15.2
775
5864
A06AD11
ATC
lactulose; oral
1.5
15.2
551
3908
N05BA04
ATC
oxazepam; oral
1.4
15.1
722
5397
Z02.7
ICD-10 Finland
Issue of medical certificate
1.9
15.1
211
1173
A10AA02, ,
ATC
2.3
15.0
114
507
Z2446
NOMESCO Finland
Social worker
2.0
14.8
163
837
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
3.1
14.7
61
200
I65.0
ICD-10 Finland
Occlusion and stenosis of vertebral artery
+∞
14.6
14
*
4300A
ICD-9 Finland
Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]
+∞
14.6
14
*
I60.8
ICD-10 Finland
Other subarachnoid haemorrhage
150.4
14.5
15
*
PA6AG
NOMESCO Finland
Limited MRI examination of neck vasculature with high intensity magnet
12.6
14.3
25
20
A04
ICPC
Weakness/tiredness general
1.5
14.3
459
3167
A10BA02
ATC
metformin; oral
1.4
14.3
856
6648
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.1
14.3
134
648
L28
ICPC
Limited function/disability (L)
1.5
14.2
618
4536
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
3.7
14.0
43
116
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
4.9
14.0
30
61
ZXD05
NOMESCO Finland
Urgent procedure
1.4
13.7
785
6043
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.6
13.7
371
2464
F01.2
ICD-10 Finland
Subcortical vascular dementia
4.7
13.7
31
66
4359X
ICD-9 Finland
Transient cerebral ischaemia, Unspecified transient cerebral ischaemia
6.2
13.7
23
37
M48.0
ICD-10 Finland
Spinal stenosis
1.6
13.7
393
2646
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.2
13.7
112
514
R13
ICD-10 Finland
Dysphagia
1.8
13.6
205
1166
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.7
13.6
272
1678
4371A
ICD-9 Finland
Other and ill-defined cerebrovascular disease, Other generalised ischaemic cerebrovascular disease
+∞
13.5
13
*
I65.3
ICD-10 Finland
Occlusion and stenosis of multiple and bilateral precerebral arteries
+∞
13.5
13
*
I60.7
ICD-10 Finland
Subarachnoid haemorrhage from intracranial artery, unspecified
+∞
13.5
13
*
PA7CC
NOMESCO Finland
Very extensive angiography of arteries of neck and brain
34.1
13.5
17
5
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
13.5
894
7051
P03
ICPC
Feeling depressed
1.9
13.4
166
887
N06AX16
ATC
venlafaxine; oral
1.7
13.4
281
1754
XF404
NOMESCO Finland
Ambulatory ECG
1.7
13.4
257
1567
ZXD35
NOMESCO Finland
Usual procedure
2.4
13.4
93
398
F01.10
ICD-10 Finland
Multi-infarct dementia without additional symptoms
18.3
13.3
20
11
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.1
13.3
131
646
G41.9
ICD-10 Finland
Status epilepticus, unspecified
6.3
13.2
22
35
Z50.5
ICD-10 Finland
Speech therapy
4.1
13.2
36
89
Q28.3
ICD-10 Finland
Other malformations of cerebral vessels
13.8
13.2
22
16
C10AA04
ATC
fluvastatin; oral
1.6
13.2
296
1881
M79.6
ICD-10 Finland
Pain in limb
1.3
13.2
1086
8854
F05.9
ICD-10 Finland
Delirium, unspecified
2.5
13.1
83
340
C09CA01
ATC
losartan; oral
1.4
13.1
749
5760
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
13.1
277
1734
A10AB01
ATC
insulin (human); parenteral
2.4
13.1
92
396
F80.1
ICD-10 Finland
Expressive language disorder
5.5
13.0
25
46
XCK10
NOMESCO Finland
Photography of fundus of eye
1.6
12.9
280
1763
SPAT1231
SPAT
Assessment of adjustments needed in living environment
2.7
12.9
70
266
G51.0
ICD-10 Finland
Bell palsy
2.6
12.9
76
301
H53.9
ICD-10 Finland
Visual disturbance, unspecified
2.3
12.9
95
417
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.7
12.9
263
1630
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
12.9
360
2409
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
5.0
12.8
27
54
N02BF01
ATC
gabapentin; oral
1.7
12.8
260
1611
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.1
12.7
119
577
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
12.6
478
3407
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.6
12.6
279
1766
Z2221
NOMESCO Finland
Medical doctor
1.4
12.5
672
5106
I60.0
ICD-10 Finland
Subarachnoid haemorrhage from carotid siphon and bifurcation
+∞
12.5
12
*
AAL00
NOMESCO Finland
Endovascular occlusion of intracranial aneurysm
+∞
12.5
12
*
I61.3
ICD-10 Finland
Intracerebral haemorrhage in brain stem
+∞
12.5
12
*
4349A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral artery occlusion, unspecified[OCCL/STENOS ARTER.CEREBRALES NUD CUM INFARCTU CEREB]
+∞
12.5
12
*
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
3.5
12.5
42
121
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.7
12.4
228
1373
PA6BG
NOMESCO Finland
MRI examination of neck vasculature with high intensity magnet
10.0
12.4
24
24
I69.2
ICD-10 Finland
Sequelae of other nontraumatic intracranial haemorrhage
130.3
12.4
13
*
AN1
HP
Coronary angiography
1.5
12.4
374
2543
OAB76
NOMESCO Finland
General guidance on nutrition and food
5.6
12.4
23
41
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
2.1
12.4
124
616
Z3229
NOMESCO Finland
Other healthcare associate professional
1.7
12.2
250
1552
C08CA02
ATC
felodipine; oral
1.6
12.1
316
2081
A10BB12
ATC
glimepiride; oral
1.7
12.1
252
1571
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.6
12.0
319
2107
I50.0
ICD-10 Finland
Congestive heart failure
1.6
11.9
327
2178
C02AC05
ATC
moxonidine; oral
1.9
11.9
140
737
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
11.8
201
1185
RS222, ,
NOMESCO Finland
3.6
11.8
38
106
R26.2
ICD-10 Finland
Difficulty in walking, not elsewhere classified
3.0
11.8
50
166
N29
ICPC
Neurological sympt/complt other
2.7
11.8
62
232
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.2
11.8
103
486
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.3
11.8
90
402
Q28.2
ICD-10 Finland
Arteriovenous malformation of cerebral vessels
14.7
11.8
19
13
G44.1
ICD-10 Finland
Vascular headache, not elsewhere classified
5.9
11.8
21
36
N06AB03
ATC
fluoxetine; oral
1.6
11.7
280
1805
W19
ICD-10 Finland
Unspecified fall
1.6
11.7
277
1783
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
3.4
11.6
40
117
H3603, E103,
ICD-10 Finland
5.5
11.6
22
40
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.6
11.6
281
1818
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
3.6
11.6
37
103
A10AD05
ATC
insulin aspart; parenteral
2.4
11.5
74
306
N03AE01
ATC
clonazepam; systemic
1.9
11.5
146
788
I67.5
ICD-10 Finland
Moyamoya disease
+∞
11.5
11
*
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
+∞
11.5
11
*
NHQ40
NOMESCO Finland
Amputation of toe
2.7
11.4
62
236
PA2CG
NOMESCO Finland
Extensive MRI examination of vessels in the head with high intensity magnet
13.6
11.4
19
14
I61.8
ICD-10 Finland
Other intracerebral haemorrhage
120.2
11.4
12
*
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
11.4
774
6098
SPAT1263
SPAT
Sampling
1.3
11.4
1069
8832
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.6
11.4
64
248
UJF32
NOMESCO Finland
Coloscopy
1.4
11.4
736
5755
81
HP
Angiography of the heart and coronary arteries
1.7
11.3
233
1447
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
2.3
11.3
88
396
4351A
ICD-9 Finland
Transient cerebral ischaemia, Vertebral artery syndrome
11.8
11.3
20
17
I50.9
ICD-10 Finland
Heart failure, unspecified
1.4
11.3
597
4517
A01
ICPC
Pain general/multiple sites
1.6
11.2
276
1791
A10AE05
ATC
insulin detemir; parenteral
1.9
11.2
145
787
G91.1
ICD-10 Finland
Obstructive hydrocephalus
8.9
11.2
23
26
ZXA05
NOMESCO Finland
Left side
1.4
11.2
697
5414
RS221, ,
NOMESCO Finland
3.5
11.2
38
110
JDB10
NOMESCO Finland
Percutaneous gastrostomy
3.3
11.2
42
130
ZXA00
NOMESCO Finland
Right side
1.4
11.1
739
5799
40199
ICD-8 Finland
Essential benign hypertension
2.3
11.1
84
374
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.7
11.1
222
1370
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
11.0
996
8178
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.4
11.0
651
5017
A10BB01
ATC
glibenclamide; oral
1.8
11.0
181
1059
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.6
10.9
274
1786
I25.2
ICD-10 Finland
Old myocardial infarction
1.6
10.9
256
1642
I68.0*E85.9
ICD-10 Finland
Cerebral amyloid angiopathy
43.4
10.9
13
*
A02BC03
ATC
lansoprazole; oral
1.3
10.9
792
6299
R52.9
ICD-10 Finland
Pain, unspecified
1.6
10.9
253
1620
C08CA13
ATC
lercanidipine; oral
1.5
10.8
428
3074
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
10.8
1010
8328
H02AB06
ATC
prednisolone; systemic
1.3
10.8
1291
11002
F01.20
ICD-10 Finland
Subcortical vascular dementia without additional symptoms
3.3
10.8
39
118
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.9
10.8
49
170
79199
ICD-8 Finland
Headache
2.9
10.7
50
176
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.6
10.7
253
1627
S22.3
ICD-10 Finland
Fracture of rib
1.7
10.7
209
1281
C03AA03
ATC
hydrochlorothiazide; oral
1.6
10.7
285
1886
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.3
10.6
814
6521
H3603, E113,
ICD-10 Finland
3.5
10.5
35
100
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
2.9
10.5
47
162
I61.4
ICD-10 Finland
Intracerebral haemorrhage in cerebellum
+∞
10.4
10
*
I65.1
ICD-10 Finland
Occlusion and stenosis of basilar artery
+∞
10.4
10
*
I67.7
ICD-10 Finland
Cerebral arteritis, not elsewhere classified
+∞
10.4
10
*
PA2KT
NOMESCO Finland
Endovascular closure of brain aneurysm
+∞
10.4
10
*
43300
ICD-8 Finland
Cerebral thrombosis, Wtih hypertension (benign)
+∞
10.4
10
*
SPAT1240
SPAT
Therapeutic discussion
1.7
10.4
181
1075
Z71.8
ICD-10 Finland
Other specified counselling
1.3
10.3
759
6040
SPAT1360
SPAT
Extensive global examination
1.7
10.3
193
1171
C02DE04, ,
ATC
2.0
10.3
112
575
SPAT1081
SPAT
Cardiorespiratory global assessment
1.7
10.2
170
997
I20.01
ICD-10 Finland
Unstable angina
2.0
10.2
107
542
C09CA06
ATC
candesartan; oral
1.4
10.1
597
4589
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.7
10.1
167
977
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
3.7
10.1
31
84
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
10.1
1182
10020
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.2
10.0
79
358
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
8.4
10.0
21
25
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
3.1
10.0
41
134
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.9
9.9
127
688
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.2
9.9
82
379
A12BA01
ATC
potassium chloride; oral
1.7
9.9
180
1083
F01.3
ICD-10 Finland
Mixed cortical and subcortical vascular dementia
7.6
9.9
22
29
F03
ICD-10 Finland
Unspecified dementia
1.7
9.9
192
1176
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
2.3
9.8
70
304
H81.2
ICD-10 Finland
Vestibular neuronitis
2.5
9.8
60
243
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
5.1
9.8
20
39
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.6
9.8
231
1485
R06.0
ICD-10 Finland
Dyspnoea
1.3
9.8
784
6310
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
2.0
9.7
105
537
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
4.5
9.7
23
51
N05CD07
ATC
temazepam; oral
1.4
9.7
397
2864
G45.3
ICD-10 Finland
Amaurosis fugax
2.6
9.7
53
203
PEF23
NOMESCO Finland
Thrombendarterectomy of femoral artery
2.6
9.7
54
209
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.5
9.7
272
1821
K99
ICPC
Cardiovascular disease other
2.1
9.6
94
464
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
3.6
9.6
31
87
CKC12
NOMESCO Finland
Photocoagulation of retina
2.0
9.6
102
520
C09DA01
ATC
losartan and diuretics; oral
1.5
9.5
300
2056
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.0
9.5
99
500
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
2.1
9.5
91
446
P99
ICPC
Psychological disorders other
2.5
9.5
56
223
A10BH01
ATC
sitagliptin; oral
1.5
9.5
271
1821
4373A
ICD-9 Finland
Other and ill-defined cerebrovascular disease, Cerebral aneurysm, nonruptured
+∞
9.4
9
*
I69.4
ICD-10 Finland
Sequelae of stroke, not specified as haemorrhage or infarction
+∞
9.4
9
*
N30
ICD-10 Finland
Cystitis
1.7
9.4
185
1138
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.6
9.4
234
1525
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.9
9.4
124
680
C09AA02
ATC
enalapril; systemic
1.4
9.3
605
4714
I20.09
ICD-10 Finland
Unstable angina
1.6
9.3
195
1217
A46
ICD-10 Finland
Erysipelas
1.4
9.3
431
3180
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
3.5
9.3
31
89
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.5
9.3
308
2134
UKC02
NOMESCO Finland
Cystoscopy
1.4
9.3
515
3917
G50.1
ICD-10 Finland
Atypical facial pain
2.8
9.2
46
168
WX704
NOMESCO Finland
Intubation
1.6
9.2
192
1197
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.6
9.2
53
209
SPAT1101
SPAT
Orthostatic test
1.7
9.2
155
914
4350A
ICD-9 Finland
Transient cerebral ischaemia, Basilar artery syndrome
7.7
9.1
20
26
N06AB06
ATC
sertraline; oral
1.6
9.1
223
1447
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.4
9.1
503
3824
S00.0
ICD-10 Finland
Superficial injury of scalp
2.2
9.1
76
354
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
9.1
1008
8458
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
9.0
392
2859
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
2.4
9.0
59
247
G43.3
ICD-10 Finland
Complicated migraine
3.4
9.0
31
91
5541
FHL
Subclavia and / or carotid endarterectomy, reconstruction or bypass surgery
36.7
9.0
11
*
S97
ICPC
Chronic ulcer skin
1.6
8.8
199
1265
K59.1
ICD-10 Finland
Functional diarrhoea
1.7
8.8
150
886
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.8
8.8
139
804
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.6
8.8
205
1314
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
1.6
8.8
207
1331
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.4
8.8
394
2891
G90.2
ICD-10 Finland
Horner syndrome
9.5
8.7
17
18
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
8.7
683
5465
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
1.8
8.7
125
703
P76
ICPC
Depressive disorder
1.9
8.7
107
573
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
3.7
8.7
27
74
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
8.7
979
8218
N06DA04
ATC
galantamine; oral
2.0
8.6
97
504
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.6
8.6
229
1513
Q21.11
ICD-10 Finland
Paten or persistent foramen ovale
11.6
8.5
15
13
F01
ICD-10 Finland
Vascular dementia
6.4
8.5
21
33
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.4
8.5
56
236
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.1
8.4
74
351
C08CA10
ATC
nilvadipine; oral
2.3
8.4
62
274
AAK80
NOMESCO Finland
Partial excision of skull cap
90.1
8.4
9
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.1
8.4
76
365
SPAT1260
SPAT
Consultation of another employee
1.4
8.4
434
3261
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.7
8.4
143
847
E0000UV, ,
ATC
1.3
8.4
1015
8589
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
4.9
8.3
18
37
43099
ICD-8 Finland
Subarachnoid haemorrhage, Without mention of hypertension
+∞
8.3
8
*
I67.4
ICD-10 Finland
Hypertensive encephalopathy
+∞
8.3
8
*
R48.2
ICD-10 Finland
Apraxia
+∞
8.3
8
*
I61.6
ICD-10 Finland
Intracerebral haemorrhage, multiple localized
+∞
8.3
8
*
N88
ICPC
Epilepsy
4.6
8.3
19
41
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
2.3
8.2
61
270
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.5
8.2
267
1841
N30.9
ICD-10 Finland
Cystitis, unspecified
1.6
8.2
180
1138
183
Kela drug reimbursment
Lamotrigin and topiramate
4.2
8.2
21
50
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.4
8.2
472
3609
ZXY02
NOMESCO Finland
Neuropsychologist
7.5
8.1
18
24
M54.8
ICD-10 Finland
Other dorsalgia
1.8
8.1
107
587
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.1
8.1
73
351
F01.19
ICD-10 Finland
Multi-infarct dementia without information on additional symptoms
8.1
8.1
17
21
PA4AC
NOMESCO Finland
Vertebralis angiography with X-ray
17.2
8.1
12
7
Z43.5
ICD-10 Finland
Attention to cystostomy
3.3
8.0
29
88
FFC22
NOMESCO Finland
Percutaneous transluminal closure of ostium secundum type ASD
22.0
8.0
11
5
Z00.0
ICD-10 Finland
General medical examination
1.4
8.0
474
3638
A02BA02
ATC
ranitidine; systemic
1.3
8.0
559
4398
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.9
8.0
102
554
PD4CC
NOMESCO Finland
Very extensive arterigography of lower extremity with X-ray
3.6
8.0
25
69
FPK00
NOMESCO Finland
Implantation of electrocardiograph with loop recorder
4.1
8.0
21
51
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.1
8.0
70
333
SPAT1251
SPAT
Organisation of medication
1.8
7.9
108
598
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
7.9
960
8109
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.6
7.9
197
1283
K59.0
ICD-10 Finland
Constipation
1.6
7.9
171
1078
H04.10
ICD-10 Finland
Dry eye syndrome
1.5
7.9
262
1816
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
7.9
432
3276
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.0
7.9
81
409
G04CA02
ATC
tamsulosin; oral
1.3
7.8
797
6589
G47.3
ICD-10 Finland
Sleep apnoea
1.3
7.8
492
3809
7231A
ICD-9 Finland
Other disorders of cervical region, Cervicalgia
2.8
7.8
37
132
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.5
7.8
238
1621
M54.5
ICD-10 Finland
Low back pain
1.3
7.8
830
6901
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.5
7.8
259
1796
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.6
7.8
181
1161
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.1
7.8
68
323
D11
ICPC
Diarrhoea
1.5
7.8
242
1656
XF600
NOMESCO Finland
Bloodpressure measurement
1.6
7.7
164
1028
J01DA09
ATC
[U] cefadroxil
1.3
7.7
622
4989
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
4.2
7.7
20
48
C08CA06
ATC
nimodipine; systemic
45.0
7.7
9
*
C10AA02
ATC
lovastatin; oral
1.7
7.7
137
821
C09AA04
ATC
perindopril; oral
1.7
7.7
140
844
R33
ICD-10 Finland
Retention of urine
1.5
7.6
274
1929
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
4.5
7.6
18
40
FM1CD
NOMESCO Finland
Very extensive CT of heart
8.0
7.6
16
20
N02AA05
ATC
oxycodone; systemic
1.3
7.6
571
4537
SPAT1050
SPAT
Extensive neurological examination
2.2
7.6
60
274
N05BA01
ATC
diazepam; systemic, rectal
1.4
7.6
325
2365
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
2.6
7.6
43
169
B01AE07
ATC
dabigatran etexilate; oral
1.8
7.6
111
630
J01AA02
ATC
doxycycline; systemic
1.3
7.5
2091
19318
A10AB04
ATC
insulin lispro; parenteral
2.1
7.5
65
307
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
2.0
7.5
78
395
XF620
NOMESCO Finland
Examination of circulation with color method
6.1
7.5
19
31
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.7
7.5
133
796
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.6
7.5
183
1187
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
7.5
443
3397
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.4
7.5
350
2585
4029A
ICD-9 Finland
Hypertensive heart disease, Unspecified[DECOMPENSATIO CORDIS NON INDICATA (WHO II)]
3.0
7.5
32
108
F60.9
ICD-10 Finland
Personality disorder, unspecified
3.7
7.4
23
63
G46.5
ICD-10 Finland
Pure motor lacunar syndrome
80.1
7.4
8
*
H36.00
ICD-10 Finland
Diabetic background retinopathy
2.7
7.4
37
136
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
4.4
7.4
18
41
S80.0
ICD-10 Finland
Contusion of knee
1.6
7.4
155
970
R60.0
ICD-10 Finland
Localized oedema
1.4
7.3
356
2644
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
3.7
7.3
22
59
SPAT1215
SPAT
Assessment of need for medical rehabilitation
1.9
7.3
94
512
C08DB01
ATC
diltiazem; oral
1.5
7.3
191
1259
G93.4
ICD-10 Finland
Encephalopathy, unspecified
8.4
7.3
15
18
S01.3
ICD-10 Finland
Open wound of ear
2.8
7.3
35
126
4341A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral embolism
+∞
7.3
7
*
I68.8
ICD-10 Finland
Other cerebrovascular disorders in diseases classified elsewhere
+∞
7.3
7
*
AAB30
NOMESCO Finland
Evacuation of spontaneous intracranial haematoma
+∞
7.3
7
*
I61.5
ICD-10 Finland
Intracerebral haemorrhage, intraventricular
+∞
7.3
7
*
4331X
ICD-9 Finland
Occlusion and stenosis of precerebral arteries, Carotid artery[OCCL/STENOSIS ARTERIAE CAROTIS SINE INFARCTU CEREBR]
+∞
7.3
7
*
I60.1
ICD-10 Finland
Subarachnoid haemorrhage from middle cerebral artery
+∞
7.3
7
*
I63.6
ICD-10 Finland
Cerebral infarction due to cerebral venous thrombosis, nonpyogenic
+∞
7.3
7
*
4331A
ICD-9 Finland
Occlusion and stenosis of precerebral arteries, Carotid artery[OCCL/STENOSIS ARTERIAE CAROTIS CUM INFARCTU CEREBRI]
+∞
7.3
7
*
SPAT1284
SPAT
Extensive health certificate
2.2
7.3
57
259
GD1AD
NOMESCO Finland
Thorax CT examination
1.6
7.3
167
1068
SPAT1234
SPAT
Support of social functional capacity
1.6
7.3
162
1029
SPAT1245
SPAT
Provision of support and information to patient’s family members
1.6
7.3
151
943
U02
ICPC
Urinary frequency/urgency
1.4
7.2
359
2676
R3110
NOMESCO Finland
Psychosocial training
4.1
7.2
19
46
S82.6
ICD-10 Finland
Fracture of lateral malleolus
1.6
7.2
143
882
R06AE07
ATC
cetirizine; oral
1.2
7.2
959
8170
AA1AM
NOMESCO Finland
Short MRI examination of brain with 3 Tesla magnet
15.7
7.2
11
7
OAB48
NOMESCO Finland
Lifestyle advice and guidance
4.3
7.2
18
42
ZXE10
NOMESCO Finland
More than one and less than three hours
1.3
7.2
887
7493
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.5
7.2
221
1510
C03DA01
ATC
spironolactone; oral
1.4
7.1
385
2911
G04BD07
ATC
tolterodine; oral
1.6
7.1
151
948
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.3
7.1
629
5102
N06AX22
ATC
agomelatine; oral
2.6
7.1
38
145
D07AA02
ATC
hydrocortisone; topical
1.4
7.1
303
2203
N06AX12
ATC
bupropion; oral
1.8
7.1
95
525
J01MA06
ATC
norfloxacin; oral
1.4
7.1
337
2496
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
12.0
7.1
12
10
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
6.0
7.1
18
30
N18.8
ICD-10 Finland
Other chronic renal failure
1.9
7.0
79
412
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
2.1
7.0
62
296
SPAT1252
SPAT
Overall medication plan or its review
1.5
7.0
194
1295
X58
ICD-10 Finland
Exposure to other specified factors
1.4
7.0
302
2199
K08.3
ICD-10 Finland
Retained dental root
1.5
7.0
191
1273
R51.81
ICD-10 Finland
Facial pain NOS
2.3
7.0
52
232
T90.5
ICD-10 Finland
Sequelae of intracranial injury
3.2
7.0
27
86
XX3XW, ,
NOMESCO Finland
3.9
7.0
20
52
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.7
6.9
123
737
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
1.6
6.9
148
931
J01FA06
ATC
roxithromycin; oral
1.2
6.9
977
8373
R07.3
ICD-10 Finland
Other chest pain
1.4
6.9
257
1822
G40
ICD-10 Finland
Epilepsy
3.7
6.9
21
57
7804A
ICD-9 Finland
General symptoms, Dizziness and giddiness
2.3
6.9
51
227
W10
ICD-10 Finland
Fall on and from stairs and steps
1.7
6.9
130
793
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
1.6
6.8
140
871
H81.3
ICD-10 Finland
Other peripheral vertigo
2.0
6.8
73
374
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.6
6.8
175
1149
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.3
6.8
475
3729
WX872
NOMESCO Finland
Intensive care
1.7
6.8
123
741
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
2.4
6.8
43
178
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
2.8
6.8
32
114
NFQ20
NOMESCO Finland
Amputation of femur
2.8
6.8
32
114
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.8
6.8
101
576
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.6
6.8
147
928
H3601, E113,
ICD-10 Finland
2.4
6.8
46
197
P01
ICPC
Feeling anxious/nervous/tense
1.6
6.7
156
1001
C07AA07
ATC
sotalol; systemic
1.7
6.7
130
799
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.2
6.7
51
230
M02AA07
ATC
piroxicam; topical
1.2
6.7
971
8341
U04
ICPC
Incontinence urine
1.5
6.7
176
1164
SPAT1243
SPAT
Psychiatric/psychological examination
2.6
6.6
37
145
F34.1
ICD-10 Finland
Dysthymia
2.0
6.6
67
338
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
1.7
6.6
111
657
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.1
6.6
59
284
A06AC51
ATC
ispaghula, combinations; oral
1.7
6.6
114
680
SPAT1262
SPAT
Handing over of treatment supplies
1.3
6.6
452
3542
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.5
6.5
208
1431
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
10.0
6.5
12
12
M54.2
ICD-10 Finland
Cervicalgia
1.6
6.5
165
1082
N02BF02
ATC
pregabalin; oral
1.6
6.5
143
907
Z31.5
ICD-10 Finland
Genetic counselling
1.8
6.5
85
467
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
6.5
1172
10290
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.0
6.5
62
306
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.9
6.5
74
389
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
2.8
6.4
31
112
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
2.3
6.4
47
208
I62.9
ICD-10 Finland
Intracranial haemorrhage (nontraumatic), unspecified
69.9
6.4
7
*
F01.29
ICD-10 Finland
Subcortical vascular dementia without information on additional symptoms
3.9
6.4
18
46
SPAT1279
SPAT
Preparation of immediate hospitalisation
2.4
6.4
41
171
H34.1
ICD-10 Finland
Central retinal artery occlusion
3.5
6.4
21
60
E11.1
ICD-10 Finland
Type 2 diabetes mellitus, with ketoacidosis
3.5
6.4
21
60
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.4
6.4
288
2113
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
2.8
6.4
30
107
S06.3
ICD-10 Finland
Focal brain injury
2.7
6.4
33
124
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.5
6.4
215
1496
J45.1
ICD-10 Finland
Nonallergic asthma
1.5
6.4
171
1135
4130X
ICD-9 Finland
Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]
1.9
6.4
81
441
F39
ICD-10 Finland
Unspecified mood [affective] disorder
3.0
6.4
27
91
Z73.6
ICD-10 Finland
Limitation of activities due to disability
3.0
6.4
27
91
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
6.3
972
8389
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.0
6.3
65
330
SPAT1255
SPAT
Intravenous administration of medicine
1.5
6.3
175
1172
PA6CM
NOMESCO Finland
Extensive MRI examination of neck vasculature with 3 Tesla magnet
18.0
6.3
9
5
K22
ICPC
Risk factor cardiovascular disease
1.5
6.3
159
1043
I60.2
ICD-10 Finland
Subarachnoid haemorrhage from anterior communicating artery
+∞
6.2
6
*
PA2MT
NOMESCO Finland
Endovascular closure of very extensive brain aneurysm
+∞
6.2
6
*
I60.3
ICD-10 Finland
Subarachnoid haemorrhage from posterior communicating artery
+∞
6.2
6
*
I60.4
ICD-10 Finland
Subarachnoid haemorrhage from basilar artery
+∞
6.2
6
*
C01AA05
ATC
digoxin; systemic
1.4
6.2
331
2495
S70.0
ICD-10 Finland
Contusion of hip
1.6
6.2
121
744
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
6.2
558
4527
H51.2
ICD-10 Finland
Internuclear ophthalmoplegia
26.7
6.2
8
*
S90.3
ICD-10 Finland
Contusion of other and unspecified parts of foot
2.3
6.2
46
205
C07AB05
ATC
betaxolol; oral
1.9
6.2
77
416
D07AC01
ATC
betamethasone; topical
1.2
6.2
888
7603
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
1.7
6.2
115
699
M03BX02
ATC
tizanidine; oral
1.2
6.2
1342
11981
L04AX01
ATC
azathioprine; systemic
1.8
6.2
82
453
G91.0
ICD-10 Finland
Communicating hydrocephalus
5.0
6.2
18
36
XF602
NOMESCO Finland
Bloodpressure monitoring
2.5
6.2
36
144
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
2.1
6.1
54
258
JN3AD
NOMESCO Finland
Abdominal CT examination
1.4
6.1
321
2413
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
6.1
635
5241
R52.1
ICD-10 Finland
Chronic intractable pain
3.1
6.1
24
77
Z29
ICPC
Social problem NOS
2.2
6.1
50
232
PEN23
NOMESCO Finland
Plastic repair of femoral artery
2.9
6.1
27
93
M96.1
ICD-10 Finland
Postlaminectomy syndrome, not elsewhere classified
3.4
6.1
21
62
S01.0
ICD-10 Finland
Open wound of scalp
1.5
6.1
210
1467
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
2.6
6.1
33
127
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
1.8
6.1
80
440
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
6.1
699
5839
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
2.4
6.1
39
163
N05AX12
ATC
aripiprazole; systemic
2.1
6.1
52
246
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
2.7
6.1
31
116
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.3
6.1
42
182
78050
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Vertigo
2.3
6.0
45
201
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.6
6.0
144
931
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.3
6.0
519
4187
N06AG02
ATC
moclobemide; oral
1.7
6.0
95
552
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.9
6.0
27
94
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
1.6
6.0
145
940
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Cerebral infarction, unspecified
I63.9 [45596216]
I63.9 [45596216]
5.4e+00
—
1.0e+50
1.0e+50
1.0e+50
6.1e+00
5.6e+00
cases:5.75%
controls:0.03%
—
—
cases:4.00%
controls:0.00%
cases:11.50%
controls:0.00%
cases:5.36%
controls:0.00%
cases:8.92%
controls:0.02%
cases:12.43%
controls:0.05%
171
8
2802
29681
—
119
0
2854
29689
342
0
2631
29689
154
0
2720
29630
243
6
2480
28746
272
12
1917
23617
acetylsalicylic acid, combinations excl. psycholeptics
N02BA51 [21604320]
N02BA51 [21604320]
1.9e+00
2.2e+00
2.1e+00
—
4.1e+00
3.4e+00
3.3e+00
cases:4.10%
controls:0.64%
cases:4.17%
controls:0.50%
cases:1.35%
controls:0.17%
—
—
cases:9.71%
controls:0.18%
cases:13.77%
controls:0.53%
cases:16.22%
controls:0.69%
122
189
2851
29500
124
149
2849
29540
40
50
2933
29639
—
279
52
2595
29578
375
153
2348
28599
355
164
1834
23465
platelet aggregation inhibitors excl. heparin - combinations
B01AC30 [21601005]
B01AC30 [21601005]
1.9e+00
2.2e+00
2.1e+00
—
4.1e+00
3.4e+00
3.3e+00
cases:4.10%
controls:0.64%
cases:4.17%
controls:0.50%
cases:1.35%
controls:0.17%
—
—
cases:9.71%
controls:0.18%
cases:13.77%
controls:0.53%
cases:16.22%
controls:0.69%
122
189
2851
29500
124
149
2849
29540
40
50
2933
29639
—
279
52
2595
29578
375
153
2348
28599
355
164
1834
23465
Sequelae of cerebral infarction
I69.3 [45533476]
I69.3 [45533476]
4.9e+00
—
—
1.0e+50
—
6.3e+00
5.5e+00
cases:3.80%
controls:0.03%
—
—
—
—
cases:3.50%
controls:0.00%
—
—
cases:11.79%
controls:0.02%
cases:17.31%
controls:0.09%
113
9
2860
29680
—
—
104
0
2869
29689
—
321
7
2402
28745
379
21
1810
23608
clopidogrel; oral
B01AC04 [21600989]
B01AC04 [21600989]
1.1e+00
1.5e+00
1.6e+00
3.7e+00
3.4e+00
2.7e+00
2.1e+00
cases:7.74%
controls:2.79%
cases:6.79%
controls:1.56%
cases:1.78%
controls:0.37%
cases:0.67%
controls:0.02%
cases:10.61%
controls:0.40%
cases:18.88%
controls:1.56%
cases:22.02%
controls:3.22%
230
827
2743
28862
202
464
2771
29225
53
111
2920
29578
20
5
2953
29684
305
118
2569
29512
514
449
2209
28303
482
761
1707
22868
Neurology
13 [38004458]
13 [38004458]
1.2e+00
1.9e+00
3.1e+00
—
4.1e+00
3.0e+00
1.8e+00
cases:22.57%
controls:8.04%
cases:19.04%
controls:3.41%
cases:11.30%
controls:0.59%
—
—
cases:23.42%
controls:0.53%
cases:40.73%
controls:3.28%
cases:36.27%
controls:8.38%
671
2386
2302
27303
566
1011
2407
28678
336
174
2637
29515
—
673
157
2201
29473
1109
943
1614
27809
794
1979
1395
21650
Inpatient Hospital
21 [8717]
21 [8717]
5.7e-01
8.1e-01
1.9e+00
7.0e+00
2.6e+00
9.9e-01
7.2e-01
cases:46.35%
controls:32.75%
cases:23.85%
controls:12.20%
cases:11.74%
controls:1.87%
cases:45.78%
controls:0.08%
cases:21.29%
controls:1.88%
cases:26.59%
controls:11.90%
cases:45.09%
controls:28.62%
1378
9723
1595
19966
709
3622
2264
26067
349
554
2624
29135
1361
24
1612
29665
612
556
2262
29074
724
3422
1999
25330
987
6763
1202
16866
Transient cerebral ischaemic attack, unspecified
G45.9 [45542892]
G45.9 [45542892]
1.6e+00
2.0e+00
3.9e+00
1.0e+50
3.4e+00
2.2e+00
1.5e+00
cases:3.63%
controls:0.75%
cases:1.92%
controls:0.25%
cases:1.28%
controls:0.03%
cases:3.26%
controls:0.00%
cases:1.18%
controls:0.04%
cases:2.20%
controls:0.25%
cases:4.29%
controls:0.99%
108
224
2865
29465
57
75
2916
29614
38
8
2935
29681
97
0
2876
29689
34
12
2840
29618
60
72
2663
28680
94
234
2095
23395
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
6.5e-01
1.0e+00
2.1e+00
5.5e+00
3.3e+00
1.1e+00
8.5e-01
cases:7.60%
controls:4.12%
cases:5.85%
controls:2.14%
cases:2.35%
controls:0.29%
cases:3.94%
controls:0.02%
cases:6.47%
controls:0.26%
cases:5.80%
controls:1.98%
cases:11.47%
controls:5.25%
226
1222
2747
28467
174
635
2799
29054
70
86
2903
29603
117
5
2856
29684
186
76
2688
29554
158
568
2565
28184
251
1240
1938
22389
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
AA1BG [2001300112]
1.3e+00
2.1e+00
4.0e+00
1.0e+50
3.4e+00
2.6e+00
1.3e+00
cases:1.85%
controls:0.53%
cases:1.65%
controls:0.20%
cases:1.04%
controls:0.02%
cases:5.55%
controls:0.00%
cases:0.77%
controls:0.03%
cases:1.80%
controls:0.14%
cases:2.28%
controls:0.66%
55
156
2918
29533
49
59
2924
29630
31
6
2942
29683
165
0
2808
29689
22
8
2852
29622
49
40
2674
28712
50
155
2139
23474
Emergency Room Visit
ER [9203]
ER [9203]
6.0e-01
8.6e-01
2.3e+00
7.3e+00
1.8e+00
8.9e-01
7.8e-01
cases:45.14%
controls:31.02%
cases:23.71%
controls:11.59%
cases:13.05%
controls:1.50%
cases:40.26%
controls:0.05%
cases:8.87%
controls:1.52%
cases:23.94%
controls:11.43%
cases:49.11%
controls:30.70%
1342
9209
1631
20480
705
3440
2268
26249
388
445
2585
29244
1197
14
1776
29675
255
451
2619
29179
652
3286
2071
25466
1075
7255
1114
16374
dipyridamole; oral, parenteral
B01AC07 [21600992]
B01AC07 [21600992]
1.7e+00
1.9e+00
2.0e+00
—
3.3e+00
2.6e+00
2.5e+00
cases:3.87%
controls:0.75%
cases:3.20%
controls:0.48%
cases:0.84%
controls:0.11%
—
—
cases:4.07%
controls:0.16%
cases:5.91%
controls:0.46%
cases:7.63%
controls:0.70%
115
224
2858
29465
95
143
2878
29546
25
34
2948
29655
—
117
46
2757
29584
161
131
2562
28621
167
165
2022
23464
acetylsalicylic acid; oral
B01AC06 [21600991]
B01AC06 [21600991]
1.1e+00
1.4e+00
1.2e+00
3.1e+00
3.0e+00
2.4e+00
1.8e+00
cases:7.87%
controls:2.90%
cases:6.83%
controls:1.84%
cases:2.29%
controls:0.70%
cases:0.67%
controls:0.03%
cases:12.18%
controls:0.72%
cases:18.07%
controls:1.97%
cases:22.02%
controls:4.27%
234
861
2739
28828
203
547
2770
29142
68
209
2905
29480
20
9
2953
29680
350
212
2524
29418
492
567
2231
28185
482
1009
1707
22620
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
5.9e-01
9.3e-01
2.0e+00
6.4e+00
2.5e+00
7.5e-01
6.3e-01
cases:7.33%
controls:4.19%
cases:6.26%
controls:2.56%
cases:2.66%
controls:0.38%
cases:11.00%
controls:0.02%
cases:4.07%
controls:0.35%
cases:6.21%
controls:3.03%
cases:15.90%
controls:9.19%
218
1244
2755
28445
186
761
2787
28928
79
112
2894
29577
327
6
2646
29683
117
103
2757
29527
169
872
2554
27880
348
2171
1841
21458
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
4.2e-01
7.4e-01
2.0e+00
5.2e+00
3.2e+00
1.3e+00
6.7e-01
cases:11.27%
controls:7.69%
cases:4.68%
controls:2.28%
cases:2.02%
controls:0.29%
cases:2.99%
controls:0.02%
cases:7.20%
controls:0.32%
cases:7.38%
controls:2.10%
cases:12.88%
controls:7.00%
335
2283
2638
27406
139
677
2834
29012
60
86
2913
29603
89
5
2884
29684
207
95
2667
29535
201
605
2522
28147
282
1655
1907
21974
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
4.6e-01
7.8e-01
2.0e+00
6.0e+00
2.5e+00
7.8e-01
4.7e-01
cases:16.08%
controls:10.83%
cases:11.71%
controls:5.70%
cases:5.01%
controls:0.70%
cases:9.01%
controls:0.02%
cases:8.77%
controls:0.79%
cases:11.64%
controls:5.72%
cases:22.98%
controls:15.70%
478
3214
2495
26475
348
1693
2625
27996
149
209
2824
29480
268
7
2705
29682
252
233
2622
29397
317
1645
2406
27107
503
3710
1686
19919
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
R29.8 [45587505]
1.0e+00
1.9e+00
3.1e+00
1.0e+50
3.4e+00
2.2e+00
1.4e+00
cases:1.88%
controls:0.68%
cases:1.38%
controls:0.21%
cases:0.50%
controls:0.02%
cases:0.64%
controls:0.00%
cases:0.49%
controls:0.02%
cases:1.76%
controls:0.20%
cases:2.51%
controls:0.62%
56
202
2917
29487
41
62
2932
29627
15
7
2958
29682
19
0
2954
29689
14
5
2860
29625
48
57
2675
28695
55
147
2134
23482
General Practice
1 [38004446]
1 [38004446]
5.9e-01
6.8e-01
1.6e+00
5.6e+00
2.6e+00
9.9e-01
7.0e-01
cases:23.55%
controls:14.54%
cases:12.34%
controls:6.64%
cases:4.88%
controls:1.01%
cases:9.28%
controls:0.04%
cases:13.19%
controls:1.11%
cases:17.44%
controls:7.28%
cases:32.98%
controls:19.63%
700
4316
2273
25373
367
1972
2606
27717
145
299
2828
29390
276
11
2697
29678
379
328
2495
29302
475
2092
2248
26660
722
4638
1467
18991
levetiracetam; oral, parenteral
N03AX14 [21604436]
N03AX14 [21604436]
1.6e+00
1.9e+00
1.9e+00
—
3.0e+00
2.5e+00
1.9e+00
cases:0.64%
controls:0.13%
cases:0.74%
controls:0.11%
cases:0.34%
controls:0.05%
—
—
cases:0.97%
controls:0.05%
cases:1.58%
controls:0.14%
cases:1.69%
controls:0.25%
19
40
2954
29649
22
34
2951
29655
10
15
2963
29674
—
28
14
2846
29616
43
39
2680
28713
37
59
2152
23570
Internal Medicine
11 [38004456]
11 [38004456]
6.1e-01
8.9e-01
1.8e+00
5.7e+00
1.7e+00
9.9e-01
7.5e-01
cases:37.00%
controls:24.22%
cases:21.09%
controls:9.93%
cases:8.78%
controls:1.54%
cases:17.12%
controls:0.07%
cases:8.94%
controls:1.76%
cases:22.81%
controls:9.88%
cases:40.48%
controls:24.22%
1100
7190
1873
22499
627
2949
2346
26740
261
457
2712
29232
509
20
2464
29669
257
522
2617
29108
621
2842
2102
25910
886
5723
1303
17906
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
14979-9 [3018677]
9.7e-01
1.5e+00
3.5e+00
—
3.4e+00
1.7e+00
1.2e+00
cases:5.01%
controls:1.97%
cases:3.63%
controls:0.81%
cases:2.25%
controls:0.07%
—
—
cases:2.92%
controls:0.10%
cases:3.42%
controls:0.66%
cases:8.18%
controls:2.59%
149
584
2824
29105
108
239
2865
29450
67
21
2906
29668
—
84
31
2790
29599
93
190
2630
28562
179
613
2010
23016
Headache
R51.80 [2000503603]
R51.80 [2000503603]
9.9e-01
1.7e+00
3.7e+00
1.0e+50
2.6e+00
1.9e+00
1.4e+00
cases:2.99%
controls:1.14%
cases:2.02%
controls:0.38%
cases:1.68%
controls:0.04%
cases:1.78%
controls:0.00%
cases:0.73%
controls:0.05%
cases:2.46%
controls:0.37%
cases:4.84%
controls:1.30%
89
337
2884
29352
60
113
2913
29576
50
13
2923
29676
53
0
2920
29689
21
16
2853
29614
67
107
2656
28645
106
307
2083
23322
Outpatient Hospital
22 [8756]
22 [8756]
4.8e-01
6.6e-01
1.5e+00
5.7e+00
2.1e+00
9.2e-01
6.4e-01
cases:35.22%
controls:25.22%
cases:14.50%
controls:8.07%
cases:4.54%
controls:1.08%
cases:15.34%
controls:0.06%
cases:8.07%
controls:1.02%
cases:16.86%
controls:7.48%
cases:33.35%
controls:20.92%
1047
7488
1926
22201
431
2397
2542
27292
135
322
2838
29367
456
18
2517
29671
232
303
2642
29327
459
2152
2264
26600
730
4943
1459
18686
Emergency Medicine
93 [38004510]
93 [38004510]
3.0e-01
6.5e-01
2.1e+00
6.2e+00
1.4e+00
6.7e-01
3.5e-01
cases:15.54%
controls:11.94%
cases:12.01%
controls:6.67%
cases:6.79%
controls:0.87%
cases:13.42%
controls:0.03%
cases:3.76%
controls:1.00%
cases:13.66%
controls:7.48%
cases:24.81%
controls:18.92%
462
3546
2511
26143
357
1980
2616
27709
202
257
2771
29432
399
9
2574
29680
108
296
2766
29334
372
2151
2351
26601
543
4470
1646
19159
Complex partial epileptic seizure with secondary generalization
G40.22 [2000502141]
G40.22 [2000502141]
1.8e+00
1.9e+00
—
1.0e+50
3.2e+00
2.6e+00
2.1e+00
cases:0.74%
controls:0.13%
cases:0.57%
controls:0.08%
—
—
cases:0.54%
controls:0.00%
cases:0.42%
controls:0.02%
cases:1.03%
controls:0.08%
cases:1.55%
controls:0.19%
22
38
2951
29651
17
25
2956
29664
—
16
0
2957
29689
12
5
2862
29625
28
23
2695
28729
34
44
2155
23585
Rehabilitation Hospital
283X00000X [38004285]
283X00000X [38004285]
1.2e+00
2.0e+00
—
1.0e+50
3.8e+00
2.8e+00
1.8e+00
cases:1.04%
controls:0.33%
cases:0.74%
controls:0.10%
—
—
cases:0.27%
controls:0.00%
cases:0.87%
controls:0.02%
cases:1.54%
controls:0.10%
cases:1.87%
controls:0.31%
31
97
2942
29592
22
29
2951
29660
—
8
0
2965
29689
25
6
2849
29624
42
28
2681
28724
41
74
2148
23555
Neurosurgery
14 [38004459]
14 [38004459]
1.0e+00
1.6e+00
2.5e+00
—
3.0e+00
2.1e+00
1.3e+00
cases:4.78%
controls:1.81%
cases:3.63%
controls:0.72%
cases:1.31%
controls:0.11%
—
—
cases:2.12%
controls:0.11%
cases:5.99%
controls:0.78%
cases:6.99%
controls:1.98%
142
536
2831
29153
108
214
2865
29475
39
34
2934
29655
—
61
33
2813
29597
163
223
2560
28529
153
467
2036
23162
Neuropsychological investigation
XA800 [2001300412]
XA800 [2001300412]
2.1e+00
2.6e+00
—
1.0e+50
1.0e+50
4.5e+00
2.3e+00
cases:1.18%
controls:0.14%
cases:0.81%
controls:0.06%
—
—
cases:0.57%
controls:0.00%
cases:0.90%
controls:0.00%
cases:3.64%
controls:0.04%
cases:1.78%
controls:0.19%
35
42
2938
29647
24
18
2949
29671
—
17
0
2956
29689
26
0
2848
29630
99
12
2624
28740
39
45
2150
23584
Dizziness and giddiness
R42 [45568132]
R42 [45568132]
9.5e-01
1.5e+00
3.4e+00
—
2.8e+00
1.7e+00
1.0e+00
cases:7.97%
controls:3.24%
cases:5.05%
controls:1.18%
cases:3.57%
controls:0.12%
—
—
cases:2.44%
controls:0.15%
cases:5.55%
controls:1.11%
cases:10.10%
controls:3.86%
237
962
2736
28727
150
349
2823
29340
106
37
2867
29652
—
70
43
2804
29587
151
318
2572
28434
221
912
1968
22717
Paralysis/weakness
N18 [2002000729]
N18 [2002000729]
1.5e+00
2.4e+00
—
—
—
4.2e+00
2.9e+00
cases:0.40%
controls:0.09%
cases:0.37%
controls:0.03%
—
—
—
—
—
—
cases:1.43%
controls:0.02%
cases:1.60%
controls:0.09%
12
26
2961
29663
11
10
2962
29679
—
—
—
39
6
2684
28746
35
21
2154
23608
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
3.8e-01
6.2e-01
1.3e+00
5.3e+00
1.9e+00
9.5e-01
5.7e-01
cases:26.67%
controls:19.92%
cases:17.29%
controls:10.08%
cases:5.52%
controls:1.63%
cases:16.75%
controls:0.10%
cases:10.72%
controls:1.78%
cases:23.50%
controls:10.65%
cases:38.28%
controls:25.93%
793
5913
2180
23776
514
2993
2459
26696
164
485
2809
29204
498
30
2475
29659
308
527
2566
29103
640
3062
2083
25690
838
6126
1351
17503
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
2157-6 [3007220]
7.7e-01
1.3e+00
2.7e+00
1.0e+50
3.7e+00
1.4e+00
9.7e-01
cases:9.82%
controls:4.79%
cases:6.63%
controls:1.93%
cases:3.33%
controls:0.23%
cases:9.01%
controls:0.00%
cases:8.84%
controls:0.24%
cases:7.42%
controls:2.02%
cases:15.17%
controls:6.35%
292
1422
2681
28267
197
574
2776
29115
99
67
2874
29622
268
0
2705
29689
254
70
2620
29560
202
580
2521
28172
332
1500
1857
22129
Other and unspecified symptoms and signs involving cognitive functions and awareness
R41.8 [45534452]
R41.8 [45534452]
7.3e-01
2.0e+00
2.8e+00
—
2.4e+00
1.9e+00
8.6e-01
cases:2.42%
controls:1.18%
cases:3.53%
controls:0.52%
cases:1.45%
controls:0.09%
—
—
cases:0.73%
controls:0.07%
cases:3.82%
controls:0.58%
cases:4.61%
controls:2.00%
72
351
2901
29338
105
153
2868
29536
43
26
2930
29663
—
21
20
2853
29610
104
168
2619
28584
101
473
2088
23156
Extensive CT of neck arteries
PA6BD [2001308697]
PA6BD [2001308697]
2.0e+00
2.9e+00
—
1.0e+50
—
2.9e+00
2.5e+00
cases:1.31%
controls:0.17%
cases:0.74%
controls:0.04%
—
—
cases:4.54%
controls:0.00%
—
—
cases:0.92%
controls:0.05%
cases:1.64%
controls:0.13%
39
51
2934
29638
22
12
2951
29677
—
135
0
2838
29689
—
25
14
2698
28738
36
31
2153
23598
Progressive vascular leukoencephalopathy
I67.3 [45538402]
I67.3 [45538402]
—
3.6e+00
1.0e+50
1.0e+50
1.0e+50
3.4e+00
3.1e+00
—
—
cases:0.61%
controls:0.02%
cases:0.24%
controls:0.00%
cases:0.24%
controls:0.00%
cases:0.21%
controls:0.00%
cases:0.99%
controls:0.03%
cases:1.64%
controls:0.07%
—
18
5
2955
29684
7
0
2966
29689
7
0
2966
29689
6
0
2868
29630
27
10
2696
28742
36
17
2153
23612
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
4.7e-01
5.6e-01
1.4e+00
4.7e+00
1.7e+00
5.7e-01
4.5e-01
cases:9.59%
controls:6.21%
cases:6.29%
controls:3.68%
cases:2.29%
controls:0.55%
cases:1.78%
controls:0.02%
cases:3.20%
controls:0.63%
cases:6.83%
controls:3.98%
cases:15.35%
controls:10.33%
285
1844
2688
27845
187
1092
2786
28597
68
163
2905
29526
53
5
2920
29684
92
186
2782
29444
186
1143
2537
27609
336
2442
1853
21187
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
2.2e-01
4.6e-01
1.4e+00
4.8e+00
2.0e+00
5.4e-01
3.2e-01
cases:29.73%
controls:25.39%
cases:24.39%
controls:16.95%
cases:12.41%
controls:3.27%
cases:20.25%
controls:0.22%
cases:21.36%
controls:3.39%
cases:26.99%
controls:17.78%
cases:42.49%
controls:35.02%
884
7539
2089
22150
725
5031
2248
24658
369
970
2604
28719
602
65
2371
29624
614
1004
2260
28626
735
5113
1988
23639
930
8275
1259
15354
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
3.3e-01
6.1e-01
1.4e+00
4.7e+00
1.7e+00
5.8e-01
4.5e-01
cases:19.07%
controls:14.53%
cases:12.88%
controls:7.46%
cases:4.24%
controls:1.08%
cases:3.53%
controls:0.03%
cases:6.58%
controls:1.27%
cases:13.55%
controls:8.03%
cases:27.36%
controls:19.31%
567
4315
2406
25374
383
2215
2590
27474
126
322
2847
29367
105
10
2868
29679
189
377
2685
29253
369
2310
2354
26442
599
4562
1590
19067
Epilepsy, unspecified
G40.9 [45562083]
G40.9 [45562083]
1.3e+00
1.8e+00
—
—
3.2e+00
1.9e+00
1.4e+00
cases:0.94%
controls:0.26%
cases:0.74%
controls:0.12%
—
—
—
—
cases:0.42%
controls:0.02%
cases:1.03%
controls:0.15%
cases:1.60%
controls:0.41%
28
78
2945
29611
22
36
2951
29653
—
—
12
5
2862
29625
28
43
2695
28709
35
96
2154
23533
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
3209-4 [3019250]
1.0e+00
1.8e+00
—
—
3.7e+00
1.7e+00
1.3e+00
cases:0.84%
controls:0.31%
cases:0.74%
controls:0.13%
—
—
—
—
cases:0.84%
controls:0.02%
cases:0.59%
controls:0.10%
cases:1.14%
controls:0.30%
25
91
2948
29598
22
38
2951
29651
—
—
24
6
2850
29624
16
30
2707
28722
25
71
2164
23558
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
3.9e-01
6.6e-01
1.3e+00
4.1e+00
2.0e+00
5.7e-01
5.0e-01
cases:12.24%
controls:8.66%
cases:8.75%
controls:4.73%
cases:2.62%
controls:0.70%
cases:1.65%
controls:0.03%
cases:5.57%
controls:0.80%
cases:8.41%
controls:4.95%
cases:18.78%
controls:12.26%
364
2572
2609
27117
260
1405
2713
28284
78
207
2895
29482
49
8
2924
29681
160
237
2714
29393
229
1423
2494
27329
411
2897
1778
20732
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
2524-7 [3014111]
7.5e-01
1.2e+00
2.3e+00
1.0e+50
3.4e+00
1.1e+00
8.2e-01
cases:2.02%
controls:0.97%
cases:1.68%
controls:0.51%
cases:0.34%
controls:0.03%
cases:0.44%
controls:0.00%
cases:1.36%
controls:0.05%
cases:1.62%
controls:0.56%
cases:4.25%
controls:1.92%
60
287
2913
29402
50
151
2923
29538
10
10
2963
29679
13
0
2960
29689
39
14
2835
29616
44
160
2679
28592
93
454
2096
23175
Atrial fibrillation and flutter
I48 [45596206]
I48 [45596206]
3.3e-01
4.2e-01
1.2e+00
4.7e+00
1.7e+00
7.5e-01
3.9e-01
cases:10.73%
controls:7.99%
cases:6.36%
controls:4.28%
cases:2.66%
controls:0.85%
cases:5.25%
controls:0.05%
cases:5.05%
controls:0.93%
cases:9.22%
controls:4.59%
cases:13.98%
controls:9.92%
319
2371
2654
27318
189
1271
2784
28418
79
251
2894
29438
156
15
2817
29674
145
277
2729
29353
251
1319
2472
27433
306
2343
1883
21286
Atherosclerosis of arteries of extremities
I70.2 [45538421]
I70.2 [45538421]
7.1e-01
1.0e+00
1.3e+00
3.6e+00
1.1e+00
1.0e+00
6.9e-01
cases:3.77%
controls:1.89%
cases:2.79%
controls:1.03%
cases:0.87%
controls:0.25%
cases:0.94%
controls:0.03%
cases:0.73%
controls:0.24%
cases:2.94%
controls:1.07%
cases:5.21%
controls:2.67%
112
560
2861
29129
83
307
2890
29382
26
74
2947
29615
28
8
2945
29681
21
70
2853
29560
80
307
2643
28445
114
631
2075
22998
oxcarbazepine; oral
N03AF02 [21604418]
N03AF02 [21604418]
1.2e+00
1.3e+00
1.7e+00
—
1.6e+00
1.9e+00
1.7e+00
cases:0.87%
controls:0.26%
cases:0.77%
controls:0.21%
cases:0.27%
controls:0.05%
—
—
cases:0.38%
controls:0.08%
cases:1.32%
controls:0.21%
cases:1.87%
controls:0.34%
26
76
2947
29613
23
62
2950
29627
8
15
2965
29674
—
11
24
2863
29606
36
59
2687
28693
41
80
2148
23549
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
2615-3 [3006217]
9.2e-01
1.1e+00
2.5e+00
1.0e+50
2.8e+00
1.1e+00
9.0e-01
cases:1.72%
controls:0.69%
cases:0.98%
controls:0.31%
cases:0.20%
controls:0.02%
cases:0.27%
controls:0.00%
cases:0.56%
controls:0.03%
cases:1.14%
controls:0.38%
cases:3.06%
controls:1.27%
51
205
2922
29484
29
93
2944
29596
6
5
2967
29684
8
0
2965
29689
16
10
2858
29620
31
109
2692
28643
67
300
2122
23329
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
2030-5 [3028653]
9.2e-01
1.1e+00
2.5e+00
1.0e+50
2.9e+00
1.2e+00
8.3e-01
cases:1.72%
controls:0.69%
cases:0.98%
controls:0.33%
cases:0.20%
controls:0.02%
cases:0.27%
controls:0.00%
cases:0.59%
controls:0.03%
cases:1.25%
controls:0.40%
cases:3.06%
controls:1.35%
51
205
2922
29484
29
99
2944
29590
6
5
2967
29684
8
0
2965
29689
17
10
2857
29620
34
114
2689
28638
67
320
2122
23309
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
4.0e-01
6.5e-01
1.3e+00
4.1e+00
1.9e+00
5.3e-01
4.2e-01
cases:13.93%
controls:9.79%
cases:10.29%
controls:5.65%
cases:3.23%
controls:0.86%
cases:2.12%
controls:0.04%
cases:6.37%
controls:0.99%
cases:9.59%
controls:5.86%
cases:20.79%
controls:14.72%
414
2906
2559
26783
306
1678
2667
28011
96
255
2877
29434
63
11
2910
29678
183
294
2691
29336
261
1685
2462
27067
455
3478
1734
20151
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
4.2e-01
5.5e-01
9.9e-01
4.7e+00
1.4e+00
7.3e-01
4.5e-01
cases:14.50%
controls:10.04%
cases:10.39%
controls:6.28%
cases:5.82%
controls:2.24%
cases:9.15%
controls:0.09%
cases:8.66%
controls:2.23%
cases:11.90%
controls:6.09%
cases:20.47%
controls:14.08%
431
2980
2542
26709
309
1863
2664
27826
173
666
2800
29023
272
26
2701
29663
249
661
2625
28969
324
1750
2399
27002
448
3328
1741
20301
pH of Serum or Plasma
2753-2 [3018418]
2753-2 [3018418]
5.3e-01
7.4e-01
1.4e+00
3.5e+00
1.9e+00
6.9e-01
5.3e-01
cases:8.85%
controls:5.39%
cases:6.22%
controls:3.07%
cases:1.88%
controls:0.47%
cases:0.64%
controls:0.02%
cases:3.69%
controls:0.54%
cases:6.02%
controls:3.13%
cases:13.25%
controls:8.23%
263
1601
2710
28088
185
912
2788
28777
56
140
2917
29549
19
6
2954
29683
106
161
2768
29469
164
899
2559
27853
290
1945
1899
21684
Other and unspecified convulsions
R56.8 [45602033]
R56.8 [45602033]
1.3e+00
1.6e+00
—
1.0e+50
3.0e+00
1.9e+00
1.4e+00
cases:0.94%
controls:0.27%
cases:0.50%
controls:0.10%
—
—
cases:0.77%
controls:0.00%
cases:0.56%
controls:0.03%
cases:0.73%
controls:0.11%
cases:1.37%
controls:0.33%
28
80
2945
29609
15
29
2958
29660
—
23
0
2950
29689
16
8
2858
29622
20
32
2703
28720
30
79
2159
23550
Psychologist
Z2445 [2001311558]
Z2445 [2001311558]
1.2e+00
2.2e+00
—
1.0e+50
1.0e+50
3.8e+00
2.0e+00
cases:0.64%
controls:0.19%
cases:0.54%
controls:0.06%
—
—
cases:0.20%
controls:0.00%
cases:0.31%
controls:0.00%
cases:1.51%
controls:0.03%
cases:0.55%
controls:0.08%
19
55
2954
29634
16
17
2957
29672
—
6
0
2967
29689
9
0
2865
29630
41
10
2682
28742
12
18
2177
23611
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
2714-4 [3014007]
9.1e-01
1.1e+00
2.3e+00
1.0e+50
2.8e+00
1.2e+00
8.9e-01
cases:1.68%
controls:0.68%
cases:1.01%
controls:0.34%
cases:0.20%
controls:0.02%
cases:0.27%
controls:0.00%
cases:0.59%
controls:0.04%
cases:1.25%
controls:0.37%
cases:3.06%
controls:1.27%
50
203
2923
29486
30
102
2943
29587
6
6
2967
29683
8
0
2965
29689
17
11
2857
29619
34
107
2689
28645
67
301
2122
23328
Supine thorax X-ray examination
GD1QA [2001303648]
GD1QA [2001303648]
8.7e-01
1.3e+00
2.8e+00
—
2.1e+00
1.2e+00
9.4e-01
cases:4.17%
controls:1.79%
cases:2.79%
controls:0.82%
cases:1.75%
controls:0.10%
—
—
cases:1.15%
controls:0.14%
cases:3.01%
controls:0.95%
cases:8.77%
controls:3.61%
124
532
2849
29157
83
242
2890
29447
52
31
2921
29658
—
33
42
2841
29588
82
273
2641
28479
192
852
1997
22777
ECG with 12 standard connections
XF400 [2001303368]
XF400 [2001303368]
8.3e-01
1.2e+00
3.0e+00
—
2.1e+00
1.0e+00
9.6e-01
cases:4.44%
controls:1.98%
cases:2.02%
controls:0.61%
cases:1.45%
controls:0.07%
—
—
cases:0.45%
controls:0.06%
cases:1.73%
controls:0.62%
cases:4.48%
controls:1.77%
132
588
2841
29101
60
180
2913
29509
43
21
2930
29668
—
13
17
2861
29613
47
177
2676
28575
98
418
2091
23211
Gas panel - Arterial blood
24336-0 [3019060]
24336-0 [3019060]
7.7e-01
1.2e+00
2.1e+00
—
3.3e+00
9.7e-01
7.9e-01
cases:1.95%
controls:0.92%
cases:1.04%
controls:0.32%
cases:0.27%
controls:0.03%
—
—
cases:0.66%
controls:0.02%
cases:1.14%
controls:0.43%
cases:3.06%
controls:1.42%
58
272
2915
29417
31
94
2942
29595
8
10
2965
29679
—
19
7
2855
29623
31
125
2692
28627
67
335
2122
23294
Carotid artery syndrome (hemispheric)
G45.1 [45576586]
G45.1 [45576586]
1.7e+00
2.7e+00
1.0e+50
1.0e+50
—
2.7e+00
2.0e+00
cases:1.24%
controls:0.23%
cases:1.01%
controls:0.07%
cases:0.17%
controls:0.00%
cases:0.87%
controls:0.00%
—
—
cases:1.07%
controls:0.07%
cases:1.64%
controls:0.22%
37
69
2936
29620
30
21
2943
29668
5
0
2968
29689
26
0
2947
29689
—
29
20
2694
28732
36
53
2153
23576
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
30313-1 [3002173]
9.7e-01
1.1e+00
2.3e+00
—
3.0e+00
9.7e-01
7.8e-01
cases:2.76%
controls:1.06%
cases:1.45%
controls:0.50%
cases:0.40%
controls:0.04%
—
—
cases:0.97%
controls:0.05%
cases:1.58%
controls:0.60%
cases:4.48%
controls:2.09%
82
315
2891
29374
43
147
2930
29542
12
12
2961
29677
—
28
15
2846
29615
43
173
2680
28579
98
495
2091
23134
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
Z00.4 [45605094]
1.0e+00
1.3e+00
2.0e+00
—
2.0e+00
1.7e+00
1.1e+00
cases:1.41%
controls:0.50%
cases:0.67%
controls:0.18%
cases:0.34%
controls:0.05%
—
—
cases:0.31%
controls:0.04%
cases:0.88%
controls:0.17%
cases:1.55%
controls:0.52%
42
149
2931
29540
20
53
2953
29636
10
14
2963
29675
—
9
13
2865
29617
24
49
2699
28703
34
124
2155
23505
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
1960-4 [3008152]
8.7e-01
8.9e-01
2.1e+00
—
3.4e+00
9.4e-01
7.1e-01
cases:2.05%
controls:0.87%
cases:0.98%
controls:0.40%
cases:0.30%
controls:0.04%
—
—
cases:0.73%
controls:0.02%
cases:1.10%
controls:0.43%
cases:3.29%
controls:1.65%
61
258
2912
29431
29
120
2944
29569
9
11
2964
29678
—
21
7
2853
29623
30
124
2693
28628
72
389
2117
23240
Atherosclerotic heart disease
I25.1 [45596196]
I25.1 [45596196]
4.4e-01
6.0e-01
1.1e+00
4.3e+00
1.4e+00
7.0e-01
4.3e-01
cases:8.61%
controls:5.70%
cases:5.62%
controls:3.16%
cases:1.78%
controls:0.62%
cases:3.26%
controls:0.05%
cases:2.44%
controls:0.60%
cases:6.87%
controls:3.53%
cases:12.47%
controls:8.51%
256
1691
2717
27998
167
938
2806
28751
53
185
2920
29504
97
14
2876
29675
70
177
2804
29453
187
1016
2536
27736
273
2012
1916
21617
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
1.5e-01
3.3e-01
1.2e+00
4.7e+00
1.8e+00
4.6e-01
2.4e-01
cases:33.50%
controls:30.30%
cases:31.32%
controls:24.61%
cases:14.46%
controls:4.73%
cases:20.79%
controls:0.24%
cases:23.59%
controls:4.81%
cases:35.55%
controls:25.79%
cases:48.38%
controls:42.35%
996
8995
1977
20694
931
7305
2042
22384
430
1405
2543
28284
618
71
2355
29618
678
1425
2196
28205
968
7414
1755
21338
1059
10006
1130
13623
Traumatic subdural haemorrhage
S06.5 [45563422]
S06.5 [45563422]
1.1e+00
2.2e+00
2.3e+00
—
2.2e+00
1.3e+00
1.2e+00
cases:0.50%
controls:0.18%
cases:0.47%
controls:0.05%
cases:0.30%
controls:0.03%
—
—
cases:0.21%
controls:0.02%
cases:0.40%
controls:0.11%
cases:1.23%
controls:0.38%
15
52
2958
29637
14
16
2959
29673
9
9
2964
29680
—
6
7
2868
29623
11
33
2712
28719
27
89
2162
23540
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
2.7e-01
4.1e-01
1.2e+00
4.5e+00
1.7e+00
4.9e-01
3.4e-01
cases:29.30%
controls:24.05%
cases:26.67%
controls:19.37%
cases:12.58%
controls:4.27%
cases:16.62%
controls:0.22%
cases:19.73%
controls:4.23%
cases:29.45%
controls:20.29%
cases:41.62%
controls:33.67%
871
7140
2102
22549
793
5751
2180
23938
374
1268
2599
28421
494
66
2479
29623
567
1254
2307
28376
802
5835
1921
22917
911
7955
1278
15674
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
1.5e-01
3.3e-01
1.2e+00
4.7e+00
1.8e+00
4.6e-01
2.4e-01
cases:33.64%
controls:30.47%
cases:31.58%
controls:24.95%
cases:14.70%
controls:4.81%
cases:20.52%
controls:0.25%
cases:23.76%
controls:4.88%
cases:35.88%
controls:26.15%
cases:48.52%
controls:42.57%
1000
9045
1973
20644
939
7408
2034
22281
437
1429
2536
28260
610
73
2363
29616
683
1447
2191
28183
977
7519
1746
21233
1062
10060
1127
13569
Visual field defects
H53.4 [45557469]
H53.4 [45557469]
1.4e+00
2.0e+00
—
1.0e+50
—
2.9e+00
2.4e+00
cases:0.47%
controls:0.11%
cases:0.34%
controls:0.04%
—
—
cases:0.20%
controls:0.00%
—
—
cases:1.03%
controls:0.06%
cases:1.14%
controls:0.10%
14
33
2959
29656
10
13
2963
29676
—
6
0
2967
29689
—
28
16
2695
28736
25
24
2164
23605
Creatine kinase.MB [Mass/volume] in Serum or Plasma
13969-1 [3005785]
13969-1 [3005785]
7.0e-01
9.9e-01
2.1e+00
1.0e+50
2.8e+00
1.1e+00
1.1e+00
cases:3.26%
controls:1.65%
cases:1.65%
controls:0.62%
cases:0.71%
controls:0.08%
cases:2.66%
controls:0.00%
cases:1.08%
controls:0.06%
cases:1.62%
controls:0.56%
cases:5.80%
controls:1.97%
97
491
2876
29198
49
184
2924
29505
21
25
2952
29664
79
0
2894
29689
31
19
2843
29611
44
162
2679
28590
127
465
2062
23164
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
2019-8 [3027946]
8.4e-01
1.0e+00
2.1e+00
—
3.0e+00
1.1e+00
7.3e-01
cases:3.26%
controls:1.44%
cases:1.95%
controls:0.69%
cases:0.50%
controls:0.06%
—
—
cases:1.25%
controls:0.06%
cases:2.31%
controls:0.81%
cases:5.44%
controls:2.70%
97
428
2876
29261
58
206
2915
29483
15
18
2958
29671
—
36
18
2838
29612
63
234
2660
28518
119
637
2070
22992
pH of Arterial blood
2744-1 [3019977]
2744-1 [3019977]
8.5e-01
1.0e+00
2.1e+00
—
3.0e+00
1.1e+00
7.1e-01
cases:3.26%
controls:1.42%
cases:1.88%
controls:0.67%
cases:0.50%
controls:0.06%
—
—
cases:1.25%
controls:0.06%
cases:2.28%
controls:0.81%
cases:5.30%
controls:2.67%
97
422
2876
29267
56
200
2917
29489
15
18
2958
29671
—
36
18
2838
29612
62
232
2661
28520
116
631
2073
22998
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
2703-7 [3027801]
8.4e-01
1.0e+00
2.1e+00
—
3.0e+00
1.1e+00
7.1e-01
cases:3.26%
controls:1.44%
cases:1.95%
controls:0.69%
cases:0.50%
controls:0.06%
—
—
cases:1.25%
controls:0.06%
cases:2.31%
controls:0.81%
cases:5.34%
controls:2.70%
97
428
2876
29261
58
206
2915
29483
15
18
2958
29671
—
36
18
2838
29612
63
234
2660
28518
117
637
2072
22992
Vertebro-basilar artery syndrome
G45.0 [45538120]
G45.0 [45538120]
1.5e+00
2.2e+00
—
1.0e+50
1.0e+50
2.9e+00
2.1e+00
cases:0.87%
controls:0.19%
cases:0.54%
controls:0.06%
—
—
cases:1.65%
controls:0.00%
cases:0.45%
controls:0.00%
cases:0.95%
controls:0.05%
cases:1.46%
controls:0.18%
26
56
2947
29633
16
17
2957
29672
—
49
0
2924
29689
13
0
2861
29630
26
15
2697
28737
32
43
2157
23586
Base excess in Arterial blood by calculation
1925-7 [3003396]
1925-7 [3003396]
8.2e-01
1.0e+00
2.1e+00
—
3.1e+00
1.1e+00
6.8e-01
cases:3.23%
controls:1.44%
cases:1.88%
controls:0.69%
cases:0.50%
controls:0.06%
—
—
cases:1.29%
controls:0.06%
cases:2.28%
controls:0.78%
cases:5.12%
controls:2.65%
96
428
2877
29261
56
206
2917
29483
15
18
2958
29671
—
37
18
2837
29612
62
225
2661
28527
112
626
2077
23003
Gas panel - Venous blood
24339-4 [3000991]
24339-4 [3000991]
8.8e-01
9.3e-01
2.2e+00
1.0e+50
2.9e+00
1.1e+00
7.8e-01
cases:2.29%
controls:0.96%
cases:1.48%
controls:0.59%
cases:0.44%
controls:0.05%
cases:0.44%
controls:0.00%
cases:1.43%
controls:0.08%
cases:1.87%
controls:0.66%
cases:4.07%
controls:1.91%
68
285
2905
29404
44
175
2929
29514
13
14
2960
29675
13
0
2960
29689
41
24
2833
29606
51
189
2672
28563
89
451
2100
23178
Appearance of Cerebral spinal fluid
10333-3 [3023410]
10333-3 [3023410]
1.8e+00
2.5e+00
—
1.0e+50
1.0e+50
2.7e+00
1.7e+00
cases:0.54%
controls:0.09%
cases:0.37%
controls:0.03%
—
—
cases:0.54%
controls:0.00%
cases:0.94%
controls:0.00%
cases:0.51%
controls:0.03%
cases:0.55%
controls:0.10%
16
27
2957
29662
11
9
2962
29680
—
16
0
2957
29689
27
0
2847
29630
14
10
2709
28742
12
23
2177
23606
pH of Urine
2756-5 [3015736]
2756-5 [3015736]
2.5e-01
5.1e-01
1.2e+00
4.1e+00
1.7e+00
5.5e-01
3.7e-01
cases:9.15%
controls:7.28%
cases:6.42%
controls:3.96%
cases:1.85%
controls:0.56%
cases:1.24%
controls:0.02%
cases:3.41%
controls:0.66%
cases:7.05%
controls:4.21%
cases:16.58%
controls:12.08%
272
2160
2701
27529
191
1177
2782
28512
55
165
2918
29524
37
6
2936
29683
98
197
2776
29433
192
1210
2531
27542
363
2854
1826
20775
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
59275-8 [40762366]
1.1e+00
9.1e-01
2.6e+00
—
3.0e+00
1.1e+00
4.8e-01
cases:1.75%
controls:0.60%
cases:0.77%
controls:0.31%
cases:0.27%
controls:0.02%
—
—
cases:0.52%
controls:0.03%
cases:0.99%
controls:0.34%
cases:2.01%
controls:1.25%
52
178
2921
29511
23
93
2950
29596
8
6
2965
29683
—
15
8
2859
29622
27
98
2696
28654
44
295
2145
23334
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
E11.9 [45561952]
3.7e-01
5.0e-01
1.1e+00
4.3e+00
1.4e+00
6.2e-01
3.3e-01
cases:8.68%
controls:6.17%
cases:5.15%
controls:3.17%
cases:1.65%
controls:0.58%
cases:3.57%
controls:0.05%
cases:2.33%
controls:0.57%
cases:5.91%
controls:3.27%
cases:11.15%
controls:8.24%
258
1831
2715
27858
153
942
2820
28747
49
171
2924
29518
106
15
2867
29674
67
169
2807
29461
161
939
2562
27813
244
1948
1945
21681
Tension-type headache
G44.2 [45581495]
G44.2 [45581495]
6.6e-01
9.6e-01
2.2e+00
1.0e+50
1.9e+00
1.5e+00
1.3e+00
cases:2.15%
controls:1.13%
cases:1.01%
controls:0.39%
cases:0.40%
controls:0.04%
cases:0.47%
controls:0.00%
cases:0.35%
controls:0.05%
cases:1.51%
controls:0.34%
cases:4.29%
controls:1.17%
64
335
2909
29354
30
115
2943
29574
12
13
2961
29676
14
0
2959
29689
10
15
2864
29615
41
99
2682
28653
94
276
2095
23353
Oxygen saturation in Arterial blood
2708-6 [3016502]
2708-6 [3016502]
8.9e-01
9.2e-01
2.2e+00
—
2.9e+00
9.7e-01
6.9e-01
cases:2.96%
controls:1.23%
cases:1.51%
controls:0.61%
cases:0.40%
controls:0.05%
—
—
cases:1.11%
controls:0.06%
cases:1.76%
controls:0.68%
cases:4.66%
controls:2.39%
88
366
2885
29323
45
180
2928
29509
12
14
2961
29675
—
32
18
2842
29612
48
195
2675
28557
102
565
2087
23064
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
GD1UA [2001303652]
6.9e-01
1.1e+00
2.5e+00
1.0e+50
2.6e+00
9.2e-01
6.9e-01
cases:3.20%
controls:1.63%
cases:1.82%
controls:0.60%
cases:0.77%
controls:0.06%
cases:2.09%
controls:0.00%
cases:0.70%
controls:0.05%
cases:1.47%
controls:0.59%
cases:4.29%
controls:2.20%
95
485
2878
29204
54
179
2919
29510
23
19
2950
29670
62
0
2911
29689
20
15
2854
29615
40
169
2683
28583
94
521
2095
23108
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
4.3e-01
8.4e-01
1.1e+00
3.0e+00
1.9e+00
6.9e-01
5.2e-01
cases:12.38%
controls:8.41%
cases:10.26%
controls:4.72%
cases:2.19%
controls:0.73%
cases:0.67%
controls:0.03%
cases:5.39%
controls:0.83%
cases:9.29%
controls:4.87%
cases:19.28%
controls:12.42%
368
2496
2605
27193
305
1401
2668
28288
65
218
2908
29471
20
10
2953
29679
155
245
2719
29385
253
1400
2470
27352
422
2935
1767
20694
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
Z50.8 [45556842]
7.5e-01
1.0e+00
1.7e+00
—
3.5e+00
1.9e+00
1.3e+00
cases:1.51%
controls:0.72%
cases:0.71%
controls:0.26%
cases:0.17%
controls:0.03%
—
—
cases:0.66%
controls:0.02%
cases:1.69%
controls:0.25%
cases:2.60%
controls:0.73%
45
214
2928
29475
21
77
2952
29612
5
9
2968
29680
—
19
6
2855
29624
46
71
2677
28681
57
172
2132
23457
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
19230-2 [3014218]
7.7e-01
1.1e+00
2.1e+00
—
2.6e+00
1.2e+00
6.6e-01
cases:1.21%
controls:0.56%
cases:0.91%
controls:0.32%
cases:0.20%
controls:0.02%
—
—
cases:0.52%
controls:0.04%
cases:1.32%
controls:0.39%
cases:2.24%
controls:1.17%
36
167
2937
29522
27
94
2946
29595
6
7
2967
29682
—
15
12
2859
29618
36
112
2687
28640
49
276
2140
23353
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
182 [2001600181]
182 [2001600181]
1.6e+00
2.6e+00
—
—
1.0e+50
2.4e+00
1.9e+00
cases:0.30%
controls:0.06%
cases:0.27%
controls:0.02%
—
—
—
—
cases:0.21%
controls:0.00%
cases:0.29%
controls:0.03%
cases:0.55%
controls:0.08%
9
18
2964
29671
8
6
2965
29683
—
—
6
0
2868
29630
8
8
2715
28744
12
20
2177
23609
Psychiatry
26 [38004469]
26 [38004469]
7.5e-01
8.9e-01
9.1e-01
2.3e+00
1.3e+00
1.3e+00
9.5e-01
cases:6.79%
controls:3.34%
cases:3.63%
controls:1.53%
cases:1.45%
controls:0.59%
cases:0.50%
controls:0.05%
cases:2.09%
controls:0.57%
cases:5.36%
controls:1.54%
cases:7.95%
controls:3.24%
202
992
2771
28697
108
453
2865
29236
43
175
2930
29514
15
15
2958
29674
60
170
2814
29460
146
443
2577
28309
174
765
2015
22864
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
50949-7 [3029937]
2.9e-01
4.0e-01
1.1e+00
4.1e+00
1.5e+00
5.6e-01
4.3e-01
cases:7.57%
controls:5.77%
cases:4.64%
controls:3.16%
cases:1.38%
controls:0.46%
cases:0.98%
controls:0.02%
cases:2.23%
controls:0.50%
cases:5.80%
controls:3.39%
cases:13.11%
controls:8.90%
225
1713
2748
27976
138
937
2835
28752
41
136
2932
29553
29
5
2944
29684
64
147
2810
29483
158
974
2565
27778
287
2103
1902
21526
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
2.8e-01
4.0e-01
1.1e+00
4.3e+00
1.6e+00
4.5e-01
2.1e-01
cases:25.60%
controls:20.56%
cases:23.92%
controls:17.42%
cases:11.67%
controls:4.10%
cases:14.03%
controls:0.23%
cases:17.47%
controls:3.99%
cases:26.37%
controls:18.65%
cases:34.99%
controls:30.43%
761
6103
2212
23586
711
5173
2262
24516
347
1218
2626
28471
417
67
2556
29622
502
1182
2372
28448
718
5362
2005
23390
766
7190
1423
16439
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
24357-6 [3037467]
2.8e-01
4.9e-01
1.2e+00
4.0e+00
1.5e+00
5.5e-01
3.0e-01
cases:19.44%
controls:15.49%
cases:12.41%
controls:7.97%
cases:3.60%
controls:1.09%
cases:2.62%
controls:0.05%
cases:5.53%
controls:1.24%
cases:13.29%
controls:8.12%
cases:24.94%
controls:19.70%
578
4599
2395
25090
369
2367
2604
27322
107
325
2866
29364
78
15
2895
29674
159
368
2715
29262
362
2334
2361
26418
546
4654
1643
18975
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2514-8 [3035350]
2.5e-01
4.8e-01
1.2e+00
3.9e+00
1.6e+00
5.3e-01
3.6e-01
cases:11.47%
controls:9.18%
cases:8.48%
controls:5.43%
cases:2.56%
controls:0.77%
cases:1.68%
controls:0.03%
cases:4.14%
controls:0.89%
cases:9.73%
controls:5.96%
cases:21.56%
controls:16.09%
341
2726
2632
26963
252
1611
2721
28078
76
230
2897
29459
50
10
2923
29679
119
264
2755
29366
265
1715
2458
27037
472
3803
1717
19826
Differential panel - Cerebral spinal fluid
29584-0 [3016018]
29584-0 [3016018]
1.4e+00
2.8e+00
—
1.0e+50
—
2.5e+00
1.6e+00
cases:0.50%
controls:0.12%
cases:0.50%
controls:0.03%
—
—
cases:0.61%
controls:0.00%
—
—
cases:0.59%
controls:0.05%
cases:0.55%
controls:0.11%
15
36
2958
29653
15
9
2958
29680
—
18
0
2955
29689
—
16
14
2707
28738
12
27
2177
23602
Occupational Medicine Clinic/Center
261QX0100X [38004267]
261QX0100X [38004267]
1.5e+00
2.5e+00
—
—
—
2.9e+00
1.4e+00
cases:0.61%
controls:0.14%
cases:0.47%
controls:0.04%
—
—
—
—
—
—
cases:0.95%
controls:0.05%
cases:0.91%
controls:0.23%
18
42
2955
29647
14
11
2959
29678
—
—
—
26
15
2697
28737
20
54
2169
23575
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
25428-4 [3009261]
2.4e-01
4.9e-01
1.2e+00
3.9e+00
1.6e+00
5.1e-01
3.5e-01
cases:11.57%
controls:9.33%
cases:8.64%
controls:5.48%
cases:2.59%
controls:0.78%
cases:1.72%
controls:0.03%
cases:4.14%
controls:0.90%
cases:9.62%
controls:5.99%
cases:21.38%
controls:16.13%
344
2771
2629
26918
257
1628
2716
28061
77
233
2896
29456
51
10
2922
29679
119
267
2755
29363
262
1723
2461
27029
468
3812
1721
19817
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4537-7 [3013707]
2.3e-01
5.4e-01
1.1e+00
3.4e+00
2.4e+00
3.7e-01
2.4e-01
cases:20.11%
controls:16.63%
cases:13.89%
controls:8.61%
cases:3.46%
controls:1.18%
cases:1.24%
controls:0.04%
cases:11.55%
controls:1.18%
cases:12.16%
controls:8.75%
cases:25.95%
controls:21.58%
598
4936
2375
24753
413
2556
2560
27133
103
349
2870
29340
37
13
2936
29676
332
350
2542
29280
331
2517
2392
26235
568
5099
1621
18530
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
1.5e-01
2.3e-01
1.1e+00
4.6e+00
1.6e+00
3.6e-01
2.1e-01
cases:31.45%
controls:28.38%
cases:23.98%
controls:20.06%
cases:9.92%
controls:3.65%
cases:13.76%
controls:0.17%
cases:16.98%
controls:3.83%
cases:26.18%
controls:19.80%
cases:41.53%
controls:36.57%
935
8425
2038
21264
713
5955
2260
23734
295
1085
2678
28604
409
49
2564
29640
488
1134
2386
28496
713
5692
2010
23060
909
8640
1280
14989
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
5802-4 [3021601]
2.3e-01
4.5e-01
1.2e+00
3.9e+00
1.6e+00
5.2e-01
3.3e-01
cases:11.07%
controls:8.98%
cases:8.14%
controls:5.36%
cases:2.49%
controls:0.77%
cases:1.68%
controls:0.03%
cases:4.04%
controls:0.87%
cases:9.55%
controls:5.88%
cases:20.74%
controls:15.81%
329
2667
2644
27022
242
1590
2731
28099
74
230
2899
29459
50
10
2923
29679
116
257
2758
29373
260
1692
2463
27060
454
3736
1735
19893
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
54067-4 [3051552]
7.7e-01
1.1e+00
1.7e+00
—
3.0e+00
9.0e-01
6.6e-01
cases:2.05%
controls:0.96%
cases:1.11%
controls:0.38%
cases:0.27%
controls:0.05%
—
—
cases:0.77%
controls:0.04%
cases:1.18%
controls:0.48%
cases:2.92%
controls:1.53%
61
284
2912
29405
33
113
2940
29576
8
14
2965
29675
—
22
11
2852
29619
32
139
2691
28613
64
361
2125
23268
Orthostatic hypotension
I95.1 [45605872]
I95.1 [45605872]
1.1e+00
1.7e+00
—
1.0e+50
2.6e+00
1.9e+00
8.5e-01
cases:1.14%
controls:0.38%
cases:0.94%
controls:0.17%
—
—
cases:0.34%
controls:0.00%
cases:0.31%
controls:0.02%
cases:0.95%
controls:0.15%
cases:1.78%
controls:0.77%
34
112
2939
29577
28
50
2945
29639
—
10
0
2963
29689
9
7
2865
29623
26
42
2697
28710
39
182
2150
23447
12 lead EKG panel
34534-8 [3044889]
34534-8 [3044889]
2.9e-01
5.1e-01
1.2e+00
3.3e+00
1.9e+00
6.0e-01
3.9e-01
cases:21.33%
controls:16.81%
cases:14.26%
controls:9.09%
cases:3.09%
controls:0.99%
cases:1.11%
controls:0.04%
cases:6.44%
controls:1.06%
cases:14.73%
controls:8.64%
cases:29.42%
controls:22.02%
634
4992
2339
24697
424
2699
2549
26990
92
293
2881
29396
33
12
2940
29677
185
313
2689
29317
401
2485
2322
26267
644
5202
1545
18427
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
30350-3 [3004119]
7.1e-01
7.6e-01
2.3e+00
—
2.9e+00
9.4e-01
5.4e-01
cases:1.65%
controls:0.82%
cases:1.01%
controls:0.47%
cases:0.37%
controls:0.04%
—
—
cases:1.15%
controls:0.06%
cases:1.29%
controls:0.51%
cases:3.24%
controls:1.92%
49
243
2924
29446
30
141
2943
29548
11
11
2962
29678
—
33
19
2841
29611
35
146
2688
28606
71
454
2118
23175
Cardiology
6 [38004451]
6 [38004451]
3.2e-01
4.6e-01
7.0e-01
3.8e+00
1.5e+00
8.4e-01
4.9e-01
cases:15.30%
controls:11.55%
cases:8.58%
controls:5.59%
cases:1.92%
controls:0.96%
cases:0.91%
controls:0.02%
cases:3.93%
controls:0.89%
cases:12.12%
controls:5.63%
cases:20.37%
controls:13.52%
455
3429
2518
26260
255
1660
2718
28029
57
286
2916
29403
27
6
2946
29683
113
264
2761
29366
330
1620
2393
27132
446
3195
1743
20434
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
1.2e-01
2.6e-01
1.1e+00
4.5e+00
1.6e+00
4.0e-01
2.0e-01
cases:34.78%
controls:32.14%
cases:33.17%
controls:27.65%
cases:16.18%
controls:6.07%
cases:20.96%
controls:0.30%
cases:24.77%
controls:5.97%
cases:37.94%
controls:28.99%
cases:49.75%
controls:44.78%
1034
9542
1939
20147
986
8210
1987
21479
481
1802
2492
27887
623
89
2350
29600
712
1768
2162
27862
1033
8334
1690
20418
1089
10581
1100
13048
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2075-0 [3014576]
7.3e-01
8.3e-01
1.8e+00
—
3.0e+00
9.9e-01
6.9e-01
cases:3.30%
controls:1.61%
cases:2.09%
controls:0.92%
cases:0.54%
controls:0.09%
—
—
cases:1.95%
controls:0.10%
cases:2.72%
controls:1.03%
cases:6.40%
controls:3.31%
98
478
2875
29211
62
272
2911
29417
16
26
2957
29663
—
56
29
2818
29601
74
295
2649
28457
140
782
2049
22847
Syncope and collapse
R55 [45568141]
R55 [45568141]
6.4e-01
1.2e+00
2.4e+00
—
2.2e+00
9.6e-01
7.1e-01
cases:2.39%
controls:1.27%
cases:1.35%
controls:0.42%
cases:0.37%
controls:0.03%
—
—
cases:0.45%
controls:0.05%
cases:1.51%
controls:0.58%
cases:3.70%
controls:1.85%
71
377
2902
29312
40
126
2933
29563
11
10
2962
29679
—
13
15
2861
29615
41
167
2682
28585
81
438
2108
23191
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
40987-0 [3043924]
7.2e-01
9.5e-01
2.7e+00
—
1.9e+00
8.4e-01
8.8e-01
cases:2.39%
controls:1.18%
cases:1.85%
controls:0.72%
cases:0.98%
controls:0.06%
—
—
cases:0.73%
controls:0.11%
cases:2.02%
controls:0.88%
cases:6.76%
controls:2.91%
71
351
2902
29338
55
214
2918
29475
29
19
2944
29670
—
21
34
2853
29596
55
254
2668
28498
148
688
2041
22941
Epilepsy and comparable convulsive disorders
111 [2001600111]
111 [2001600111]
1.0e+00
2.5e+00
—
—
—
2.6e+00
1.9e+00
cases:0.54%
controls:0.20%
cases:0.44%
controls:0.04%
—
—
—
—
—
—
cases:0.62%
controls:0.05%
cases:1.51%
controls:0.22%
16
58
2957
29631
13
11
2960
29678
—
—
—
17
14
2706
28738
33
53
2156
23576
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
10839-9 [3021337]
7.1e-01
1.0e+00
2.1e+00
—
2.5e+00
9.8e-01
5.8e-01
cases:6.79%
controls:3.46%
cases:4.88%
controls:1.83%
cases:1.78%
controls:0.22%
—
—
cases:2.92%
controls:0.24%
cases:4.59%
controls:1.78%
cases:8.86%
controls:5.17%
202
1026
2771
28663
145
542
2828
29147
53
65
2920
29624
—
84
70
2790
29560
125
511
2598
28241
194
1221
1995
22408
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
7.7e-01
9.1e-01
1.7e+00
1.0e+50
2.7e+00
1.0e+00
8.9e-01
cases:8.38%
controls:4.07%
cases:4.14%
controls:1.70%
cases:1.11%
controls:0.21%
cases:4.41%
controls:0.00%
cases:2.30%
controls:0.17%
cases:3.71%
controls:1.35%
cases:9.27%
controls:4.04%
249
1209
2724
28480
123
506
2850
29183
33
63
2940
29626
131
0
2842
29689
66
49
2808
29581
101
387
2622
28365
203
954
1986
22675
Leukocytes [#/volume] in Cerebral spinal fluid
26465-5 [3016543]
26465-5 [3016543]
1.5e+00
2.8e+00
—
1.0e+50
1.0e+50
2.4e+00
1.2e+00
cases:0.94%
controls:0.20%
cases:0.91%
controls:0.06%
—
—
cases:0.77%
controls:0.00%
cases:1.36%
controls:0.00%
cases:0.92%
controls:0.09%
cases:0.87%
controls:0.26%
28
60
2945
29629
27
17
2946
29672
—
23
0
2950
29689
39
0
2835
29630
25
25
2698
28727
19
61
2170
23568
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
40982-1 [3038288]
7.6e-01
9.4e-01
2.6e+00
—
1.8e+00
8.9e-01
9.4e-01
cases:2.52%
controls:1.19%
cases:1.78%
controls:0.70%
cases:0.84%
controls:0.06%
—
—
cases:0.59%
controls:0.10%
cases:1.95%
controls:0.81%
cases:6.76%
controls:2.75%
75
354
2898
29335
53
208
2920
29481
25
19
2948
29670
—
17
30
2857
29600
53
233
2670
28519
148
650
2041
22979
Erythrocytes [#/volume] in Cerebral spinal fluid
26454-9 [3027475]
26454-9 [3027475]
1.5e+00
2.8e+00
—
1.0e+50
1.0e+50
2.3e+00
1.2e+00
cases:0.94%
controls:0.20%
cases:0.91%
controls:0.06%
—
—
cases:0.77%
controls:0.00%
cases:1.36%
controls:0.00%
cases:0.92%
controls:0.09%
cases:0.87%
controls:0.27%
28
60
2945
29629
27
17
2946
29672
—
23
0
2950
29689
39
0
2835
29630
25
26
2698
28726
19
63
2170
23566
Paraesthesia of skin
R20.2 [45568120]
R20.2 [45568120]
1.0e+00
1.6e+00
2.1e+00
1.0e+50
2.3e+00
1.6e+00
1.2e+00
cases:1.31%
controls:0.47%
cases:0.74%
controls:0.14%
cases:0.17%
controls:0.02%
cases:0.61%
controls:0.00%
cases:0.28%
controls:0.03%
cases:0.81%
controls:0.17%
cases:2.01%
controls:0.60%
39
139
2934
29550
22
43
2951
29646
5
6
2968
29683
18
0
2955
29689
8
8
2866
29622
22
48
2701
28704
44
141
2145
23488
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
9.7e-02
2.5e-01
1.0e+00
4.4e+00
1.5e+00
3.4e-01
1.7e-01
cases:35.82%
controls:33.64%
cases:34.51%
controls:29.18%
cases:16.68%
controls:6.64%
cases:21.26%
controls:0.32%
cases:24.91%
controls:6.59%
cases:38.27%
controls:30.54%
cases:50.48%
controls:46.30%
1065
9986
1908
19703
1026
8664
1947
21025
496
1970
2477
27719
632
94
2341
29595
716
1954
2158
27676
1042
8782
1681
19970
1105
10941
1084
12688
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
6968-2 [3009445]
3.0e-01
9.1e-01
2.6e+00
—
2.9e+00
1.3e+00
1.4e-01
cases:0.77%
controls:0.58%
cases:0.71%
controls:0.29%
cases:0.37%
controls:0.03%
—
—
cases:0.63%
controls:0.03%
cases:0.66%
controls:0.18%
cases:0.82%
controls:0.72%
23
171
2950
29518
21
85
2952
29604
11
8
2962
29681
—
18
10
2856
29620
18
51
2705
28701
18
169
2171
23460
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
9.8e-02
2.5e-01
1.0e+00
4.4e+00
1.5e+00
3.4e-01
1.7e-01
cases:35.82%
controls:33.61%
cases:34.48%
controls:29.15%
cases:16.62%
controls:6.63%
cases:21.22%
controls:0.32%
cases:24.84%
controls:6.58%
cases:38.23%
controls:30.51%
cases:50.48%
controls:46.27%
1065
9979
1908
19710
1025
8655
1948
21034
494
1967
2479
27722
631
94
2342
29595
714
1951
2160
27679
1041
8771
1682
19981
1105
10933
1084
12696
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
9.7e-02
2.5e-01
1.0e+00
4.4e+00
1.5e+00
3.4e-01
1.7e-01
cases:35.82%
controls:33.63%
cases:34.54%
controls:29.18%
cases:16.62%
controls:6.63%
cases:21.26%
controls:0.32%
cases:24.84%
controls:6.59%
cases:38.27%
controls:30.55%
cases:50.48%
controls:46.30%
1065
9984
1908
19705
1027
8664
1946
21025
494
1969
2479
27720
632
94
2341
29595
714
1952
2160
27678
1042
8784
1681
19968
1105
10941
1084
12688
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
9.7e-02
2.5e-01
1.0e+00
4.4e+00
1.5e+00
3.4e-01
1.7e-01
cases:35.82%
controls:33.64%
cases:34.54%
controls:29.16%
cases:16.58%
controls:6.62%
cases:21.22%
controls:0.32%
cases:24.84%
controls:6.59%
cases:38.27%
controls:30.53%
cases:50.43%
controls:46.29%
1065
9986
1908
19703
1027
8657
1946
21032
493
1966
2480
27723
631
94
2342
29595
714
1952
2160
27678
1042
8779
1681
19973
1104
10938
1085
12691
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
9.5e-02
2.5e-01
1.0e+00
4.4e+00
1.5e+00
3.4e-01
1.7e-01
cases:35.82%
controls:33.67%
cases:34.58%
controls:29.21%
cases:16.62%
controls:6.65%
cases:21.26%
controls:0.32%
cases:24.88%
controls:6.60%
cases:38.30%
controls:30.59%
cases:50.48%
controls:46.34%
1065
9996
1908
19693
1028
8673
1945
21016
494
1974
2479
27715
632
94
2341
29595
715
1956
2159
27674
1043
8794
1680
19958
1105
10949
1084
12680
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
9.7e-02
2.5e-01
1.0e+00
4.4e+00
1.5e+00
3.5e-01
1.7e-01
cases:35.76%
controls:33.57%
cases:34.51%
controls:29.15%
cases:16.62%
controls:6.62%
cases:21.22%
controls:0.32%
cases:24.84%
controls:6.58%
cases:38.27%
controls:30.50%
cases:50.48%
controls:46.25%
1063
9966
1910
19723
1026
8655
1947
21034
494
1966
2479
27723
631
95
2342
29594
714
1951
2160
27679
1042
8768
1681
19984
1105
10929
1084
12700
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
9.6e-02
2.5e-01
1.0e+00
4.4e+00
1.5e+00
3.4e-01
1.7e-01
cases:35.82%
controls:33.65%
cases:34.54%
controls:29.21%
cases:16.55%
controls:6.63%
cases:21.22%
controls:0.32%
cases:24.81%
controls:6.60%
cases:38.23%
controls:30.58%
cases:50.53%
controls:46.33%
1065
9989
1908
19700
1027
8672
1946
21017
492
1968
2481
27721
631
94
2342
29595
713
1956
2161
27674
1041
8792
1682
19960
1106
10947
1083
12682
Migraine with aura [classical migraine]
G43.1 [45562086]
G43.1 [45562086]
1.1e+00
1.6e+00
—
—
2.3e+00
1.6e+00
1.1e+00
cases:1.08%
controls:0.36%
cases:0.64%
controls:0.12%
—
—
—
—
cases:0.24%
controls:0.02%
cases:0.70%
controls:0.15%
cases:1.42%
controls:0.47%
32
108
2941
29581
19
37
2954
29652
—
—
7
7
2867
29623
19
42
2704
28710
31
110
2158
23519
Cell count panel - Cerebral spinal fluid
34563-7 [3044290]
34563-7 [3044290]
1.2e+00
2.9e+00
—
1.0e+50
—
2.5e+00
1.1e+00
cases:0.77%
controls:0.23%
cases:0.91%
controls:0.05%
—
—
cases:0.74%
controls:0.00%
—
—
cases:0.92%
controls:0.08%
cases:0.69%
controls:0.22%
23
67
2950
29622
27
15
2946
29674
—
22
0
2951
29689
—
25
22
2698
28730
15
53
2174
23576
Respiratory and circulatory monitoring
WX700 [2001310817]
WX700 [2001310817]
6.5e-01
1.1e+00
1.6e+00
—
2.5e+00
1.0e+00
8.6e-01
cases:3.87%
controls:2.06%
cases:1.72%
controls:0.59%
cases:0.40%
controls:0.08%
—
—
cases:0.56%
controls:0.04%
cases:1.69%
controls:0.60%
cases:4.93%
controls:2.15%
115
611
2858
29078
51
176
2922
29513
12
25
2961
29664
—
16
13
2858
29617
46
172
2677
28580
108
509
2081
23120
Physiotherapist
Z3226 [2001311560]
Z3226 [2001311560]
7.3e-01
1.0e+00
1.6e+00
1.0e+50
2.5e+00
1.1e+00
7.8e-01
cases:4.10%
controls:2.01%
cases:1.55%
controls:0.58%
cases:0.34%
controls:0.07%
cases:1.72%
controls:0.00%
cases:0.94%
controls:0.08%
cases:1.54%
controls:0.50%
cases:3.43%
controls:1.60%
122
597
2851
29092
46
171
2927
29518
10
20
2963
29669
51
0
2922
29689
27
24
2847
29606
42
144
2681
28608
75
378
2114
23251
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
2705-2 [3024354]
7.7e-01
7.5e-01
1.9e+00
—
2.7e+00
9.3e-01
6.6e-01
cases:2.19%
controls:1.02%
cases:1.28%
controls:0.61%
cases:0.37%
controls:0.06%
—
—
cases:1.18%
controls:0.08%
cases:1.73%
controls:0.69%
cases:4.43%
controls:2.35%
65
303
2908
29386
38
181
2935
29508
11
17
2962
29672
—
34
23
2840
29607
47
197
2676
28555
97
555
2092
23074
Otolaryngology
4 [38004449]
4 [38004449]
4.0e-01
4.5e-01
8.1e-01
3.4e+00
1.6e+00
6.8e-01
3.6e-01
cases:16.78%
controls:11.91%
cases:7.00%
controls:4.56%
cases:1.65%
controls:0.74%
cases:1.38%
controls:0.05%
cases:3.51%
controls:0.73%
cases:8.81%
controls:4.68%
cases:17.27%
controls:12.68%
499
3537
2474
26152
208
1355
2765
28334
49
219
2924
29470
41
14
2932
29675
101
216
2773
29414
240
1345
2483
27407
378
2997
1811
20632
Glucose [Moles/volume] in Cerebral spinal fluid
14744-7 [3020044]
14744-7 [3020044]
1.3e+00
2.8e+00
—
1.0e+50
—
2.3e+00
1.3e+00
cases:0.74%
controls:0.21%
cases:0.98%
controls:0.06%
—
—
cases:0.81%
controls:0.00%
—
—
cases:0.88%
controls:0.09%
cases:0.96%
controls:0.28%
22
61
2951
29628
29
17
2944
29672
—
24
0
2949
29689
—
24
26
2699
28726
21
65
2168
23564
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 [3001334]
5128-4 [3001334]
2.4e-01
9.3e-01
3.0e+00
—
3.1e+00
1.5e+00
4.2e-02
cases:0.67%
controls:0.53%
cases:0.54%
controls:0.21%
cases:0.34%
controls:0.02%
—
—
cases:0.63%
controls:0.03%
cases:0.55%
controls:0.12%
cases:0.64%
controls:0.61%
20
158
2953
29531
16
63
2957
29626
10
5
2963
29684
—
18
8
2856
29622
15
35
2708
28717
14
145
2175
23484
Bacteria identified in Cerebral spinal fluid by Culture
606-4 [3016914]
606-4 [3016914]
1.5e+00
3.3e+00
1.0e+50
1.0e+50
—
2.8e+00
8.8e-01
cases:0.44%
controls:0.10%
cases:0.47%
controls:0.02%
cases:0.24%
controls:0.00%
cases:0.27%
controls:0.00%
—
—
cases:0.29%
controls:0.02%
cases:0.27%
controls:0.11%
13
30
2960
29659
14
5
2959
29684
7
0
2966
29689
8
0
2965
29689
—
8
5
2715
28747
6
27
2183
23602
Lupus anticoagulant assay
63300003 [4268621]
63300003 [4268621]
1.1e+00
2.2e+00
—
—
—
3.3e+00
2.1e+00
cases:0.30%
controls:0.10%
cases:0.34%
controls:0.04%
—
—
—
—
—
—
cases:0.66%
controls:0.02%
cases:0.69%
controls:0.08%
9
31
2964
29658
10
11
2963
29678
—
—
—
18
7
2705
28745
15
20
2174
23609
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
20454-5 [3014051]
2.9e-01
5.6e-01
1.3e+00
3.7e+00
1.6e+00
4.1e-01
1.5e-01
cases:4.61%
controls:3.50%
cases:3.87%
controls:2.25%
cases:1.18%
controls:0.31%
cases:0.71%
controls:0.02%
cases:1.81%
controls:0.38%
cases:3.82%
controls:2.58%
cases:8.50%
controls:7.42%
137
1039
2836
28650
115
668
2858
29021
35
93
2938
29596
21
5
2952
29684
52
114
2822
29516
104
741
2619
28011
186
1754
2003
21875
Cholesterol in HDL [Moles/volume] in Serum or Plasma
14646-4 [3023602]
14646-4 [3023602]
6.7e-02
2.8e-01
8.2e-01
3.5e+00
2.4e+00
4.2e-01
1.5e-01
cases:26.54%
controls:25.26%
cases:18.90%
controls:14.99%
cases:3.83%
controls:1.72%
cases:1.85%
controls:0.06%
cases:15.59%
controls:1.72%
cases:21.74%
controls:15.47%
cases:37.64%
controls:34.09%
789
7500
2184
22189
562
4451
2411
25238
114
512
2859
29177
55
17
2918
29672
448
511
2426
29119
592
4449
2131
24303
824
8054
1365
15575
Triglyceride [Moles/volume] in Serum or Plasma --fasting
47210-0 [3048773]
47210-0 [3048773]
6.4e-02
2.2e-01
7.4e-01
3.5e+00
2.5e+00
3.7e-01
1.7e-01
cases:25.40%
controls:24.20%
cases:15.57%
controls:12.85%
cases:2.93%
controls:1.42%
cases:1.68%
controls:0.05%
cases:14.34%
controls:1.37%
cases:17.30%
controls:12.67%
cases:33.26%
controls:29.50%
755
7186
2218
22503
463
3815
2510
25874
87
421
2886
29268
50
15
2923
29674
412
406
2462
29224
471
3643
2252
25109
728
6971
1461
16658
Protein [Mass/volume] in Cerebral spinal fluid
2880-3 [3019473]
2880-3 [3019473]
1.2e+00
2.8e+00
—
1.0e+50
—
2.3e+00
1.1e+00
cases:0.87%
controls:0.25%
cases:1.14%
controls:0.07%
—
—
cases:0.87%
controls:0.00%
—
—
cases:0.95%
controls:0.10%
cases:0.96%
controls:0.31%
26
75
2947
29614
34
20
2939
29669
—
26
0
2947
29689
—
26
28
2697
28724
21
74
2168
23555
Recurrent depression, moderate episode without somatic syndrome
F33.10 [2000501984]
F33.10 [2000501984]
1.1e+00
1.6e+00
2.1e+00
—
1.7e+00
1.4e+00
1.3e+00
cases:0.81%
controls:0.28%
cases:0.64%
controls:0.12%
cases:0.37%
controls:0.05%
—
—
cases:0.21%
controls:0.04%
cases:0.59%
controls:0.14%
cases:1.05%
controls:0.28%
24
83
2949
29606
19
37
2954
29652
11
14
2962
29675
—
6
11
2868
29619
16
41
2707
28711
23
67
2166
23562
Assessment of need for aid
SPAT1229 [2001700330]
SPAT1229 [2001700330]
5.1e-01
8.7e-01
2.0e+00
—
2.3e+00
1.3e+00
9.5e-01
cases:1.61%
controls:0.97%
cases:0.77%
controls:0.33%
cases:0.20%
controls:0.03%
—
—
cases:0.45%
controls:0.04%
cases:1.43%
controls:0.39%
cases:3.20%
controls:1.26%
48
289
2925
29400
23
97
2950
29592
6
8
2967
29681
—
13
13
2861
29617
39
111
2684
28641
70
297
2119
23332
Asthma, unspecified
J45.9 [45562456]
J45.9 [45562456]
3.2e-01
3.4e-01
1.1e+00
3.7e+00
1.3e+00
6.1e-01
3.9e-01
cases:4.31%
controls:3.15%
cases:2.19%
controls:1.57%
cases:0.94%
controls:0.30%
cases:1.35%
controls:0.03%
cases:1.18%
controls:0.32%
cases:3.08%
controls:1.70%
cases:5.66%
controls:3.89%
128
935
2845
28754
65
465
2908
29224
28
90
2945
29599
40
10
2933
29679
34
96
2840
29534
84
489
2639
28263
124
919
2065
22710
Speech therapy
R4130 [2001310235]
R4130 [2001310235]
2.0e+00
1.9e+00
—
1.0e+50
—
2.2e+00
1.4e+00
cases:0.57%
controls:0.08%
cases:0.27%
controls:0.04%
—
—
cases:0.57%
controls:0.00%
—
—
cases:0.51%
controls:0.06%
cases:0.73%
controls:0.19%
17
23
2956
29666
8
12
2965
29677
—
17
0
2956
29689
—
14
17
2709
28735
16
44
2173
23585
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
2601-3 [3012095]
6.4e-01
8.9e-01
1.6e+00
1.0e+50
2.8e+00
8.4e-01
6.7e-01
cases:3.97%
controls:2.13%
cases:2.46%
controls:1.02%
cases:0.81%
controls:0.16%
cases:0.50%
controls:0.00%
cases:2.54%
controls:0.16%
cases:2.39%
controls:1.04%
cases:5.98%
controls:3.14%
118
631
2855
29058
73
304
2900
29385
24
48
2949
29641
15
0
2958
29689
73
48
2801
29582
65
300
2658
28452
131
742
2058
22887
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
3016-3 [3009201]
1.6e-01
4.3e-01
1.0e+00
3.2e+00
2.1e+00
3.6e-01
2.3e-01
cases:26.00%
controls:23.04%
cases:19.98%
controls:14.03%
cases:4.51%
controls:1.71%
cases:1.35%
controls:0.06%
cases:12.73%
controls:1.78%
cases:19.13%
controls:14.19%
cases:36.73%
controls:31.55%
773
6840
2200
22849
594
4164
2379
25525
134
508
2839
29181
40
17
2933
29672
366
527
2508
29103
521
4080
2202
24672
804
7454
1385
16175
Cholesterol [Moles/volume] in Serum or Plasma
14647-2 [3019900]
14647-2 [3019900]
6.6e-02
2.8e-01
8.0e-01
3.4e+00
2.3e+00
3.9e-01
1.6e-01
cases:27.11%
controls:25.82%
cases:19.71%
controls:15.64%
cases:3.94%
controls:1.81%
cases:1.85%
controls:0.06%
cases:15.80%
controls:1.79%
cases:22.37%
controls:16.29%
cases:38.65%
controls:34.96%
806
7665
2167
22024
586
4643
2387
25046
117
538
2856
29151
55
18
2918
29671
454
530
2420
29100
609
4683
2114
24069
846
8260
1343
15369
DNA double strand Ab [Units/volume] in Serum
5130-0 [3023420]
5130-0 [3023420]
4.2e-01
1.3e+00
2.1e+00
—
2.6e+00
1.4e+00
1.2e-01
cases:0.77%
controls:0.51%
cases:0.67%
controls:0.19%
cases:0.27%
controls:0.03%
—
—
cases:0.56%
controls:0.04%
cases:0.70%
controls:0.17%
cases:0.73%
controls:0.65%
23
152
2950
29537
20
57
2953
29632
8
10
2965
29679
—
16
12
2858
29618
19
50
2704
28702
16
153
2173
23476
Cholesterol in LDL [Moles/volume] in Serum or Plasma
22748-8 [3001308]
22748-8 [3001308]
9.2e-02
3.0e-01
8.3e-01
3.4e+00
2.2e+00
4.2e-01
2.1e-01
cases:29.10%
controls:27.23%
cases:22.91%
controls:18.03%
cases:4.78%
controls:2.13%
cases:1.85%
controls:0.06%
cases:16.08%
controls:2.09%
cases:26.29%
controls:18.96%
cases:42.80%
controls:37.82%
865
8083
2108
21606
681
5353
2292
24336
142
633
2831
29056
55
19
2918
29670
462
620
2412
29010
716
5452
2007
23300
937
8936
1252
14693
Outpatient Visit
OP [9202]
OP [9202]
3.5e-01
3.9e-01
5.1e-01
3.7e+00
9.1e-01
8.5e-01
5.9e-01
cases:76.15%
controls:69.34%
cases:59.77%
controls:50.19%
cases:16.15%
controls:10.33%
cases:17.32%
controls:0.50%
cases:22.55%
controls:10.49%
cases:70.07%
controls:49.94%
cases:85.11%
controls:76.03%
2264
20586
709
9103
1777
14902
1196
14787
480
3068
2493
26621
515
149
2458
29540
648
3108
2226
26522
1908
14359
815
14393
1863
17964
326
5665
Base excess in Venous blood by calculation
1927-3 [3002032]
1927-3 [3002032]
7.6e-01
5.6e-01
2.0e+00
—
2.6e+00
8.1e-01
6.5e-01
cases:2.59%
controls:1.22%
cases:1.51%
controls:0.87%
cases:0.61%
controls:0.08%
—
—
cases:1.50%
controls:0.12%
cases:1.98%
controls:0.89%
cases:5.16%
controls:2.76%
77
363
2896
29326
45
258
2928
29431
18
25
2955
29664
—
43
35
2831
29595
54
256
2669
28496
113
652
2076
22977
Type 1 diabetes mellitus, With multiple complications
E10.7 [45571655]
E10.7 [45571655]
1.0e+00
1.2e+00
1.7e+00
—
2.2e+00
1.2e+00
7.4e-01
cases:0.91%
controls:0.33%
cases:0.74%
controls:0.22%
cases:0.37%
controls:0.07%
—
—
cases:0.52%
controls:0.06%
cases:0.77%
controls:0.24%
cases:0.91%
controls:0.44%
27
97
2946
29592
22
65
2951
29624
11
20
2962
29669
—
15
18
2859
29612
21
68
2702
28684
20
104
2169
23525
Care involving use of rehabilitation procedure, unspecified
Z50.9 [45595525]
Z50.9 [45595525]
8.9e-01
1.3e+00
—
—
2.0e+00
1.6e+00
1.5e+00
cases:0.74%
controls:0.31%
cases:0.47%
controls:0.13%
—
—
—
—
cases:0.21%
controls:0.03%
cases:0.59%
controls:0.12%
cases:1.74%
controls:0.41%
22
91
2951
29598
14
40
2959
29649
—
—
6
8
2868
29622
16
34
2707
28718
38
97
2151
23532
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
1963-8 [3016293]
5.2e-01
8.0e-01
2.2e+00
—
2.4e+00
1.2e+00
6.8e-01
cases:0.98%
controls:0.58%
cases:0.74%
controls:0.33%
cases:0.24%
controls:0.03%
—
—
cases:0.38%
controls:0.03%
cases:1.03%
controls:0.32%
cases:2.10%
controls:1.07%
29
173
2944
29516
22
99
2951
29590
7
8
2966
29681
—
11
10
2863
29620
28
93
2695
28659
46
254
2143
23375
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
2021-4 [3021447]
7.8e-01
6.5e-01
1.9e+00
—
2.5e+00
7.8e-01
6.5e-01
cases:2.59%
controls:1.21%
cases:1.58%
controls:0.84%
cases:0.54%
controls:0.08%
—
—
cases:1.50%
controls:0.12%
cases:1.98%
controls:0.91%
cases:5.25%
controls:2.81%
77
359
2896
29330
47
248
2926
29441
16
25
2957
29664
—
43
36
2831
29594
54
263
2669
28489
115
664
2074
22965
Complement C3 [Mass/volume] in Serum or Plasma
4485-9 [3000620]
4485-9 [3000620]
5.7e-01
1.1e+00
2.0e+00
—
2.8e+00
1.2e+00
7.7e-02
cases:0.67%
controls:0.38%
cases:0.50%
controls:0.17%
cases:0.27%
controls:0.04%
—
—
cases:0.52%
controls:0.03%
cases:0.48%
controls:0.14%
cases:0.55%
controls:0.51%
20
113
2953
29576
15
49
2958
29640
8
11
2965
29678
—
15
9
2859
29621
13
40
2710
28712
12
120
2177
23509
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 [3023081]
20563-3 [3023081]
9.4e-01
9.1e-01
2.6e+00
—
2.7e+00
7.0e-01
3.7e-01
cases:1.31%
controls:0.52%
cases:0.67%
controls:0.27%
cases:0.27%
controls:0.02%
—
—
cases:0.52%
controls:0.03%
cases:0.62%
controls:0.31%
cases:1.92%
controls:1.33%
39
153
2934
29536
20
81
2953
29608
8
6
2965
29683
—
15
10
2859
29620
17
89
2706
28663
42
314
2147
23315
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
2614-6 [3007930]
8.9e-01
8.9e-01
2.6e+00
—
2.8e+00
8.1e-01
3.1e-01
cases:1.21%
controls:0.50%
cases:0.67%
controls:0.28%
cases:0.27%
controls:0.02%
—
—
cases:0.49%
controls:0.03%
cases:0.62%
controls:0.28%
cases:1.74%
controls:1.28%
36
149
2937
29540
20
82
2953
29607
8
6
2965
29683
—
14
9
2860
29621
17
80
2706
28672
38
303
2151
23326
Normal-pressure hydrocephalus
G91.2 [45547765]
G91.2 [45547765]
1.1e+00
1.1e+00
—
1.0e+50
2.3e+00
2.0e+00
1.7e+00
cases:0.50%
controls:0.17%
cases:0.24%
controls:0.08%
—
—
cases:0.27%
controls:0.00%
cases:0.17%
controls:0.02%
cases:0.40%
controls:0.06%
cases:0.78%
controls:0.14%
15
50
2958
29639
7
24
2966
29665
—
8
0
2965
29689
5
5
2869
29625
11
16
2712
28736
17
33
2172
23596
Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7817-0 [3016888]
7817-0 [3016888]
7.6e-01
1.4e+00
—
1.0e+50
4.0e+00
9.9e-01
5.4e-01
cases:1.75%
controls:0.82%
cases:1.04%
controls:0.26%
—
—
cases:0.17%
controls:0.00%
cases:0.87%
controls:0.02%
cases:0.66%
controls:0.25%
cases:1.51%
controls:0.88%
52
244
2921
29445
31
76
2942
29613
—
5
0
2968
29689
25
5
2849
29625
18
71
2705
28681
33
209
2156
23420
pH of Venous blood
2746-6 [3012544]
2746-6 [3012544]
6.9e-01
6.0e-01
2.0e+00
—
2.5e+00
6.9e-01
6.7e-01
cases:2.49%
controls:1.27%
cases:1.58%
controls:0.88%
cases:0.61%
controls:0.08%
—
—
cases:1.46%
controls:0.12%
cases:1.80%
controls:0.91%
cases:5.44%
controls:2.86%
74
377
2899
29312
47
260
2926
29429
18
25
2955
29664
—
42
37
2832
29593
49
262
2674
28490
119
675
2070
22954
Geriatric Medicine
38 [38004478]
38 [38004478]
3.8e-01
9.9e-01
2.2e+00
1.0e+50
2.1e+00
1.2e+00
4.9e-01
cases:1.48%
controls:1.01%
cases:1.48%
controls:0.55%
cases:0.74%
controls:0.08%
cases:1.48%
controls:0.00%
cases:0.63%
controls:0.07%
cases:2.09%
controls:0.62%
cases:3.11%
controls:1.93%
44
301
2929
29388
44
164
2929
29525
22
24
2951
29665
44
0
2929
29689
18
22
2856
29608
57
177
2666
28575
68
456
2121
23173
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
2.9e-02
1.6e-01
1.0e+00
4.2e+00
1.4e+00
3.0e-01
1.0e-01
cases:22.64%
controls:22.13%
cases:22.03%
controls:19.41%
cases:10.73%
controls:4.25%
cases:12.51%
controls:0.22%
cases:15.45%
controls:4.14%
cases:26.07%
controls:20.71%
cases:35.40%
controls:33.13%
673
6569
2300
23120
655
5764
2318
23925
319
1263
2654
28426
372
65
2601
29624
444
1227
2430
28403
710
5955
2013
22797
775
7829
1414
15800
Malaise and fatigue
R53 [45553741]
R53 [45553741]
7.2e-01
1.1e+00
2.0e+00
—
1.4e+00
1.0e+00
7.4e-01
cases:5.21%
controls:2.61%
cases:3.53%
controls:1.20%
cases:1.14%
controls:0.15%
—
—
cases:0.63%
controls:0.15%
cases:3.71%
controls:1.33%
cases:9.27%
controls:4.66%
155
776
2818
28913
105
355
2868
29334
34
45
2939
29644
—
18
45
2856
29585
101
383
2622
28369
203
1101
1986
22528
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]
4498-2 [3017766]
5.5e-01
1.1e+00
1.9e+00
—
2.8e+00
1.2e+00
4.1e-02
cases:0.64%
controls:0.37%
cases:0.47%
controls:0.17%
cases:0.24%
controls:0.03%
—
—
cases:0.52%
controls:0.03%
cases:0.48%
controls:0.14%
cases:0.50%
controls:0.48%
19
110
2954
29579
14
49
2959
29640
7
10
2966
29679
—
15
9
2859
29621
13
41
2710
28711
11
114
2178
23515
Occupational therapy
R4120 [2001310234]
R4120 [2001310234]
1.4e+00
2.1e+00
—
1.0e+50
—
2.3e+00
1.2e+00
cases:1.51%
controls:0.37%
cases:1.01%
controls:0.12%
—
—
cases:2.52%
controls:0.00%
—
—
cases:0.99%
controls:0.10%
cases:1.14%
controls:0.35%
45
109
2928
29580
30
37
2943
29652
—
75
0
2898
29689
—
27
28
2696
28724
25
83
2164
23546
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
2.4e-01
3.2e-01
7.9e-01
3.7e+00
1.3e+00
3.5e-01
3.3e-01
cases:9.55%
controls:7.65%
cases:8.27%
controls:6.16%
cases:3.23%
controls:1.49%
cases:2.56%
controls:0.07%
cases:4.77%
controls:1.35%
cases:9.29%
controls:6.73%
cases:16.31%
controls:12.27%
284
2270
2689
27419
246
1828
2727
27861
96
442
2877
29247
76
20
2897
29669
137
399
2737
29231
253
1935
2470
26817
357
2900
1832
20729
Short blood count panel - Blood
55429-5 [40758558]
55429-5 [40758558]
4.1e-01
5.8e-01
4.8e-01
3.6e+00
1.2e+00
6.5e-01
5.7e-01
cases:6.53%
controls:4.42%
cases:4.27%
controls:2.43%
cases:0.98%
controls:0.61%
cases:0.61%
controls:0.02%
cases:1.77%
controls:0.55%
cases:4.85%
controls:2.60%
cases:10.23%
controls:6.06%
194
1312
2779
28377
127
721
2846
28968
29
180
2944
29509
18
5
2955
29684
51
162
2823
29468
132
747
2591
28005
224
1433
1965
22196
Complex partial seizures with only alteration of consciousness
G40.20 [2000502139]
G40.20 [2000502139]
1.8e+00
2.3e+00
—
—
—
2.2e+00
2.5e+00
cases:0.20%
controls:0.03%
cases:0.20%
controls:0.02%
—
—
—
—
—
—
cases:0.22%
controls:0.02%
cases:0.55%
controls:0.05%
6
10
2967
29679
6
6
2967
29683
—
—
—
6
7
2717
28745
12
11
2177
23618
Hemoglobin A1c/Hemoglobin.total in Blood
4548-4 [3004410]
4548-4 [3004410]
1.2e-01
3.1e-01
7.3e-01
3.4e+00
2.0e+00
2.9e-01
2.4e-01
cases:25.70%
controls:23.49%
cases:20.89%
controls:16.24%
cases:4.24%
controls:2.10%
cases:1.58%
controls:0.05%
cases:14.06%
controls:2.13%
cases:21.30%
controls:16.81%
cases:39.65%
controls:34.05%
764
6973
2209
22716
621
4822
2352
24867
126
623
2847
29066
47
16
2926
29673
404
632
2470
28998
580
4833
2143
23919
868
8046
1321
15583
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
19232-8 [3007628]
9.1e-01
6.3e-01
2.3e+00
1.0e+50
1.9e+00
9.1e-01
9.2e-01
cases:1.28%
controls:0.52%
cases:0.74%
controls:0.39%
cases:0.27%
controls:0.03%
cases:0.30%
controls:0.00%
cases:0.35%
controls:0.05%
cases:1.03%
controls:0.42%
cases:2.74%
controls:1.11%
38
154
2935
29535
22
117
2951
29572
8
8
2965
29681
9
0
2964
29689
10
15
2864
29615
28
120
2695
28632
60
263
2129
23366
CT of neck arteries
PA6AD [2001308692]
PA6AD [2001308692]
9.7e-01
2.5e+00
—
1.0e+50
—
2.8e+00
1.6e+00
cases:0.17%
controls:0.06%
cases:0.64%
controls:0.05%
—
—
cases:1.48%
controls:0.00%
—
—
cases:0.70%
controls:0.04%
cases:1.23%
controls:0.26%
5
19
2968
29670
19
15
2954
29674
—
44
0
2929
29689
—
19
12
2704
28740
27
61
2162
23568
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
34487-9 [3044938]
5.8e-01
7.9e-01
2.4e+00
—
1.7e+00
7.7e-01
7.3e-01
cases:3.23%
controls:1.83%
cases:2.32%
controls:1.07%
cases:1.24%
controls:0.12%
—
—
cases:0.90%
controls:0.17%
cases:2.53%
controls:1.19%
cases:7.86%
controls:3.96%
96
544
2877
29145
69
318
2904
29371
37
35
2936
29654
—
26
49
2848
29581
69
342
2654
28410
172
936
2017
22693
Heart failure, unspecified
I50.9 [45576879]
I50.9 [45576879]
2.5e-01
3.1e-01
1.2e+00
3.6e+00
1.2e+00
4.9e-01
3.5e-01
cases:3.20%
controls:2.50%
cases:2.12%
controls:1.56%
cases:0.98%
controls:0.29%
cases:0.87%
controls:0.02%
cases:0.94%
controls:0.28%
cases:2.72%
controls:1.69%
cases:6.62%
controls:4.77%
95
741
2878
28948
63
464
2910
29225
29
87
2944
29602
26
7
2947
29682
27
82
2847
29548
74
486
2649
28266
145
1128
2044
22501
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 [3008230]
7818-8 [3008230]
6.8e-01
1.3e+00
—
1.0e+50
3.9e+00
1.0e+00
4.9e-01
cases:1.82%
controls:0.93%
cases:1.14%
controls:0.31%
—
—
cases:0.24%
controls:0.00%
cases:0.97%
controls:0.02%
cases:0.73%
controls:0.27%
cases:1.60%
controls:0.99%
54
275
2919
29414
34
92
2939
29597
—
7
0
2966
29689
28
6
2846
29624
20
77
2703
28675
35
234
2154
23395
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2874-6 [3023465]
2874-6 [3023465]
4.0e-01
1.4e+00
2.0e+00
—
2.4e+00
1.0e+00
1.9e-01
cases:1.01%
controls:0.68%
cases:0.98%
controls:0.24%
cases:0.34%
controls:0.04%
—
—
cases:0.38%
controls:0.03%
cases:0.66%
controls:0.24%
cases:1.10%
controls:0.91%
30
202
2943
29487
29
72
2944
29617
10
13
2963
29676
—
11
10
2863
29620
18
70
2705
28682
24
214
2165
23415
Cardiac ultrasound examination through oesophagus
FM1BE [2001303285]
FM1BE [2001303285]
5.2e-01
1.4e+00
2.6e+00
—
—
1.6e+00
1.2e+00
cases:1.01%
controls:0.60%
cases:0.64%
controls:0.17%
cases:0.24%
controls:0.02%
—
—
—
—
cases:0.59%
controls:0.11%
cases:1.46%
controls:0.45%
30
179
2943
29510
19
49
2954
29640
7
5
2966
29684
—
—
16
33
2707
28719
32
106
2157
23523
SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94759-8 [586526]
94759-8 [586526]
4.4e-01
1.1e+00
1.8e+00
1.0e+50
2.3e+00
9.6e-01
6.5e-01
cases:1.01%
controls:0.65%
cases:0.74%
controls:0.25%
cases:0.24%
controls:0.04%
cases:0.17%
controls:0.00%
cases:0.35%
controls:0.03%
cases:0.73%
controls:0.28%
cases:2.38%
controls:1.25%
30
194
2943
29495
22
73
2951
29616
7
12
2966
29677
5
0
2968
29689
10
10
2864
29620
20
81
2703
28671
52
296
2137
23333
Thrombin time
3243-3 [3036489]
3243-3 [3036489]
1.3e+00
2.0e+00
—
1.0e+50
—
2.0e+00
1.6e+00
cases:1.28%
controls:0.36%
cases:1.04%
controls:0.15%
—
—
cases:0.74%
controls:0.00%
—
—
cases:0.88%
controls:0.12%
cases:1.78%
controls:0.37%
38
107
2935
29582
31
44
2942
29645
—
22
0
2951
29689
—
24
35
2699
28717
39
88
2150
23541
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
2.4e-01
5.4e-01
1.0e+00
3.0e+00
1.1e+00
5.7e-01
3.9e-01
cases:11.97%
controls:9.66%
cases:8.61%
controls:5.22%
cases:2.89%
controls:1.05%
cases:1.24%
controls:0.06%
cases:3.06%
controls:1.09%
cases:8.81%
controls:5.18%
cases:18.68%
controls:13.49%
356
2868
2617
26821
256
1551
2717
28138
86
313
2887
29376
37
19
2936
29670
88
322
2786
29308
240
1489
2483
27263
409
3187
1780
20442
Stroke/cerebrovascular accident
K90 [2002000617]
K90 [2002000617]
3.0e+00
—
1.0e+50
—
1.0e+50
—
3.8e+00
cases:0.81%
controls:0.04%
—
—
cases:0.20%
controls:0.00%
—
—
cases:1.57%
controls:0.00%
—
—
cases:3.06%
controls:0.07%
24
12
2949
29677
—
6
0
2967
29689
—
45
0
2829
29630
—
67
17
2122
23612
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
AA1CG [2001300116]
1.1e+00
2.2e+00
—
1.0e+50
—
2.1e+00
1.4e+00
cases:1.58%
controls:0.54%
cases:1.41%
controls:0.17%
—
—
cases:2.72%
controls:0.00%
—
—
cases:1.32%
controls:0.16%
cases:1.83%
controls:0.47%
47
160
2926
29529
42
49
2931
29640
—
81
0
2892
29689
—
36
46
2687
28706
40
111
2149
23518
Inpatient Visit
IP [9201]
IP [9201]
3.9e-01
7.1e-01
1.6e+00
—
2.5e+00
9.1e-01
6.6e-01
cases:11.03%
controls:7.77%
cases:6.16%
controls:3.12%
cases:1.88%
controls:0.38%
—
—
cases:4.80%
controls:0.43%
cases:7.05%
controls:2.97%
cases:15.49%
controls:8.68%
328
2308
2645
27381
183
925
2790
28764
56
114
2917
29575
—
138
126
2736
29504
192
853
2531
27899
339
2050
1850
21579
atorvastatin; oral
C10AA05 [21601860]
C10AA05 [21601860]
3.6e-01
4.9e-01
4.4e-01
1.7e+00
1.7e+00
1.1e+00
9.5e-01
cases:15.27%
controls:11.20%
cases:14.60%
controls:9.44%
cases:4.27%
controls:2.81%
cases:0.61%
controls:0.11%
cases:12.80%
controls:2.72%
cases:25.63%
controls:10.13%
cases:30.01%
controls:14.22%
454
3326
2519
26363
434
2803
2539
26886
127
833
2846
28856
18
33
2955
29656
368
806
2506
28824
698
2914
2025
25838
657
3361
1532
20268
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 [3005229]
2868-8 [3005229]
3.8e-01
1.4e+00
2.0e+00
—
2.3e+00
9.2e-01
1.0e-01
cases:1.04%
controls:0.71%
cases:1.04%
controls:0.26%
cases:0.34%
controls:0.04%
—
—
cases:0.42%
controls:0.04%
cases:0.66%
controls:0.26%
cases:1.19%
controls:1.07%
31
212
2942
29477
31
76
2942
29613
10
13
2963
29676
—
12
12
2862
29618
18
76
2705
28676
26
253
2163
23376
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 [3043747]
32731-2 [3043747]
3.9e-01
1.4e+00
2.0e+00
—
2.3e+00
9.2e-01
1.0e-01
cases:1.04%
controls:0.71%
cases:1.04%
controls:0.26%
cases:0.34%
controls:0.04%
—
—
cases:0.42%
controls:0.04%
cases:0.66%
controls:0.26%
cases:1.19%
controls:1.07%
31
211
2942
29478
31
76
2942
29613
10
13
2963
29676
—
12
12
2862
29618
18
76
2705
28676
26
253
2163
23376
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 [3043723]
32730-4 [3043723]
3.9e-01
1.4e+00
2.0e+00
—
2.3e+00
9.2e-01
1.0e-01
cases:1.04%
controls:0.71%
cases:1.04%
controls:0.26%
cases:0.34%
controls:0.04%
—
—
cases:0.42%
controls:0.04%
cases:0.66%
controls:0.26%
cases:1.19%
controls:1.07%
31
211
2942
29478
31
76
2942
29613
10
13
2963
29676
—
12
12
2862
29618
18
76
2705
28676
26
253
2163
23376
Epilepsy
G40 [45595935]
G40 [45595935]
1.3e+00
1.6e+00
—
—
—
2.1e+00
1.7e+00
cases:0.71%
controls:0.19%
cases:0.27%
controls:0.05%
—
—
—
—
—
—
cases:0.37%
controls:0.05%
cases:0.96%
controls:0.18%
21
57
2952
29632
8
16
2965
29673
—
—
—
10
13
2713
28739
21
42
2168
23587
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
1.3e-01
3.0e-01
7.4e-01
3.3e+00
1.7e+00
4.1e-01
2.2e-01
cases:32.56%
controls:29.83%
cases:28.99%
controls:23.25%
cases:8.44%
controls:4.20%
cases:4.07%
controls:0.15%
cases:17.95%
controls:4.01%
cases:32.28%
controls:24.07%
cases:47.28%
controls:41.73%
968
8856
2005
20833
862
6904
2111
22785
251
1248
2722
28441
121
45
2852
29644
516
1187
2358
28443
879
6921
1844
21831
1035
9861
1154
13768
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
34548-8 [3045783]
2.1e-01
6.9e-01
1.4e+00
—
2.5e+00
1.1e+00
9.2e-01
cases:4.37%
controls:3.57%
cases:3.06%
controls:1.57%
cases:0.84%
controls:0.20%
—
—
cases:2.44%
controls:0.21%
cases:3.97%
controls:1.35%
cases:7.54%
controls:3.14%
130
1060
2843
28629
91
465
2882
29224
25
59
2948
29630
—
70
62
2804
29568
108
388
2615
28364
165
742
2024
22887
Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
56764-4 [40759883]
56764-4 [40759883]
1.5e+00
2.3e+00
—
—
1.0e+50
2.8e+00
—
cases:0.30%
controls:0.07%
cases:0.34%
controls:0.03%
—
—
—
—
cases:0.42%
controls:0.00%
cases:0.29%
controls:0.02%
—
—
9
20
2964
29669
10
10
2963
29679
—
—
12
0
2862
29630
8
5
2715
28747
—
Thrombophilia screening test
314089003 [4195642]
314089003 [4195642]
5.3e-01
2.1e+00
—
—
—
2.8e+00
1.7e+00
cases:0.30%
controls:0.18%
cases:0.37%
controls:0.04%
—
—
—
—
—
—
cases:0.51%
controls:0.03%
cases:0.59%
controls:0.11%
9
53
2964
29636
11
13
2962
29676
—
—
—
14
9
2709
28743
13
26
2176
23603
Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
3181-5 [3009041]
3181-5 [3009041]
9.8e-01
2.0e+00
—
1.0e+50
—
2.8e+00
1.8e+00
cases:0.40%
controls:0.15%
cases:0.40%
controls:0.05%
—
—
cases:0.17%
controls:0.00%
—
—
cases:0.62%
controls:0.04%
cases:0.69%
controls:0.11%
12
45
2961
29644
12
16
2961
29673
—
5
0
2968
29689
—
17
11
2706
28741
15
27
2174
23602
Pure hypercholesterolaemia
E78.01 [2000501514]
E78.01 [2000501514]
3.4e-01
5.9e-01
1.5e+00
—
2.3e+00
1.3e+00
5.9e-01
cases:4.44%
controls:3.20%
cases:2.72%
controls:1.54%
cases:1.18%
controls:0.25%
—
—
cases:2.92%
controls:0.31%
cases:5.80%
controls:1.70%
cases:9.00%
controls:5.21%
132
950
2841
28739
81
456
2892
29233
35
75
2938
29614
—
84
93
2790
29537
158
488
2565
28264
197
1230
1992
22399
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
51486-9 [3029879]
6.8e-01
8.0e-01
1.7e+00
1.0e+50
2.1e+00
6.2e-01
6.1e-01
cases:4.41%
controls:2.29%
cases:3.06%
controls:1.40%
cases:1.21%
controls:0.22%
cases:0.98%
controls:0.00%
cases:1.98%
controls:0.24%
cases:3.05%
controls:1.67%
cases:7.49%
controls:4.22%
131
679
2842
29010
91
416
2882
29273
36
65
2937
29624
29
0
2944
29689
57
70
2817
29560
83
479
2640
28273
164
996
2025
22633
Chronic hypertension
205 [2001600203]
205 [2001600203]
1.9e-01
6.6e-01
2.5e+00
—
2.2e+00
1.9e+00
4.3e-01
cases:2.32%
controls:1.92%
cases:0.77%
controls:0.40%
cases:0.34%
controls:0.03%
—
—
cases:0.35%
controls:0.04%
cases:1.87%
controls:0.29%
cases:1.92%
controls:1.26%
69
570
2904
29119
23
119
2950
29570
10
8
2963
29681
—
10
12
2864
29618
51
83
2672
28669
42
297
2147
23332
Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
22118-4 [3011166]
22118-4 [3011166]
1.5e+00
2.4e+00
1.0e+50
1.0e+50
1.0e+50
2.6e+00
—
cases:0.37%
controls:0.08%
cases:0.30%
controls:0.03%
cases:0.17%
controls:0.00%
cases:0.17%
controls:0.00%
cases:0.31%
controls:0.00%
cases:0.33%
controls:0.02%
—
—
11
24
2962
29665
9
8
2964
29681
5
0
2968
29689
5
0
2968
29689
9
0
2865
29630
9
7
2714
28745
—
Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
22126-7 [3010380]
22126-7 [3010380]
1.6e+00
2.7e+00
—
1.0e+50
1.0e+50
2.3e+00
—
cases:0.44%
controls:0.09%
cases:0.54%
controls:0.04%
—
—
cases:0.17%
controls:0.00%
cases:0.31%
controls:0.00%
cases:0.33%
controls:0.03%
—
—
13
27
2960
29662
16
11
2957
29678
—
5
0
2968
29689
9
0
2865
29630
9
10
2714
28742
—
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-5.4e-01
-4.6e-01
5.3e-02
—
2.4e+00
2.4e+00
2.7e+00
cases:15.61%
controls:24.06%
cases:4.78%
controls:7.38%
cases:0.71%
controls:0.67%
—
—
cases:0.84%
controls:0.08%
cases:5.10%
controls:0.48%
cases:13.75%
controls:1.09%
464
7143
2509
22546
142
2190
2831
27499
21
199
2952
29490
—
24
23
2850
29607
139
137
2584
28615
301
257
1888
23372
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
6.2e-02
1.6e-01
8.1e-01
4.0e+00
1.3e+00
2.9e-01
1.4e-01
cases:37.77%
controls:36.33%
cases:38.45%
controls:34.79%
cases:22.47%
controls:11.38%
cases:23.68%
controls:0.59%
cases:31.32%
controls:11.43%
cases:43.11%
controls:36.25%
cases:52.81%
controls:49.20%
1123
10786
1850
18903
1143
10330
1830
19359
668
3380
2305
26309
704
176
2269
29513
900
3388
1974
26242
1174
10424
1549
18328
1156
11625
1033
12004
Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
22133-3 [3014973]
22133-3 [3014973]
1.6e+00
2.6e+00
1.0e+50
1.0e+50
1.0e+50
2.3e+00
—
cases:0.44%
controls:0.09%
cases:0.50%
controls:0.04%
cases:0.17%
controls:0.00%
cases:0.17%
controls:0.00%
cases:0.45%
controls:0.00%
cases:0.33%
controls:0.03%
—
—
13
27
2960
29662
15
11
2958
29678
5
0
2968
29689
5
0
2968
29689
13
0
2861
29630
9
10
2714
28742
—
Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
44448-9 [3044355]
44448-9 [3044355]
9.6e-01
2.0e+00
—
1.0e+50
—
2.7e+00
1.7e+00
cases:0.44%
controls:0.17%
cases:0.47%
controls:0.06%
—
—
cases:0.17%
controls:0.00%
—
—
cases:0.70%
controls:0.05%
cases:0.64%
controls:0.12%
13
50
2960
29639
14
19
2959
29670
—
5
0
2968
29689
—
19
13
2704
28739
14
29
2175
23600
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
3.6e-01
4.4e-01
8.8e-01
2.2e+00
1.5e+00
4.8e-01
4.4e-01
cases:12.21%
controls:8.85%
cases:8.34%
controls:5.53%
cases:2.56%
controls:1.08%
cases:0.57%
controls:0.06%
cases:4.18%
controls:0.93%
cases:8.89%
controls:5.67%
cases:18.68%
controls:12.88%
363
2627
2610
27062
248
1642
2725
28047
76
320
2897
29369
17
18
2956
29671
120
277
2754
29353
242
1630
2481
27122
409
3044
1780
20585
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
3.6e-01
4.4e-01
8.9e-01
2.2e+00
1.5e+00
4.8e-01
4.4e-01
cases:12.24%
controls:8.87%
cases:8.38%
controls:5.57%
cases:2.59%
controls:1.08%
cases:0.57%
controls:0.06%
cases:4.18%
controls:0.94%
cases:8.92%
controls:5.71%
cases:18.73%
controls:12.98%
364
2633
2609
27056
249
1653
2724
28036
77
320
2896
29369
17
18
2956
29671
120
278
2754
29352
243
1642
2480
27110
410
3066
1779
20563
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
2000-8 [3015377]
3.2e-01
8.7e-01
8.1e-01
2.0e+00
1.3e+00
5.2e-01
5.4e-01
cases:8.17%
controls:6.06%
cases:6.76%
controls:2.96%
cases:1.11%
controls:0.50%
cases:0.20%
controls:0.03%
cases:1.77%
controls:0.49%
cases:5.10%
controls:3.11%
cases:13.43%
controls:8.32%
243
1799
2730
27890
201
878
2772
28811
33
147
2940
29542
6
8
2967
29681
51
144
2823
29486
139
894
2584
27858
294
1966
1895
21663
Other diagnostic examination of periferal vessel
XPX99 [2001309755]
XPX99 [2001309755]
8.2e-01
8.7e-01
2.4e+00
—
—
1.3e+00
9.6e-01
cases:1.82%
controls:0.81%
cases:0.77%
controls:0.33%
cases:0.54%
controls:0.05%
—
—
—
—
cases:1.18%
controls:0.33%
cases:2.51%
controls:0.97%
54
241
2919
29448
23
97
2950
29592
16
14
2957
29675
—
—
32
95
2691
28657
55
230
2134
23399
Physical Medicine And Rehabilitation
25 [38004468]
25 [38004468]
5.7e-01
7.4e-01
1.3e+00
—
1.8e+00
1.2e+00
7.6e-01
cases:9.35%
controls:5.54%
cases:3.94%
controls:1.92%
cases:1.01%
controls:0.27%
—
—
cases:1.91%
controls:0.32%
cases:5.77%
controls:1.89%
cases:11.01%
controls:5.48%
278
1644
2695
28045
117
571
2856
29118
30
79
2943
29610
—
55
95
2819
29535
157
543
2566
28209
241
1294
1948
22335
Sleep apnoea
G47.3 [45562094]
G47.3 [45562094]
1.4e-01
3.2e-01
6.2e-01
4.3e+00
9.4e-01
6.5e-01
5.0e-01
cases:4.47%
controls:3.93%
cases:3.20%
controls:2.33%
cases:0.77%
controls:0.42%
cases:1.18%
controls:0.02%
cases:1.15%
controls:0.45%
cases:4.66%
controls:2.48%
cases:7.40%
controls:4.64%
133
1167
2840
28522
95
693
2878
28996
23
124
2950
29565
35
5
2938
29684
33
134
2841
29496
127
714
2596
28038
162
1097
2027
22532
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
51485-1 [3030306]
5.2e-01
6.9e-01
1.8e+00
1.0e+50
2.1e+00
6.1e-01
6.2e-01
cases:3.73%
controls:2.25%
cases:2.79%
controls:1.42%
cases:1.18%
controls:0.21%
cases:0.84%
controls:0.00%
cases:2.02%
controls:0.24%
cases:3.05%
controls:1.69%
cases:8.18%
controls:4.57%
111
669
2862
29020
83
423
2890
29266
35
61
2938
29628
25
0
2948
29689
58
71
2816
29559
83
485
2640
28267
179
1079
2010
22550
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
5.2e-01
8.5e-01
1.7e+00
—
2.1e+00
4.8e-01
6.2e-01
cases:6.56%
controls:4.03%
cases:4.54%
controls:2.00%
cases:1.38%
controls:0.25%
—
—
cases:2.37%
controls:0.29%
cases:3.64%
controls:2.27%
cases:12.29%
controls:6.98%
195
1195
2778
28494
135
593
2838
29096
41
74
2932
29615
—
68
85
2806
29545
99
654
2624
28098
269
1650
1920
21979
Hyperlipidaemia, unspecified
E78.5 [45537986]
E78.5 [45537986]
4.0e-01
7.7e-01
1.7e+00
1.0e+50
2.1e+00
1.2e+00
5.6e-01
cases:2.02%
controls:1.36%
cases:1.08%
controls:0.50%
cases:0.34%
controls:0.06%
cases:1.75%
controls:0.00%
cases:0.77%
controls:0.10%
cases:1.87%
controls:0.57%
cases:2.97%
controls:1.71%
60
405
2913
29284
32
149
2941
29540
10
18
2963
29671
52
0
2921
29689
22
29
2852
29601
51
165
2672
28587
65
404
2124
23225
Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5013-8 [3008733]
5013-8 [3008733]
2.0e+00
—
—
1.0e+50
1.0e+50
2.5e+00
1.7e+00
cases:0.30%
controls:0.04%
—
—
—
—
cases:0.27%
controls:0.00%
cases:0.45%
controls:0.00%
cases:0.22%
controls:0.02%
cases:0.41%
controls:0.07%
9
12
2964
29677
—
—
8
0
2965
29689
13
0
2861
29630
6
5
2717
28747
9
17
2180
23612
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
3.1e-01
5.4e-01
2.0e+00
—
2.4e+00
6.0e-01
4.2e-01
cases:9.62%
controls:7.25%
cases:6.05%
controls:3.62%
cases:3.13%
controls:0.43%
—
—
cases:5.25%
controls:0.49%
cases:6.90%
controls:3.91%
cases:15.90%
controls:11.05%
286
2152
2687
27537
180
1076
2793
28613
93
129
2880
29560
—
151
145
2723
29485
188
1124
2535
27628
348
2610
1841
21019
Eosinophils [#/volume] in Blood
26449-9 [3013115]
26449-9 [3013115]
3.3e-01
4.3e-01
8.8e-01
2.2e+00
1.5e+00
4.7e-01
4.3e-01
cases:12.58%
controls:9.39%
cases:8.58%
controls:5.77%
cases:2.69%
controls:1.13%
cases:0.57%
controls:0.06%
cases:4.24%
controls:0.98%
cases:9.18%
controls:5.92%
cases:19.05%
controls:13.33%
374
2788
2599
26901
255
1712
2718
27977
80
336
2893
29353
17
18
2956
29671
122
291
2752
29339
250
1703
2473
27049
417
3150
1772
20479
Differential panel, method unspecified - Blood
69738-3 [42870588]
69738-3 [42870588]
3.5e-01
4.7e-01
9.7e-01
2.0e+00
1.5e+00
5.0e-01
4.9e-01
cases:8.31%
controls:5.98%
cases:5.58%
controls:3.56%
cases:1.85%
controls:0.71%
cases:0.37%
controls:0.05%
cases:2.78%
controls:0.64%
cases:5.77%
controls:3.56%
cases:12.15%
controls:7.84%
247
1774
2726
27915
166
1057
2807
28632
55
210
2918
29479
11
15
2962
29674
80
190
2794
29440
157
1024
2566
27728
266
1853
1923
21776
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]
27811-9 [3000515]
1.0e+00
1.7e+00
—
—
—
2.0e+00
1.4e+00
cases:0.91%
controls:0.32%
cases:0.81%
controls:0.14%
—
—
—
—
—
—
cases:0.81%
controls:0.11%
cases:1.28%
controls:0.31%
27
96
2946
29593
24
42
2949
29647
—
—
—
22
31
2701
28721
28
74
2161
23555
Type 2 diabetes mellitus, with unspecified complications
E11.8 [45561951]
E11.8 [45561951]
4.0e-01
8.0e-01
1.6e+00
—
2.3e+00
9.4e-01
5.8e-01
cases:2.15%
controls:1.46%
cases:1.88%
controls:0.85%
cases:0.81%
controls:0.16%
—
—
cases:1.29%
controls:0.13%
cases:2.35%
controls:0.93%
cases:4.66%
controls:2.67%
64
432
2909
29257
56
253
2917
29436
24
47
2949
29642
—
37
40
2837
29590
64
268
2659
28484
102
630
2087
22999
Protein C actual/normal in Platelet poor plasma by Coagulation assay
27819-2 [3020287]
27819-2 [3020287]
6.1e-01
1.8e+00
—
—
—
2.6e+00
1.8e+00
cases:0.30%
controls:0.17%
cases:0.30%
controls:0.05%
—
—
—
—
—
—
cases:0.51%
controls:0.04%
cases:0.55%
controls:0.09%
9
49
2964
29640
9
15
2964
29674
—
—
—
14
11
2709
28741
12
21
2177
23608
Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
50797-0 [3029379]
50797-0 [3029379]
3.1e-01
1.5e+00
2.0e+00
—
2.7e+00
8.5e-01
3.4e-01
cases:0.64%
controls:0.47%
cases:0.77%
controls:0.17%
cases:0.20%
controls:0.03%
—
—
cases:0.35%
controls:0.02%
cases:0.37%
controls:0.16%
cases:0.87%
controls:0.62%
19
139
2954
29550
23
51
2950
29638
6
8
2967
29681
—
10
7
2864
29623
10
45
2713
28707
19
147
2170
23482
Depressive episode, unspecified
F32.9 [45571760]
F32.9 [45571760]
5.5e-01
8.6e-01
1.1e+00
1.0e+50
2.3e+00
1.8e+00
7.4e-01
cases:1.72%
controls:1.00%
cases:0.84%
controls:0.36%
cases:0.20%
controls:0.07%
cases:0.50%
controls:0.00%
cases:0.66%
controls:0.07%
cases:2.02%
controls:0.35%
cases:2.51%
controls:1.22%
51
296
2922
29393
25
106
2948
29583
6
20
2967
29669
15
0
2958
29689
19
20
2855
29610
55
100
2668
28652
55
288
2134
23341
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
35559-4 [3035797]
35559-4 [3035797]
2.6e-01
1.5e+00
2.0e+00
—
2.7e+00
7.3e-01
2.1e-01
cases:0.67%
controls:0.52%
cases:0.84%
controls:0.18%
cases:0.20%
controls:0.03%
—
—
cases:0.38%
controls:0.03%
cases:0.40%
controls:0.19%
cases:0.87%
controls:0.71%
20
155
2953
29534
25
54
2948
29635
6
8
2967
29681
—
11
8
2863
29622
11
56
2712
28696
19
167
2170
23462
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
4.8e-01
7.5e-01
1.7e+00
—
1.5e+00
9.4e-01
7.7e-01
cases:4.17%
controls:2.62%
cases:2.09%
controls:1.00%
cases:0.74%
controls:0.13%
—
—
cases:0.59%
controls:0.13%
cases:2.64%
controls:1.05%
cases:6.67%
controls:3.20%
124
778
2849
28911
62
297
2911
29392
22
39
2951
29650
—
17
39
2857
29591
72
301
2651
28451
146
757
2043
22872
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
24351-9 [3004588]
2.6e-01
9.3e-01
2.0e+00
—
2.5e+00
7.6e-01
1.5e-01
cases:1.58%
controls:1.23%
cases:1.45%
controls:0.58%
cases:0.57%
controls:0.08%
—
—
cases:0.87%
controls:0.07%
cases:1.03%
controls:0.48%
cases:1.92%
controls:1.66%
47
365
2926
29324
43
171
2930
29518
17
24
2956
29665
—
25
21
2849
29609
28
139
2695
28613
42
392
2147
23237
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
26474-7 [3019198]
3.4e-01
4.1e-01
8.4e-01
2.2e+00
1.5e+00
4.6e-01
4.2e-01
cases:12.51%
controls:9.24%
cases:8.48%
controls:5.77%
cases:2.52%
controls:1.10%
cases:0.57%
controls:0.06%
cases:4.18%
controls:0.97%
cases:9.03%
controls:5.91%
cases:18.87%
controls:13.31%
372
2743
2601
26946
252
1714
2721
27975
75
328
2898
29361
17
19
2956
29670
120
287
2754
29343
246
1699
2477
27053
413
3145
1776
20484
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50796-2 [3029338]
50796-2 [3029338]
2.9e-01
1.6e+00
2.0e+00
—
2.6e+00
6.4e-01
3.0e-01
cases:0.64%
controls:0.48%
cases:0.81%
controls:0.17%
cases:0.20%
controls:0.03%
—
—
cases:0.35%
controls:0.03%
cases:0.37%
controls:0.19%
cases:0.87%
controls:0.65%
19
142
2954
29547
24
51
2949
29638
6
8
2967
29681
—
10
8
2864
29622
10
56
2713
28696
19
153
2170
23476
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
2.8e-01
4.6e-01
6.8e-01
2.6e+00
1.2e+00
4.6e-01
4.7e-01
cases:13.96%
controls:10.90%
cases:10.63%
controls:6.96%
cases:3.43%
controls:1.76%
cases:1.14%
controls:0.09%
cases:5.05%
controls:1.61%
cases:10.61%
controls:7.00%
cases:21.84%
controls:14.81%
415
3235
2558
26454
316
2066
2657
27623
102
523
2871
29166
34
26
2939
29663
145
476
2729
29154
289
2012
2434
26740
478
3499
1711
20130
Benign paroxysmal vertigo
H81.1 [45572061]
H81.1 [45572061]
6.0e-01
1.2e+00
2.8e+00
—
1.5e+00
9.0e-01
6.5e-01
cases:1.75%
controls:0.96%
cases:0.94%
controls:0.30%
cases:0.61%
controls:0.04%
—
—
cases:0.24%
controls:0.05%
cases:0.77%
controls:0.32%
cases:2.28%
controls:1.20%
52
286
2921
29403
28
88
2945
29601
18
11
2955
29678
—
7
16
2867
29614
21
91
2702
28661
50
284
2139
23345
Weakness/tiredness general
A04 [2002000145]
A04 [2002000145]
6.1e-01
6.7e-01
1.0e+00
2.2e+00
9.1e-01
1.0e+00
5.4e-01
cases:3.06%
controls:1.69%
cases:1.35%
controls:0.69%
cases:0.47%
controls:0.17%
cases:0.27%
controls:0.03%
cases:0.45%
controls:0.18%
cases:2.28%
controls:0.82%
cases:4.71%
controls:2.78%
91
501
2882
29188
40
205
2933
29484
14
50
2959
29639
8
9
2965
29680
13
54
2861
29576
62
236
2661
28516
103
658
2086
22971
General Surgery
2 [38004447]
2 [38004447]
3.2e-01
3.5e-01
9.8e-01
3.6e+00
4.6e-01
5.0e-01
2.5e-01
cases:26.98%
controls:21.15%
cases:9.72%
controls:7.08%
cases:2.52%
controls:0.96%
cases:1.28%
controls:0.03%
cases:1.77%
controls:1.12%
cases:10.28%
controls:6.49%
cases:22.02%
controls:18.02%
802
6279
2171
23410
289
2103
2684
27586
75
285
2898
29404
38
10
2935
29679
51
333
2823
29297
280
1865
2443
26887
482
4259
1707
19370
Clopidogrel
280 [2001600212]
280 [2001600212]
1.4e+00
—
—
—
1.0e+50
2.9e+00
1.7e+00
cases:0.47%
controls:0.12%
—
—
—
—
—
—
cases:0.24%
controls:0.00%
cases:0.33%
controls:0.02%
cases:0.69%
controls:0.12%
14
36
2959
29653
—
—
—
7
0
2867
29630
9
5
2714
28747
15
29
2174
23600
Alzheimer disease with late onset
G30.1 [45552521]
G30.1 [45552521]
-5.9e-01
-3.2e-01
9.0e-01
3.6e+00
1.6e+00
7.6e-01
2.5e-01
cases:0.67%
controls:1.21%
cases:0.61%
controls:0.83%
cases:0.44%
controls:0.18%
cases:1.21%
controls:0.03%
cases:0.94%
controls:0.18%
cases:2.28%
controls:1.08%
cases:3.38%
controls:2.66%
20
358
2953
29331
18
247
2955
29442
13
53
2960
29636
36
10
2937
29679
27
54
2847
29576
62
310
2661
28442
74
628
2115
23001
Carboxyhemoglobin/Hemoglobin.total in Venous blood
2032-1 [3010517]
2032-1 [3010517]
6.6e-01
8.0e-01
1.9e+00
1.0e+50
3.1e+00
8.8e-01
5.4e-01
cases:1.21%
controls:0.63%
cases:0.74%
controls:0.33%
cases:0.20%
controls:0.03%
cases:0.54%
controls:0.00%
cases:0.94%
controls:0.04%
cases:1.03%
controls:0.43%
cases:2.42%
controls:1.43%
36
186
2937
29503
22
99
2951
29590
6
9
2967
29680
16
0
2957
29689
27
13
2847
29617
28
123
2695
28629
53
338
2136
23291
Concussion
S06.0 [45582805]
S06.0 [45582805]
9.7e-01
1.2e+00
—
1.0e+50
2.1e+00
1.0e+00
6.2e-01
cases:2.09%
controls:0.80%
cases:1.01%
controls:0.30%
—
—
cases:0.30%
controls:0.00%
cases:0.24%
controls:0.03%
cases:0.81%
controls:0.29%
cases:2.33%
controls:1.27%
62
237
2911
29452
30
88
2943
29601
—
9
0
2964
29689
7
9
2867
29621
22
82
2701
28670
51
299
2138
23330
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51435-6 [3029713]
51435-6 [3029713]
3.2e-01
1.4e+00
2.2e+00
—
2.3e+00
8.1e-01
1.6e-01
cases:0.81%
controls:0.59%
cases:0.98%
controls:0.24%
cases:0.27%
controls:0.03%
—
—
cases:0.38%
controls:0.04%
cases:0.55%
controls:0.25%
cases:1.01%
controls:0.86%
24
175
2949
29514
29
70
2944
29619
8
9
2965
29680
—
11
11
2863
29619
15
71
2708
28681
22
203
2167
23426
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
29953-7 [3037522]
2.9e-01
7.6e-01
1.6e+00
—
2.5e+00
1.1e+00
3.0e-01
cases:2.46%
controls:1.85%
cases:1.55%
controls:0.73%
cases:0.34%
controls:0.07%
—
—
cases:0.84%
controls:0.07%
cases:1.62%
controls:0.53%
cases:2.92%
controls:2.19%
73
549
2900
29140
46
216
2927
29473
10
21
2963
29668
—
24
21
2850
29609
44
151
2679
28601
64
518
2125
23111
Hemiplegia, unspecified
G81.9 [45562106]
G81.9 [45562106]
2.8e+00
—
—
1.0e+50
1.0e+50
—
3.2e+00
cases:0.37%
controls:0.02%
—
—
—
—
cases:0.61%
controls:0.00%
cases:0.24%
controls:0.00%
—
—
cases:0.50%
controls:0.02%
11
7
2962
29682
—
—
18
0
2955
29689
7
0
2867
29630
—
11
5
2178
23624
Basophils/Leukocytes in Blood
30180-4 [3022096]
30180-4 [3022096]
3.1e-01
3.8e-01
8.2e-01
2.2e+00
1.4e+00
3.9e-01
3.5e-01
cases:11.27%
controls:8.54%
cases:7.47%
controls:5.23%
cases:2.32%
controls:1.03%
cases:0.54%
controls:0.06%
cases:3.62%
controls:0.91%
cases:7.57%
controls:5.25%
cases:15.99%
controls:11.86%
335
2535
2638
27154
222
1554
2751
28135
69
306
2904
29383
16
17
2957
29672
104
270
2770
29360
206
1510
2517
27242
350
2802
1839
20827
Rheumatism, unspecified
M79.0 [45567658]
M79.0 [45567658]
1.1e+00
1.6e+00
—
1.0e+50
—
1.9e+00
1.3e+00
cases:0.50%
controls:0.18%
cases:0.27%
controls:0.05%
—
—
cases:0.20%
controls:0.00%
—
—
cases:0.33%
controls:0.05%
cases:0.64%
controls:0.17%
15
52
2958
29637
8
16
2965
29673
—
6
0
2967
29689
—
9
14
2714
28738
14
41
2175
23588
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
2.3e-01
4.6e-01
7.7e-01
2.6e+00
1.0e+00
4.4e-01
3.6e-01
cases:21.06%
controls:17.53%
cases:16.08%
controls:10.83%
cases:4.47%
controls:2.13%
cases:1.38%
controls:0.10%
cases:5.60%
controls:2.06%
cases:16.34%
controls:11.13%
cases:31.06%
controls:23.86%
626
5203
2347
24486
478
3215
2495
26474
133
631
2840
29058
41
31
2932
29658
161
609
2713
29021
445
3201
2278
25551
680
5638
1509
17991
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
26450-7 [3006504]
3.1e-01
3.8e-01
8.1e-01
2.2e+00
1.4e+00
3.9e-01
3.6e-01
cases:11.34%
controls:8.57%
cases:7.50%
controls:5.25%
cases:2.29%
controls:1.03%
cases:0.54%
controls:0.06%
cases:3.62%
controls:0.92%
cases:7.57%
controls:5.25%
cases:16.08%
controls:11.83%
337
2544
2636
27145
223
1558
2750
28131
68
306
2905
29383
16
17
2957
29672
104
273
2770
29357
206
1509
2517
27243
352
2795
1837
20834
Left sided colitis
K51.5 [45533604]
K51.5 [45533604]
7.9e-01
1.0e+00
1.9e+00
—
1.9e+00
1.1e+00
7.2e-01
cases:0.67%
controls:0.31%
cases:0.54%
controls:0.19%
cases:0.27%
controls:0.04%
—
—
cases:0.24%
controls:0.04%
cases:0.59%
controls:0.20%
cases:0.69%
controls:0.33%
20
91
2953
29598
16
57
2957
29632
8
12
2965
29677
—
7
11
2867
29619
16
58
2707
28694
15
79
2174
23550
Monocytes/Leukocytes in Blood
26485-3 [3019069]
26485-3 [3019069]
3.1e-01
3.8e-01
8.2e-01
2.2e+00
1.4e+00
3.9e-01
3.6e-01
cases:11.34%
controls:8.60%
cases:7.53%
controls:5.26%
cases:2.32%
controls:1.03%
cases:0.54%
controls:0.06%
cases:3.62%
controls:0.93%
cases:7.53%
controls:5.24%
cases:16.13%
controls:11.85%
337
2553
2636
27136
224
1562
2749
28127
69
307
2904
29382
16
17
2957
29672
104
276
2770
29354
205
1508
2518
27244
353
2800
1836
20829
F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
21668-9 [3015816]
21668-9 [3015816]
6.2e-01
2.0e+00
—
—
—
2.4e+00
1.5e+00
cases:0.34%
controls:0.18%
cases:0.34%
controls:0.05%
—
—
—
—
—
—
cases:0.44%
controls:0.04%
cases:0.46%
controls:0.10%
10
54
2963
29635
10
14
2963
29675
—
—
—
12
12
2711
28740
10
23
2179
23606
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
G40.29 [2000502142]
G40.29 [2000502142]
1.2e+00
1.8e+00
—
1.0e+50
—
2.1e+00
1.9e+00
cases:0.37%
controls:0.11%
cases:0.30%
controls:0.05%
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.59%
controls:0.07%
cases:1.05%
controls:0.15%
11
34
2962
29655
9
15
2964
29674
—
10
0
2963
29689
—
16
20
2707
28732
23
36
2166
23593
Vascular dementia, unspecified
F01.9 [45533058]
F01.9 [45533058]
8.7e-01
2.0e+00
—
—
—
2.1e+00
1.8e+00
cases:0.17%
controls:0.07%
cases:0.40%
controls:0.05%
—
—
—
—
—
—
cases:0.48%
controls:0.06%
cases:1.51%
controls:0.26%
5
21
2968
29668
12
16
2961
29673
—
—
—
13
17
2710
28735
33
62
2156
23567
Bacteria identified in Urine by Culture
630-4 [3026008]
630-4 [3026008]
5.6e-01
6.5e-01
1.7e+00
—
1.9e+00
6.3e-01
4.9e-01
cases:9.38%
controls:5.61%
cases:5.85%
controls:3.16%
cases:2.15%
controls:0.41%
—
—
cases:3.38%
controls:0.53%
cases:6.54%
controls:3.60%
cases:13.75%
controls:8.87%
279
1665
2694
28024
174
937
2799
28752
64
123
2909
29566
—
97
157
2777
29473
178
1034
2545
27718
301
2097
1888
21532
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 [3015322]
2865-4 [3015322]
3.5e-01
1.4e+00
2.2e+00
—
2.2e+00
8.2e-01
1.4e-01
cases:0.94%
controls:0.67%
cases:0.98%
controls:0.24%
cases:0.34%
controls:0.04%
—
—
cases:0.38%
controls:0.04%
cases:0.55%
controls:0.24%
cases:1.10%
controls:0.95%
28
198
2945
29491
29
72
2944
29617
10
11
2963
29678
—
11
12
2863
29618
15
70
2708
28682
24
225
2165
23404
Bacteria [Presence] in Urine
87829-8 [36304419]
87829-8 [36304419]
4.9e-01
5.9e-01
1.7e+00
—
1.9e+00
6.4e-01
5.1e-01
cases:7.16%
controls:4.52%
cases:4.31%
controls:2.43%
cases:1.75%
controls:0.33%
—
—
cases:2.47%
controls:0.37%
cases:4.59%
controls:2.47%
cases:11.15%
controls:6.99%
213
1343
2760
28346
128
720
2845
28969
52
97
2921
29592
—
71
110
2803
29520
125
711
2598
28041
244
1651
1945
21978
Norovirus RNA [Presence] in Stool by NAA with probe detection
7974-9 [3008909]
7974-9 [3008909]
7.4e-01
1.3e+00
2.1e+00
—
2.7e+00
1.1e+00
6.9e-01
cases:0.64%
controls:0.31%
cases:0.50%
controls:0.13%
cases:0.17%
controls:0.02%
—
—
cases:0.42%
controls:0.03%
cases:0.48%
controls:0.17%
cases:1.51%
controls:0.76%
19
91
2954
29598
15
39
2958
29650
5
6
2968
29683
—
12
8
2862
29622
13
48
2710
28704
33
180
2156
23449
Subjective visual disturbances
H53.1 [45557467]
H53.1 [45557467]
8.4e-01
1.4e+00
2.0e+00
1.0e+50
2.3e+00
1.2e+00
6.7e-01
cases:1.11%
controls:0.48%
cases:0.67%
controls:0.17%
cases:0.17%
controls:0.02%
cases:0.44%
controls:0.00%
cases:0.17%
controls:0.02%
cases:0.66%
controls:0.19%
cases:1.32%
controls:0.68%
33
143
2940
29546
20
51
2953
29638
5
7
2968
29682
13
0
2960
29689
5
5
2869
29625
18
55
2705
28697
29
161
2160
23468
Diplopia
H53.2 [45576792]
H53.2 [45576792]
2.7e-01
1.8e+00
—
1.0e+50
—
2.6e+00
1.4e+00
cases:0.27%
controls:0.21%
cases:0.40%
controls:0.07%
—
—
cases:0.50%
controls:0.00%
—
—
cases:0.95%
controls:0.07%
cases:0.87%
controls:0.22%
8
61
2965
29628
12
20
2961
29669
—
15
0
2958
29689
—
26
20
2697
28732
19
53
2170
23576
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
26478-8 [3002030]
3.1e-01
3.6e-01
8.1e-01
2.2e+00
1.3e+00
3.6e-01
3.4e-01
cases:11.44%
controls:8.68%
cases:7.60%
controls:5.41%
cases:2.29%
controls:1.03%
cases:0.54%
controls:0.06%
cases:3.58%
controls:0.96%
cases:7.64%
controls:5.44%
cases:16.45%
controls:12.25%
340
2576
2633
27113
226
1607
2747
28082
68
307
2905
29382
16
17
2957
29672
103
285
2771
29345
208
1565
2515
27187
360
2895
1829
20734
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]
14920-3 [3008486]
2.1e-01
3.2e-01
8.4e-01
2.2e+00
1.5e+00
4.1e-01
2.4e-01
cases:20.08%
controls:16.87%
cases:12.48%
controls:9.41%
cases:2.59%
controls:1.13%
cases:0.34%
controls:0.04%
cases:5.46%
controls:1.23%
cases:13.55%
controls:9.45%
cases:27.68%
controls:23.19%
597
5008
2376
24681
371
2794
2602
26895
77
336
2896
29353
10
11
2963
29678
157
363
2717
29267
369
2716
2354
26036
606
5479
1583
18150
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
26511-6 [3018010]
2.9e-01
3.8e-01
8.1e-01
2.2e+00
1.4e+00
3.7e-01
3.4e-01
cases:11.10%
controls:8.53%
cases:7.43%
controls:5.20%
cases:2.25%
controls:1.01%
cases:0.50%
controls:0.06%
cases:3.44%
controls:0.89%
cases:7.53%
controls:5.34%
cases:15.99%
controls:11.93%
330
2531
2643
27158
221
1543
2752
28146
67
300
2906
29389
15
17
2958
29672
99
263
2775
29367
205
1534
2518
27218
350
2819
1839
20810
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
4.5e-01
6.0e-01
1.6e+00
—
2.0e+00
6.2e-01
5.2e-01
cases:7.27%
controls:4.75%
cases:4.74%
controls:2.65%
cases:1.88%
controls:0.38%
—
—
cases:2.61%
controls:0.38%
cases:5.03%
controls:2.78%
cases:11.97%
controls:7.49%
216
1410
2757
28279
141
786
2832
28903
56
114
2917
29575
—
75
112
2799
29518
137
798
2586
27954
262
1769
1927
21860
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
14731-4 [3019309]
4.1e-01
1.0e+00
1.2e+00
—
1.9e+00
6.6e-01
5.1e-01
cases:6.83%
controls:4.64%
cases:3.50%
controls:1.27%
cases:0.50%
controls:0.15%
—
—
cases:0.84%
controls:0.12%
cases:2.28%
controls:1.19%
cases:6.58%
controls:4.06%
203
1377
2770
28312
104
376
2869
29313
15
46
2958
29643
—
24
36
2850
29594
62
342
2661
28410
144
960
2045
22669
Migraine, unspecified
G43.9 [45595943]
G43.9 [45595943]
1.3e+00
1.7e+00
—
1.0e+50
—
1.7e+00
1.1e+00
cases:0.94%
controls:0.26%
cases:0.47%
controls:0.09%
—
—
cases:0.27%
controls:0.00%
—
—
cases:0.51%
controls:0.09%
cases:0.96%
controls:0.33%
28
78
2945
29611
14
26
2959
29663
—
8
0
2965
29689
—
14
27
2709
28725
21
79
2168
23550
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
2885-2 [3020630]
4.0e-01
1.0e+00
2.0e+00
—
2.7e+00
6.1e-01
1.1e-01
cases:2.05%
controls:1.38%
cases:1.85%
controls:0.67%
cases:0.91%
controls:0.12%
—
—
cases:1.22%
controls:0.08%
cases:1.10%
controls:0.60%
cases:2.24%
controls:2.01%
61
411
2912
29278
55
200
2918
29489
27
36
2946
29653
—
35
25
2839
29605
30
173
2693
28579
49
474
2140
23155
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
33959-8 [3046279]
1.8e-01
1.3e+00
2.3e+00
—
2.1e+00
3.8e-01
4.6e-01
cases:0.64%
controls:0.54%
cases:0.67%
controls:0.19%
cases:0.27%
controls:0.03%
—
—
cases:0.49%
controls:0.06%
cases:0.33%
controls:0.23%
cases:1.60%
controls:1.02%
19
159
2954
29530
20
56
2953
29633
8
8
2965
29681
—
14
17
2860
29613
9
65
2714
28687
35
241
2154
23388
Lumbar puncture
TAB00 [2001300538]
TAB00 [2001300538]
8.8e-01
3.0e+00
—
1.0e+50
—
2.7e+00
9.8e-01
cases:0.57%
controls:0.24%
cases:0.74%
controls:0.04%
—
—
cases:0.77%
controls:0.00%
—
—
cases:0.62%
controls:0.04%
cases:0.59%
controls:0.22%
17
71
2956
29618
22
11
2951
29678
—
23
0
2950
29689
—
17
12
2706
28740
13
53
2176
23576
carbamazepine; oral, rectal
N03AF01 [21604417]
N03AF01 [21604417]
7.8e-01
9.8e-01
1.3e+00
—
1.2e+00
1.4e+00
1.2e+00
cases:1.48%
controls:0.69%
cases:1.24%
controls:0.47%
cases:0.37%
controls:0.10%
—
—
cases:0.38%
controls:0.12%
cases:1.73%
controls:0.44%
cases:2.24%
controls:0.66%
44
204
2929
29485
37
140
2936
29549
11
30
2962
29659
—
11
36
2863
29594
47
126
2676
28626
49
155
2140
23474
Fasting glucose [Moles/volume] in Serum or Plasma
14771-0 [3018251]
14771-0 [3018251]
8.1e-02
2.1e-01
6.8e-01
3.1e+00
1.7e+00
1.5e-01
1.3e-01
cases:28.25%
controls:26.65%
cases:19.68%
controls:16.56%
cases:3.67%
controls:1.90%
cases:1.11%
controls:0.05%
cases:9.26%
controls:1.84%
cases:18.84%
controls:16.68%
cases:38.56%
controls:35.55%
840
7912
2133
21777
585
4917
2388
24772
109
564
2864
29125
33
15
2940
29674
266
546
2608
29084
513
4795
2210
23957
844
8400
1345
15229
Ophthalmology
18 [38004463]
18 [38004463]
3.5e-01
4.4e-01
6.1e-01
2.5e+00
8.8e-01
6.3e-01
2.5e-01
cases:24.05%
controls:18.28%
cases:12.21%
controls:8.22%
cases:2.69%
controls:1.49%
cases:0.81%
controls:0.07%
cases:3.79%
controls:1.60%
cases:14.76%
controls:8.47%
cases:25.99%
controls:21.47%
715
5426
2258
24263
363
2441
2610
27248
80
441
2893
29248
24
20
2949
29669
109
475
2765
29155
402
2436
2321
26316
569
5073
1620
18556
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
5.1e-01
6.1e-01
1.4e+00
—
1.9e+00
6.3e-01
5.5e-01
cases:10.70%
controls:6.71%
cases:6.16%
controls:3.44%
cases:2.12%
controls:0.51%
—
—
cases:3.51%
controls:0.56%
cases:6.76%
controls:3.71%
cases:15.76%
controls:9.76%
318
1993
2655
27696
183
1022
2790
28667
63
151
2910
29538
—
101
166
2773
29464
184
1066
2539
27686
345
2306
1844
21323
Speech disorder
N19 [2002000730]
N19 [2002000730]
1.5e+00
—
—
—
—
3.4e+00
2.2e+00
cases:0.20%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.51%
controls:0.02%
cases:0.50%
controls:0.06%
6
14
2967
29675
—
—
—
—
14
5
2709
28747
11
13
2178
23616
Standard cardiac ultrasound examination
FM1AE [2001303278]
FM1AE [2001303278]
4.4e-01
4.7e-01
1.2e+00
1.0e+50
2.1e+00
8.3e-01
5.2e-01
cases:4.74%
controls:3.11%
cases:2.09%
controls:1.31%
cases:0.44%
controls:0.13%
cases:1.72%
controls:0.00%
cases:1.04%
controls:0.13%
cases:2.42%
controls:1.07%
cases:5.34%
controls:3.26%
141
924
2832
28765
62
389
2911
29300
13
38
2960
29651
51
0
2922
29689
30
38
2844
29592
66
309
2657
28443
117
771
2072
22858
Body temperature
8310-5 [3020891]
8310-5 [3020891]
5.4e-01
8.3e-01
1.4e+00
1.0e+50
3.6e+00
1.0e+00
9.7e-01
cases:0.94%
controls:0.55%
cases:0.57%
controls:0.25%
cases:0.17%
controls:0.04%
cases:0.34%
controls:0.00%
cases:1.11%
controls:0.03%
cases:0.88%
controls:0.33%
cases:2.74%
controls:1.06%
28
164
2945
29525
17
74
2956
29615
5
12
2968
29677
10
0
2963
29689
32
9
2842
29621
24
94
2699
28658
60
251
2129
23378
rosuvastatin; oral
C10AA07 [21601862]
C10AA07 [21601862]
3.5e-01
3.5e-01
4.0e-01
2.3e+00
1.1e+00
8.0e-01
6.6e-01
cases:7.74%
controls:5.60%
cases:7.20%
controls:5.20%
cases:2.32%
controls:1.57%
cases:0.50%
controls:0.05%
cases:4.28%
controls:1.48%
cases:11.83%
controls:5.69%
cases:15.81%
controls:8.83%
230
1664
2743
28025
214
1544
2759
28145
69
465
2904
29224
15
15
2958
29674
123
438
2751
29192
322
1637
2401
27115
346
2087
1843
21542
Type 2 diabetes mellitus, with multiple complications
E11.7 [45561950]
E11.7 [45561950]
7.9e-01
1.2e+00
1.0e+00
—
1.6e+00
9.4e-01
1.0e+00
cases:1.98%
controls:0.91%
cases:1.78%
controls:0.55%
cases:0.44%
controls:0.16%
—
—
cases:0.63%
controls:0.12%
cases:1.62%
controls:0.64%
cases:3.52%
controls:1.33%
59
271
2914
29418
53
164
2920
29525
13
47
2960
29642
—
18
37
2856
29593
44
183
2679
28569
77
314
2112
23315
Old myocardial infarction
I25.2 [45601025]
I25.2 [45601025]
4.3e-01
7.4e-01
1.6e+00
—
1.8e+00
7.8e-01
6.1e-01
cases:1.95%
controls:1.27%
cases:1.08%
controls:0.52%
cases:0.44%
controls:0.09%
—
—
cases:0.73%
controls:0.12%
cases:1.36%
controls:0.63%
cases:2.79%
controls:1.53%
58
378
2915
29311
32
154
2941
29535
13
27
2960
29662
—
21
35
2853
29595
37
181
2686
28571
61
362
2128
23267
Acute cystitis
N30.0 [45601724]
N30.0 [45601724]
4.8e-01
6.9e-01
1.5e+00
—
1.5e+00
6.9e-01
6.2e-01
cases:2.76%
controls:1.72%
cases:1.45%
controls:0.73%
cases:0.47%
controls:0.10%
—
—
cases:0.31%
controls:0.07%
cases:1.80%
controls:0.91%
cases:5.07%
controls:2.79%
82
511
2891
29178
43
218
2930
29471
14
30
2959
29659
—
9
21
2865
29609
49
261
2674
28491
111
660
2078
22969
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
14732-2 [3021960]
4.9e-01
7.4e-01
1.5e+00
—
2.0e+00
4.9e-01
3.4e-01
cases:4.68%
controls:2.93%
cases:4.44%
controls:2.18%
cases:0.94%
controls:0.22%
—
—
cases:1.88%
controls:0.26%
cases:4.08%
controls:2.54%
cases:10.96%
controls:8.04%
139
870
2834
28819
132
646
2841
29043
28
66
2945
29623
—
54
77
2820
29553
111
729
2612
28023
240
1900
1949
21729
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
W01 [45756243]
6.8e-01
9.5e-01
1.1e+00
—
1.3e+00
9.4e-01
4.8e-01
cases:8.44%
controls:4.48%
cases:4.20%
controls:1.67%
cases:0.84%
controls:0.27%
—
—
cases:1.15%
controls:0.31%
cases:4.66%
controls:1.88%
cases:10.60%
controls:6.84%
251
1330
2722
28359
125
496
2848
29193
25
81
2948
29608
—
33
91
2841
29539
127
541
2596
28211
232
1617
1957
22012
Limited function/disability (N)
N28 [2002000733]
N28 [2002000733]
8.2e-01
2.0e+00
—
—
—
1.8e+00
1.7e+00
cases:0.17%
controls:0.07%
cases:0.30%
controls:0.04%
—
—
—
—
—
—
cases:0.33%
controls:0.06%
cases:0.82%
controls:0.15%
5
22
2968
29667
9
12
2964
29677
—
—
—
9
16
2714
28736
18
36
2171
23593
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
5794-3 [3011397]
4.5e-01
5.9e-01
1.2e+00
—
1.8e+00
7.4e-01
6.6e-01
cases:6.16%
controls:4.03%
cases:4.31%
controls:2.44%
cases:1.18%
controls:0.35%
—
—
cases:2.47%
controls:0.41%
cases:5.29%
controls:2.59%
cases:12.84%
controls:7.05%
183
1197
2790
28492
128
724
2845
28965
35
104
2938
29585
—
71
122
2803
29508
144
745
2579
28007
281
1665
1908
21964
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
29265-6 [3020059]
4.2e-01
1.0e+00
1.1e+00
—
1.5e+00
7.0e-01
6.7e-01
cases:5.05%
controls:3.36%
cases:4.71%
controls:1.73%
cases:0.74%
controls:0.25%
—
—
cases:1.22%
controls:0.26%
cases:3.45%
controls:1.75%
cases:9.37%
controls:5.01%
150
999
2823
28690
140
515
2833
29174
22
74
2951
29615
—
35
78
2839
29552
94
502
2629
28250
205
1183
1984
22446
Albumin [Mass/volume] in Cerebral spinal fluid
1746-7 [3024474]
1746-7 [3024474]
1.3e+00
2.5e+00
—
1.0e+50
1.0e+50
2.9e+00
—
cases:0.27%
controls:0.07%
cases:0.40%
controls:0.03%
—
—
cases:0.17%
controls:0.00%
cases:0.42%
controls:0.00%
cases:0.33%
controls:0.02%
—
—
8
22
2965
29667
12
10
2961
29679
—
5
0
2968
29689
12
0
2862
29630
9
5
2714
28747
—
Ambulatory ECG
XF404 [2001303370]
XF404 [2001303370]
4.2e-01
9.8e-01
—
1.0e+50
2.7e+00
1.7e+00
6.0e-01
cases:1.72%
controls:1.13%
cases:0.74%
controls:0.28%
—
—
cases:0.40%
controls:0.00%
cases:0.42%
controls:0.03%
cases:1.32%
controls:0.24%
cases:1.42%
controls:0.78%
51
336
2922
29353
22
83
2951
29606
—
12
0
2961
29689
12
8
2862
29622
36
70
2687
28682
31
185
2158
23444
insulin (human); parenteral
A10AB01 [21600715]
A10AB01 [21600715]
7.2e-01
9.3e-01
1.1e+00
—
1.0e+00
9.2e-01
7.7e-01
cases:2.66%
controls:1.32%
cases:2.32%
controls:0.93%
cases:0.74%
controls:0.26%
—
—
cases:0.70%
controls:0.25%
cases:2.09%
controls:0.85%
cases:2.38%
controls:1.11%
79
391
2894
29298
69
277
2904
29412
22
76
2951
29613
—
20
75
2854
29555
57
243
2666
28509
52
263
2137
23366
lacosamide; oral, parenteral
N03AX18 [21604440]
N03AX18 [21604440]
1.6e+00
—
—
—
—
2.9e+00
2.5e+00
cases:0.17%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.44%
controls:0.02%
cases:0.41%
controls:0.03%
5
10
2968
29679
—
—
—
—
12
7
2711
28745
9
8
2180
23621
Mild cognitive disorder
F06.7 [45605450]
F06.7 [45605450]
4.8e-01
1.2e+00
3.0e+00
1.0e+50
2.0e+00
1.2e+00
6.4e-01
cases:0.47%
controls:0.29%
cases:0.61%
controls:0.19%
cases:0.34%
controls:0.02%
cases:0.27%
controls:0.00%
cases:0.17%
controls:0.02%
cases:0.73%
controls:0.21%
cases:1.23%
controls:0.65%
14
87
2959
29602
18
57
2955
29632
10
5
2963
29684
8
0
2965
29689
5
7
2869
29623
20
61
2703
28691
27
154
2162
23475
Type 2 diabetes mellitus
E11 [45571656]
E11 [45571656]
2.1e-01
4.0e-01
8.7e-01
2.6e+00
7.9e-01
4.6e-01
2.9e-01
cases:7.97%
controls:6.55%
cases:4.04%
controls:2.75%
cases:0.84%
controls:0.35%
cases:0.27%
controls:0.02%
cases:0.84%
controls:0.38%
cases:4.22%
controls:2.71%
cases:8.82%
controls:6.74%
237
1946
2736
27743
120
817
2853
28872
25
105
2948
29584
8
6
2965
29683
24
113
2850
29517
115
780
2608
27972
193
1592
1996
22037
Other specified special examinations
Z01.8 [45581003]
Z01.8 [45581003]
5.4e-01
9.2e-01
9.5e-01
—
2.2e+00
1.1e+00
6.0e-01
cases:4.41%
controls:2.61%
cases:2.22%
controls:0.89%
cases:0.27%
controls:0.10%
—
—
cases:0.70%
controls:0.08%
cases:2.39%
controls:0.79%
cases:5.12%
controls:2.89%
131
776
2842
28913
66
265
2907
29424
8
31
2965
29658
—
20
23
2854
29607
65
226
2658
28526
112
682
2077
22947
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19258-3 [3004529]
19258-3 [3004529]
6.4e-01
6.0e-01
1.8e+00
—
2.9e+00
6.7e-01
4.0e-01
cases:1.21%
controls:0.64%
cases:0.77%
controls:0.43%
cases:0.34%
controls:0.05%
—
—
cases:1.08%
controls:0.06%
cases:0.99%
controls:0.51%
cases:2.60%
controls:1.75%
36
191
2937
29498
23
127
2950
29562
10
16
2963
29673
—
31
18
2843
29612
27
147
2696
28605
57
414
2132
23215
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
3.4e-01
7.7e-03
2.8e-01
2.9e+00
1.2e+00
5.6e-01
3.3e-01
cases:8.85%
controls:6.49%
cases:1.88%
controls:1.87%
cases:0.30%
controls:0.23%
cases:0.30%
controls:0.02%
cases:0.56%
controls:0.16%
cases:2.57%
controls:1.49%
cases:6.12%
controls:4.49%
263
1926
2710
27763
56
555
2917
29134
9
68
2964
29621
9
5
2964
29684
16
48
2858
29582
70
427
2653
28325
134
1060
2055
22569
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
2465-3 [3005719]
2.7e-01
8.3e-01
1.5e+00
—
2.3e+00
7.4e-01
1.2e-01
cases:1.35%
controls:1.03%
cases:1.28%
controls:0.56%
cases:0.37%
controls:0.08%
—
—
cases:0.84%
controls:0.08%
cases:1.10%
controls:0.53%
cases:1.60%
controls:1.42%
40
307
2933
29382
38
167
2935
29522
11
25
2962
29664
—
24
25
2850
29605
30
152
2693
28600
35
335
2154
23294
Oxygen saturation in Venous blood
2711-0 [3024928]
2711-0 [3024928]
1.2e+00
1.4e+00
—
1.0e+50
—
1.8e+00
9.8e-01
cases:0.74%
controls:0.23%
cases:0.37%
controls:0.09%
—
—
cases:0.24%
controls:0.00%
—
—
cases:0.66%
controls:0.11%
cases:1.19%
controls:0.45%
22
68
2951
29621
11
28
2962
29661
—
7
0
2966
29689
—
18
31
2705
28721
26
106
2163
23523
gabapentin; oral
N02BF01 [955005]
N02BF01 [955005]
7.0e-01
8.3e-01
9.5e-01
—
1.1e+00
1.0e+00
7.1e-01
cases:4.47%
controls:2.28%
cases:2.89%
controls:1.28%
cases:0.94%
controls:0.37%
—
—
cases:1.18%
controls:0.39%
cases:4.11%
controls:1.51%
cases:6.90%
controls:3.52%
133
678
2840
29011
86
381
2887
29308
28
109
2945
29580
—
34
116
2840
29514
112
433
2611
28319
151
831
2038
22798
Headache
N01 [2002000720]
N01 [2002000720]
7.9e-01
1.1e+00
2.7e+00
1.0e+50
—
9.4e-01
7.0e-01
cases:1.65%
controls:0.75%
cases:0.64%
controls:0.21%
cases:0.30%
controls:0.02%
cases:0.17%
controls:0.00%
—
—
cases:0.51%
controls:0.20%
cases:1.64%
controls:0.82%
49
223
2924
29466
19
63
2954
29626
9
6
2964
29683
5
0
2968
29689
—
14
58
2709
28694
36
194
2153
23435
Bicarbonate [Moles/volume] in Venous blood
14627-4 [3027273]
14627-4 [3027273]
6.6e-01
6.0e-01
1.9e+00
—
2.8e+00
6.9e-01
4.2e-01
cases:1.38%
controls:0.72%
cases:0.84%
controls:0.46%
cases:0.37%
controls:0.06%
—
—
cases:1.18%
controls:0.07%
cases:0.99%
controls:0.50%
cases:2.56%
controls:1.70%
41
214
2932
29475
25
138
2948
29551
11
17
2962
29672
—
34
22
2840
29608
27
143
2696
28609
56
401
2133
23228
citalopram; oral, parenteral
N06AB04 [21604712]
N06AB04 [21604712]
7.5e-01
8.3e-01
1.2e+00
—
7.1e-01
9.2e-01
8.9e-01
cases:6.02%
controls:2.94%
cases:4.04%
controls:1.80%
cases:1.45%
controls:0.45%
—
—
cases:0.94%
controls:0.46%
cases:4.37%
controls:1.78%
cases:6.67%
controls:2.85%
179
874
2794
28815
120
534
2853
29155
43
134
2930
29555
—
27
137
2847
29493
119
512
2604
28240
146
673
2043
22956
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
N03AG01 [21604422]
6.0e-01
9.0e-01
8.8e-01
—
1.7e+00
1.3e+00
1.4e+00
cases:1.11%
controls:0.61%
cases:1.18%
controls:0.48%
cases:0.44%
controls:0.18%
—
—
cases:0.87%
controls:0.17%
cases:1.95%
controls:0.53%
cases:2.70%
controls:0.71%
33
181
2940
29508
35
143
2938
29546
13
54
2960
29635
—
25
49
2849
29581
53
151
2670
28601
59
167
2130
23462
CT angiography of head and neck vasculature
PA7AD [2001300233]
PA7AD [2001300233]
1.2e+00
2.2e+00
—
1.0e+50
1.0e+50
1.9e+00
9.6e-01
cases:0.44%
controls:0.13%
cases:0.47%
controls:0.05%
—
—
cases:2.46%
controls:0.00%
cases:0.35%
controls:0.00%
cases:0.55%
controls:0.08%
cases:0.69%
controls:0.26%
13
40
2960
29649
14
16
2959
29673
—
73
0
2900
29689
10
0
2864
29630
15
24
2708
28728
15
62
2174
23567
duloxetine; oral
N06AX21 [21604749]
N06AX21 [21604749]
6.2e-01
8.1e-01
9.7e-01
—
8.9e-01
1.0e+00
9.1e-01
cases:2.15%
controls:1.17%
cases:1.51%
controls:0.68%
cases:0.64%
controls:0.24%
—
—
cases:0.66%
controls:0.27%
cases:2.06%
controls:0.74%
cases:3.65%
controls:1.50%
64
348
2909
29341
45
201
2928
29488
19
72
2954
29617
—
19
81
2855
29549
56
214
2667
28538
80
355
2109
23274
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
4.7e-01
5.6e-01
1.5e+00
—
1.8e+00
5.5e-01
4.3e-01
cases:8.61%
controls:5.55%
cases:5.42%
controls:3.17%
cases:2.02%
controls:0.47%
—
—
cases:2.92%
controls:0.52%
cases:5.77%
controls:3.41%
cases:13.39%
controls:9.14%
256
1647
2717
28042
161
941
2812
28748
60
141
2913
29548
—
84
154
2790
29476
157
980
2566
27772
293
2160
1896
21469
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]
95941-1 [36031861]
3.4e-01
6.9e-01
2.7e+00
1.0e+50
1.8e+00
6.9e-01
7.5e-01
cases:0.54%
controls:0.38%
cases:0.71%
controls:0.36%
cases:0.44%
controls:0.03%
cases:0.30%
controls:0.00%
cases:0.35%
controls:0.06%
cases:0.73%
controls:0.37%
cases:2.97%
controls:1.43%
16
114
2957
29575
21
106
2952
29583
13
9
2960
29680
9
0
2964
29689
10
17
2864
29613
20
106
2703
28646
65
338
2124
23291
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
72160-5 [43054903]
4.9e-01
8.3e-01
1.1e+00
—
1.9e+00
5.2e-01
3.7e-01
cases:12.78%
controls:8.20%
cases:9.08%
controls:4.16%
cases:1.45%
controls:0.50%
—
—
cases:2.92%
controls:0.44%
cases:7.42%
controls:4.55%
cases:18.50%
controls:13.55%
380
2435
2593
27254
270
1234
2703
28455
43
149
2930
29540
—
84
129
2790
29501
202
1308
2521
27444
405
3202
1784
20427
potassium chloride; oral
A12BA01 [21600877]
A12BA01 [21600877]
6.6e-01
7.8e-01
9.9e-01
—
1.2e+00
9.0e-01
6.8e-01
cases:4.27%
controls:2.25%
cases:2.86%
controls:1.33%
cases:0.98%
controls:0.36%
—
—
cases:1.36%
controls:0.41%
cases:3.67%
controls:1.53%
cases:6.58%
controls:3.44%
127
669
2846
29020
85
395
2888
29294
29
108
2944
29581
—
39
122
2835
29508
100
440
2623
28312
144
812
2045
22817
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2324-2 [3026910]
1.6e-01
5.9e-01
1.1e+00
—
2.7e+00
4.8e-01
3.2e-01
cases:13.22%
controls:11.46%
cases:9.28%
controls:5.39%
cases:1.85%
controls:0.63%
—
—
cases:8.32%
controls:0.58%
cases:8.19%
controls:5.23%
cases:19.64%
controls:15.13%
393
3403
2580
26286
276
1601
2697
28088
55
186
2918
29503
—
239
173
2635
29457
223
1505
2500
27247
430
3575
1759
20054
Aid fitting and borrowing and monitoring of use
SPAT1230 [2001700331]
SPAT1230 [2001700331]
2.9e-01
7.2e-01
1.1e+00
—
1.9e+00
8.9e-01
6.0e-01
cases:3.50%
controls:2.64%
cases:1.98%
controls:0.98%
cases:0.44%
controls:0.14%
—
—
cases:0.87%
controls:0.13%
cases:2.57%
controls:1.07%
cases:5.71%
controls:3.21%
104
785
2869
28904
59
290
2914
29399
13
43
2960
29646
—
25
39
2849
29591
70
309
2653
28443
125
759
2064
22870
Cervical spine MRI examination with high intensity magnet
NA1BG [2001306990]
NA1BG [2001306990]
9.3e-01
1.5e+00
—
—
—
1.8e+00
9.5e-01
cases:0.87%
controls:0.35%
cases:0.47%
controls:0.10%
—
—
—
—
—
—
cases:0.48%
controls:0.08%
cases:0.87%
controls:0.34%
26
103
2947
29586
14
30
2959
29659
—
—
—
13
23
2710
28729
19
80
2170
23549
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
620-5 [3007853]
5.2e-01
8.1e-01
1.7e+00
—
1.5e+00
1.5e-01
6.8e-01
cases:2.99%
controls:1.80%
cases:1.41%
controls:0.63%
cases:0.34%
controls:0.06%
—
—
cases:0.45%
controls:0.10%
cases:0.84%
controls:0.73%
cases:4.52%
controls:2.34%
89
535
2884
29154
42
188
2931
29501
10
19
2963
29670
—
13
29
2861
29601
23
210
2700
28542
99
552
2090
23077
Methemoglobin/Hemoglobin.total in Venous blood
2617-9 [3024889]
2617-9 [3024889]
7.0e-01
8.0e-01
1.9e+00
1.0e+50
3.1e+00
8.7e-01
5.6e-01
cases:1.21%
controls:0.60%
cases:0.71%
controls:0.32%
cases:0.20%
controls:0.03%
cases:0.54%
controls:0.00%
cases:0.94%
controls:0.04%
cases:0.99%
controls:0.42%
cases:2.47%
controls:1.42%
36
179
2937
29510
21
95
2952
29594
6
9
2967
29680
16
0
2957
29689
27
13
2847
29617
27
120
2696
28632
54
336
2135
23293
Cerebrovascular disease
K91 [2002000618]
K91 [2002000618]
2.3e+00
—
—
—
1.0e+50
—
2.9e+00
cases:0.30%
controls:0.03%
—
—
—
—
—
—
cases:0.35%
controls:0.00%
—
—
cases:1.14%
controls:0.06%
9
9
2964
29680
—
—
—
10
0
2864
29630
—
25
15
2164
23614
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
14675-3 [3036481]
4.9e-01
8.9e-01
9.6e-01
—
2.4e+00
9.2e-01
5.1e-01
cases:2.05%
controls:1.26%
cases:1.14%
controls:0.47%
cases:0.20%
controls:0.08%
—
—
cases:0.73%
controls:0.07%
cases:1.43%
controls:0.57%
cases:2.70%
controls:1.64%
61
375
2912
29314
34
141
2939
29548
6
23
2967
29666
—
21
20
2853
29610
39
165
2684
28587
59
387
2130
23242
Other gastroenteritis and colitis of infectious and unspecified origin
A09 [45605189]
A09 [45605189]
5.4e-01
7.8e-01
2.4e+00
—
—
7.8e-01
7.0e-01
cases:2.96%
controls:1.75%
cases:1.14%
controls:0.53%
cases:0.40%
controls:0.04%
—
—
—
—
cases:1.25%
controls:0.58%
cases:4.39%
controls:2.23%
88
519
2885
29170
34
156
2939
29533
12
11
2961
29678
—
—
34
166
2689
28586
96
528
2093
23101
IgG [Mass/volume] in Cerebral spinal fluid
2464-6 [3007368]
2464-6 [3007368]
1.3e+00
2.3e+00
—
1.0e+50
1.0e+50
2.9e+00
—
cases:0.27%
controls:0.07%
cases:0.40%
controls:0.04%
—
—
cases:0.17%
controls:0.00%
cases:0.42%
controls:0.00%
cases:0.37%
controls:0.02%
—
—
8
22
2965
29667
12
12
2961
29677
—
5
0
2968
29689
12
0
2862
29630
10
6
2713
28746
—
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
966
3470
3.60
216.42
2.1
1.9
29.25
29.96
s
3.20
934
3339
1497
7536
2.93
181.97
2.9
2.1
203.12
243.19
u/l
0.67
1435
7024
190
420
4.75
79.95
1.4
1.3
41.54
46.53
e6/l
0.05
132
316
190
425
4.69
78.79
1.5
1.4
1270.54
545.63
e6/l
0.63
136
334
190
443
4.50
74.78
1.3
1.3
3.73
3.74
mmol/l
0.05
180
411
203
502
4.25
74.04
1.5
1.3
505.18
619.76
mg/l
2.57
194
471
1756
12696
1.89
62.85
25.2
18.5
1.42
1.35
inr
4.57
1498
10693
524
2495
2.32
60.29
2.9
2.4
4.98
6.99
ug/l
2.03
460
2153
984
5985
1.95
59.10
4.7
4.1
84.03
85.02
%
0.53
963
5847
631
3284
2.16
58.22
7.2
6.9
5.06
5.10
kpa
0.45
603
3138
630
3282
2.15
57.96
7.2
6.9
11.87
11.81
kpa
0.11
602
3139
1955
14906
1.86
56.17
6.6
5.0
6.92
6.86
mmol/l
0.63
1888
14157
620
3272
2.12
54.84
7.2
6.9
1.19
1.05
mmol/l
0.38
492
2646
106
224
4.86
46.95
1.3
1.2
1.66
2.65
u/ml
0.70
32
80
553
2953
2.06
46.69
7.5
7.1
95.15
95.19
%
0.03
531
2844
612
3450
1.96
44.11
2.1
1.8
—
—
—
0
0
98
211
4.76
42.45
1.3
1.2
5.65
4.13
u/ml
0.41
40
98
506
2702
2.04
42.38
7.9
7.6
118.71
119.46
g/l
0.34
492
2634
632
3679
1.90
41.07
2.1
1.8
—
—
—
0
0
823
5261
1.77
39.15
5.1
4.1
212.16
643.96
ng/l
1.75
708
4505
366
1786
2.19
38.64
7.0
6.3
24.70
24.50
mmol/l
0.41
350
1707
463
2472
2.02
38.53
3.3
2.9
4.58
4.39
kpa
1.05
451
2398
527
2961
1.94
37.81
4.0
3.4
5.90
5.81
kpa
1.09
514
2872
465
2507
2.00
37.59
6.9
6.6
1.37
1.38
mmol/l
0.04
456
2448
1575
12051
1.63
37.26
5.5
4.8
34.59
34.83
g/l
0.88
1475
11206
824
5338
1.74
37.08
1.8
1.8
1167.38
1169.84
nmol/l
0.03
653
3964
511
2866
1.94
36.77
4.4
3.5
1.80
1.80
mmol/l
0.01
454
2454
89
207
4.39
35.06
1.1
1.1
—
—
—
0
0
1567
12118
1.60
34.36
7.7
6.4
1.20
1.21
mmol/l
5.76
1489
11105
150
506
3.06
34.04
2.4
2.5
195.86
206.09
%
0.71
145
477
1714
13596
1.59
33.27
8.8
7.2
1.20
1.21
mmol/l
4.31
1548
11646
757
4955
1.70
32.07
2.2
1.9
—
—
—
0
0
54
90
6.08
31.01
1.3
1.1
0.56
0.50
ratio
0.69
31
52
847
5807
1.63
29.59
6.1
4.5
1.03
1.27
kg/l
0.46
606
3972
59
113
5.29
29.28
1.3
1.1
—
—
—
0
0
64
133
4.88
28.95
1.3
1.1
36.46
43.53
mg/l
0.87
57
113
1984
16551
1.56
28.74
6.8
5.2
321.32
2827.01
e6/l
3.73
28
285
348
1858
1.98
28.50
3.4
3.0
127.96
127.00
g/l
0.34
341
1807
1535
12129
1.53
28.39
2.5
2.2
92.39
94.22
pmol/l
0.83
869
6397
1341
10293
1.53
28.38
5.8
4.3
41.62
95.38
ng/l
2.02
1079
7995
301
1546
2.05
27.44
3.1
2.5
0.66
0.62
%
1.47
301
1537
61
128
4.83
27.29
1.2
1.0
287.44
291.73
mg/l
0.05
55
111
92
271
3.46
26.08
4.0
5.2
343.18
341.55
umol/l
0.04
85
243
57
119
4.85
25.67
1.2
1.0
—
—
—
0
0
331
1801
1.94
25.54
9.1
8.5
93.64
93.69
%
0.05
331
1790
74
193
3.90
25.08
1.5
1.2
—
—
—
0
0
1149
8766
1.49
23.74
4.3
3.5
58.57
87.07
e6/l
1.22
917
6829
1006
7520
1.50
22.72
4.1
3.4
0.52
0.47
e6/l
0.29
779
5656
354
2047
1.82
22.49
1.8
1.6
—
—
—
0
0
1242
9719
1.46
22.12
5.1
4.1
140.67
120.71
e6/l
0.16
921
7085
1593
13072
1.45
22.06
5.5
4.2
0.00
4.86
estimate
2.44
289
2891
63
162
3.94
21.80
1.1
1.0
—
—
—
0
0
548
3605
1.63
21.74
6.5
5.5
1.04
1.05
mmol/l
0.09
515
3327
642
4393
1.58
21.60
3.1
3.0
0.82
0.82
mmol/l
0.36
606
4091
1597
13160
1.44
21.31
5.5
4.2
0.04
0.12
estimate
0.32
267
2699
673
4670
1.56
21.26
3.5
3.1
1.75
1.11
e6/l
0.97
375
2567
265
1421
1.94
21.25
3.5
3.3
25.46
25.16
mmol/l
0.79
257
1365
784
5641
1.52
20.94
3.2
3.1
2.46
2.46
mmol/l
0.59
706
5040
44
88
5.05
20.85
1.5
1.2
—
—
—
0
0
286
1583
1.89
20.83
5.1
3.5
24.23
24.04
mmol/l
0.43
281
1560
2062
17870
1.47
20.72
35.6
24.2
330.45
331.25
g/l
3.49
2050
17729
1495
12215
1.43
20.63
6.3
5.9
0.63
0.62
e9/l
1.52
1279
10279
1404
11342
1.44
20.61
3.3
2.9
—
—
estimate
—
0
0
1499
12259
1.43
20.55
6.4
6.0
0.04
0.04
e9/l
0.70
1285
10328
46
97
4.79
20.51
1.0
1.0
1.56
1.27
u/l
0.38
18
49
194
943
2.12
20.39
4.3
3.5
1.28
1.42
mmol/l
1.35
189
925
282
1566
1.88
20.32
9.3
9.5
15.73
15.76
%
0.07
271
1507
1068
8222
1.46
20.21
1.9
1.7
19.02
19.98
nmol/l
1.21
952
6875
986
7490
1.46
19.95
2.8
2.4
2.99
2.96
mg/l
0.15
865
6389
1556
12870
1.42
19.69
5.5
4.2
0.00
0.00
estimate
0.80
277
2799
246
1338
1.91
18.87
4.8
5.0
1.59
1.55
%
0.27
231
1266
123
511
2.46
18.74
1.8
2.6
27.58
35.20
umol/l
3.66
106
453
288
1652
1.82
18.68
9.0
8.4
24.18
24.27
mmol/l
0.17
277
1604
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
46
105
4.42
18.64
1.2
1.1
—
—
—
0
0
1509
12486
1.41
18.64
6.4
6.0
1.88
1.86
e9/l
0.08
1317
10789
1166
9242
1.42
18.35
3.3
3.5
2.34
2.35
mmol/l
1.55
1056
8315
410
2618
1.65
18.07
6.9
6.3
10.74
11.60
mmol/l
1.20
394
2485
38
76
5.04
18.03
1.2
1.1
1.05
1.07
ratio
0.52
33
59
828
6196
1.46
17.70
3.3
2.7
5.08
5.39
e6/l
0.34
764
5634
1514
12612
1.39
17.56
6.6
6.2
0.20
0.20
e9/l
0.23
1318
10797
1649
13990
1.38
16.82
3.5
3.2
51.79
54.73
u/l
0.51
1550
12793
606
4310
1.50
16.59
3.7
3.3
2.82
2.20
e6/l
0.81
307
2199
224
1234
1.88
16.50
5.0
5.1
0.84
0.87
%
0.48
209
1163
391
2532
1.62
16.21
3.3
3.1
238.35
251.25
ng/l
0.22
367
2313
707
5208
1.46
16.18
2.1
1.6
1.55
1.57
mg/l
0.03
555
4074
132
606
2.23
16.04
2.4
2.3
3.63
3.65
g/l
0.04
127
577
663
4831
1.47
16.03
3.0
2.6
11.00
12.14
umol/l
4.42
615
4449
1628
13859
1.37
15.83
9.2
9.3
4.55
4.30
e9/l
3.53
1420
11907
125
568
2.25
15.58
6.1
6.9
105.63
105.11
mmol/l
0.69
112
507
125
568
2.25
15.58
6.1
6.9
11.16
11.33
mmol/l
0.22
112
507
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
178
927
1.97
15.52
3.2
2.5
0.36
0.33
iu/ml
0.62
102
495
808
6170
1.42
15.04
2.9
2.5
—
—
—
0
0
122
560
2.22
14.85
1.4
1.3
—
—
—
0
0
122
560
2.22
14.85
1.4
1.3
—
—
—
0
0
51
150
3.43
14.61
1.2
1.2
2.01
2.16
mmol/l
0.54
45
138
1586
13547
1.35
14.56
6.1
6.4
11.44
12.34
umol/l
1.87
1518
12902
1990
17602
1.37
14.54
5.0
4.4
14.44
14.14
mm/h
0.34
1882
16196
455
3139
1.52
14.21
12.0
8.0
—
—
—
0
0
388
2611
1.55
13.55
2.3
2.7
65.83
65.97
g/l
0.14
358
2372
233
1379
1.74
13.53
2.5
2.5
15.91
22.88
au/ml
0.95
16
113
216
1255
1.77
13.38
1.4
1.3
42.86
55.82
au/ml
—
10
95
1957
17371
1.35
13.30
4.6
4.3
15.08
15.06
pmol/l
0.17
1793
15600
40
108
3.73
13.03
1.7
2.1
—
—
—
0
0
1150
9519
1.33
12.36
3.7
3.3
1877.86
1821.64
ng/l
0.14
1020
8307
567
4199
1.43
12.21
3.1
2.6
19.64
21.76
%
3.83
530
3864
926
7440
1.35
12.13
6.0
4.3
0.00
0.00
estimate
1.54
252
2502
2092
18887
1.33
11.86
8.7
8.2
81.78
81.81
u/l
0.01
1993
17819
603
4539
1.41
11.80
3.1
2.6
2.26
2.26
g/l
0.11
562
4158
29
67
4.35
11.65
1.1
1.1
—
—
—
0
0
168
949
1.81
11.45
2.3
2.1
327.98
755.45
ug/l
1.19
163
898
994
8170
1.32
10.87
2.9
2.6
62.37
70.36
u/l
0.32
932
7519
300
2006
1.55
10.71
2.8
2.9
60.96
59.82
ml/min/173m2
0.19
134
913
1156
9724
1.30
10.59
5.8
4.3
0.03
0.28
estimate
0.59
226
2305
132
709
1.90
10.57
3.7
3.4
2.04
1.95
index
0.05
68
359
1273
10862
1.29
10.40
3.7
3.1
124.81
147.66
ug/l
3.96
1185
9932
27
65
4.17
10.31
2.3
2.4
50.19
47.16
umol/l
0.16
21
52
2432
22611
1.36
10.30
27.1
18.3
27.87
27.64
mg/l
0.12
2160
19051
161
942
1.74
9.78
1.4
1.2
—
—
—
0
0
31
88
3.54
9.46
1.2
1.1
28.14
258.79
ng/l
—
7
24
1331
11549
1.27
9.09
6.5
6.3
25.29
26.08
%
1.92
1247
10855
808
6593
1.30
8.99
3.7
3.3
0.05
0.05
0.01
22
238
328
2318
1.46
8.95
2.7
2.4
36.41
40.02
u/l
0.41
285
1929
1301
11290
1.26
8.77
6.4
6.1
59.09
58.59
%
0.79
1238
10694
1275
11064
1.26
8.52
2.7
2.4
76.59
79.44
nmol/l
3.27
1146
9758
44
166
2.67
8.34
1.1
1.0
271.50
311.69
ng/l
0.71
30
108
112
618
1.84
8.32
1.2
1.2
—
—
—
0
0
44
167
2.65
8.25
1.1
1.0
36.28
41.77
ng/l
0.53
30
107
44
167
2.65
8.25
1.1
1.0
761.90
695.39
ng/l
0.34
31
104
112
621
1.83
8.20
1.2
1.2
—
—
—
0
0
1975
18063
1.26
8.13
32.4
22.8
14.06
13.88
%
5.99
1956
17795
303
2148
1.45
8.13
2.1
2.2
376.22
383.84
nmol/l
0.28
265
1965
210
3091
0.65
8.03
6.0
5.1
34.39
33.03
%
0.93
145
1901
2245
20868
1.28
7.96
6.1
5.4
1.91
2.03
mu/l
4.14
2098
18876
61
281
2.19
7.53
1.2
1.2
0.18
0.20
nmol/l
0.77
47
233
900
7583
1.26
7.52
3.3
3.1
31.55
36.44
u/l
1.86
847
7106
152
944
1.64
7.46
1.5
1.9
39.80
39.30
u/l
0.10
128
828
25
73
3.44
7.36
2.4
2.7
31.13
29.58
umol/l
0.30
16
49
67
326
2.07
7.21
1.3
1.3
0.58
6.11
nmol/l
0.51
67
312
1316
11605
1.23
7.19
2.9
2.6
—
—
—
0
0
380
2866
1.37
7.13
2.1
2.5
68.77
67.40
e9/l
0.36
272
2135
144
893
1.64
7.12
2.0
1.7
36.08
6.51
iu/ml
0.51
43
199
259
1844
1.44
6.80
2.0
1.7
—
—
—
0
0
67
336
2.01
6.68
1.3
1.3
0.26
0.29
nmol/l
—
7
18
298
2186
1.40
6.62
4.4
3.7
104.64
95.45
ng/l
0.83
266
1859
22
64
3.45
6.54
1.1
1.1
—
—
—
0
0
17
41
4.16
6.52
1.4
1.2
—
—
—
0
0
190
1284
1.51
6.50
2.2
1.9
1.98
2.26
ug/l
0.13
168
1135
32
119
2.70
6.31
1.4
1.2
149.06
142.25
nmol/l
0.23
32
119
24
76
3.17
6.26
1.5
1.1
—
—
—
0
0
131
821
1.62
6.25
1.2
1.2
0.29
0.79
u/ml
0.85
18
61
2278
21419
1.24
6.17
8.3
7.1
41.76
40.19
mmol/mol
10.64
2160
19643
30
110
2.74
6.09
1.2
1.1
—
—
—
0
0
361
2797
1.33
5.66
2.3
2.6
7.58
9.42
umol/l
0.95
311
2484
1176
10435
1.20
5.60
13.5
12.4
0.01
0.00
e9/l
0.29
941
8455
212
1513
1.43
5.53
1.5
1.7
1.57
1.54
g/l
0.15
190
1294
15
28
5.37
5.52
11.4
13.7
5.47
5.71
mmol/l
0.19
15
28
2190
20591
1.22
5.50
5.1
4.4
1.31
1.27
mmol/l
1.65
2040
18349
1022
8979
1.20
5.35
4.2
4.2
10.53
8.42
mg/mmol
0.70
688
5665
781
6686
1.22
5.33
3.1
2.9
358.74
358.35
umol/l
0.03
665
5755
20
63
3.18
5.29
1.5
1.4
45.64
31.68
%
0.68
14
41
2463
23474
1.24
5.25
33.3
22.4
139.53
139.57
mmol/l
0.37
2436
22943
2465
23505
1.24
5.17
33.4
22.7
4.00
4.01
mmol/l
0.18
2432
22937
19
59
3.23
5.15
1.1
1.1
—
—
—
0
0
49
246
2.00
4.96
4.2
3.4
14.82
11.07
index
0.97
28
128
19
61
3.12
4.89
1.1
1.1
—
—
—
0
0
33
142
2.33
4.89
1.3
1.4
1.21
1.04
promille
0.24
25
112
693
5908
1.22
4.88
1.9
1.8
9475905.63
24415148.23
pmol/l
0.72
591
4784
478
3935
1.25
4.66
1.3
1.3
39.69
35.98
iu/ml
0.11
136
1192
1011
8977
1.19
4.54
3.6
3.4
7.13
7.17
mmol/l
0.11
873
7476
129
872
1.50
4.50
1.3
1.3
—
—
—
0
0
43
214
2.02
4.49
1.3
1.7
—
1268.57
—
0
7
10
15
6.67
4.46
1.1
1.5
—
—
—
0
0
54
292
1.86
4.44
1.7
1.4
—
—
—
0
0
560
4714
1.23
4.43
1.3
1.3
2.16
1.45
u/ml
0.49
147
1209
57
314
1.83
4.42
2.7
3.2
9.52
10.47
mmol/l
1.33
57
309
178
1291
1.40
4.30
2.8
3.4
4.17
4.42
pmol/l
3.23
162
1128
421
3447
1.25
4.29
3.7
4.0
230.65
250.01
u/l
3.99
397
3246
103
673
1.55
4.23
1.3
1.5
0.23
19.56
iu/ml
0.90
30
129
27
116
2.33
4.06
1.1
1.1
—
—
—
0
0
155
1109
1.42
4.06
2.3
2.5
9.14
10.32
g/l
2.38
139
991
88
562
1.58
4.01
1.8
1.5
—
—
—
0
0
48
260
1.86
3.96
1.8
1.6
—
—
—
0
0
230
1762
1.33
3.94
2.7
3.0
10.26
10.73
g/l
0.72
212
1609
44
235
1.88
3.80
1.7
1.6
40.60
24.50
u/ml
0.87
15
40
23
95
2.43
3.78
2.0
2.6
66.31
103.98
umol/l
1.06
13
64
17
60
2.84
3.77
1.2
1.1
—
—
—
0
0
53
302
1.76
3.73
1.3
1.3
314.17
300.23
pmol/l
0.09
48
256
23
96
2.40
3.70
4.9
1.7
71.47
63.86
mg/l
0.23
15
66
38
195
1.96
3.70
1.6
1.3
—
—
—
0
0
28
128
2.19
3.68
4.7
3.4
0.75
0.89
index
0.46
28
128
17
61
2.79
3.67
1.1
1.1
—
—
—
0
0
97
1412
0.68
3.59
2.0
2.1
3.40
3.46
ratio
0.18
79
1139
38
198
1.93
3.55
1.6
1.3
—
—
—
0
0
100
678
1.49
3.52
1.6
1.6
—
—
—
0
0
66
1034
0.63
3.48
1.7
1.8
3.02
3.44
mmol/l
1.85
49
763
11
27
4.08
3.38
1.1
1.2
32.50
67.13
%
—
6
8
87
578
1.52
3.38
1.4
1.4
—
—
—
0
0
76
491
1.56
3.35
1.4
1.3
—
—
—
0
0
8
14
5.72
3.33
1.0
2.5
—
—
—
0
0
42
232
1.82
3.31
1.0
1.2
—
—
—
0
0
249
1980
1.28
3.28
1.9
1.7
1.54
1.52
%
0.15
227
1677
171
1292
1.34
3.27
2.2
2.4
7.38
7.45
g/l
0.22
155
1185
74
479
1.56
3.25
1.3
1.3
140.00
380.41
titre
—
6
49
170
1289
1.33
3.18
2.2
2.4
3.60
3.74
g/l
0.59
154
1183
58
357
1.63
3.14
14.4
6.2
7.98
7.26
mmol/l
0.87
48
296
170
1292
1.33
3.14
2.2
2.4
4.18
4.15
g/l
0.18
154
1187
236
1882
1.27
3.05
1.6
1.4
—
—
—
0
0
53
323
1.65
3.00
1.7
1.5
—
—
—
0
0
69
449
1.55
2.99
1.2
1.2
29.00
54.68
u/ml
—
7
46
9
21
4.29
2.98
1.0
1.2
—
—
—
0
0
9
21
4.29
2.98
1.0
1.1
—
—
—
0
0
483
4161
1.19
2.97
1.4
1.5
2.47
2.60
g/l
0.75
273
2451
158
1200
1.33
2.95
2.3
2.5
2.92
2.94
g/l
0.12
142
1094
21
94
2.24
2.95
1.1
1.3
141.80
169.50
mmol/24h
1.18
21
94
57
356
1.61
2.94
5.9
6.2
11.51
12.62
mg/l
1.12
52
328
32
169
1.90
2.93
2.2
2.0
—
—
—
0
0
120
876
1.38
2.89
2.1
2.5
0.00
0.00
g/l
-0.00
111
770
42
243
1.73
2.88
1.9
1.6
—
—
—
0
0
311
2577
1.23
2.88
2.1
2.2
142.82
144.55
ug/g
0.03
263
2035
20
89
2.25
2.85
1.1
1.1
—
—
—
0
0
2478
23970
1.17
2.85
34.7
24.8
86.35
83.49
umol/l
2.41
2454
23588
27
136
1.99
2.83
1.1
1.1
3.69
11.48
nmol/l
—
5
26
18
77
2.34
2.80
1.2
1.1
1864.28
1560.19
miu/ml
0.48
18
77
100
712
1.42
2.79
1.7
1.5
—
—
—
0
0
46
276
1.67
2.78
1.7
1.5
55.50
62.41
%
0.58
32
172
17
72
2.36
2.71
3.5
2.1
0.63
0.61
mmol/l
0.33
17
72
102
738
1.39
2.62
1.8
1.5
0.22
0.31
mg/l
1.51
46
316
13
49
2.65
2.61
1.2
1.8
—
—
—
0
0
309
2592
1.21
2.55
2.0
2.1
0.21
0.20
g/l
0.76
284
2406
42
253
1.67
2.53
1.5
1.3
103665.81
75063.90
e6/l
0.11
26
173
10
31
3.23
2.51
1.1
1.0
—
—
—
0
0
10
31
3.23
2.51
1.1
1.1
—
—
—
0
0
19
88
2.16
2.49
1.1
1.1
—
—
—
0
0
144
1113
1.31
2.43
2.2
2.5
0.98
1.14
g/l
0.18
128
949
2302
22230
1.14
2.39
7.3
6.1
2.27
2.59
mmol/l
58.70
2183
20150
25
131
1.91
2.39
1.5
1.5
62.53
67.96
%
0.25
17
106
9
27
3.33
2.38
1.1
1.2
—
—
—
0
0
2232
21520
1.13
2.35
6.0
5.2
1.37
1.45
mmol/l
17.31
2101
19428
103
763
1.36
2.33
1.3
1.3
—
—
—
0
0
106
789
1.35
2.32
3.9
3.3
1.53
1.67
mmol/l
1.40
106
766
136
1050
1.31
2.32
2.8
2.7
—
—
—
0
0
97
713
1.37
2.30
2.6
2.2
128.49
127.46
g/l
0.15
80
556
73
511
1.44
2.29
1.4
1.4
—
—
—
0
0
106
791
1.35
2.29
3.3
3.3
0.84
0.83
nmol/l
0.12
88
629
21
105
2.00
2.29
1.5
1.9
95.57
100.18
%
0.26
21
100
56
373
1.51
2.26
2.5
2.5
4.11
4.11
mmol/l
0.00
56
368
56
373
1.51
2.26
2.5
2.5
105.02
105.61
mmol/l
0.48
56
368
50
325
1.54
2.25
1.5
1.4
183.94
152.59
au/ml
1.56
17
92
77
548
1.41
2.22
1.3
1.2
—
—
—
0
0
55
368
1.50
2.18
2.5
2.5
1.21
1.19
mmol/l
1.34
55
363
24
129
1.86
2.15
1.1
1.2
88.00
86.29
—
5
7
2428
23575
1.14
2.14
15.0
12.6
26.26
24.72
u/l
0.77
2362
22687
9
30
3.00
2.14
1.1
1.0
—
—
—
0
0
417
3654
1.16
2.10
1.3
1.3
13.58
12.29
u/ml
0.12
149
1280
21
110
1.91
2.04
1.0
1.1
—
—
—
0
0
20
103
1.94
2.04
1.3
1.4
3.27
3.30
mmol/l
0.02
20
95
88
653
1.36
2.01
2.3
2.2
111.76
104.37
ug/min
0.05
48
366
8
26
3.08
2.01
1.1
1.2
—
—
—
0
0
70
503
1.40
1.95
1.3
1.3
27.50
30.70
iu/l
0.37
56
427
8
27
2.96
1.93
1.3
1.2
—
—
—
0
0
19
99
1.92
1.89
1.4
1.3
—
—
—
0
0
7
22
3.18
1.87
1.0
1.0
—
—
—
0
0
39
254
1.54
1.80
2.7
2.7
—
—
—
0
0
102
791
1.30
1.76
1.5
1.4
251.00
272.49
ug/g
0.53
72
482
2482
24209
1.12
1.76
39.5
27.8
91.55
91.72
fl
1.03
2463
23806
2482
24211
1.12
1.75
40.4
28.4
39.12
39.57
%
3.75
2463
23796
2482
24211
1.12
1.75
39.5
27.9
4.34
4.39
e12/l
4.75
2441
23463
2482
24214
1.12
1.73
39.5
28.0
7.22
6.89
e9/l
5.49
2441
23460
2482
24215
1.12
1.73
39.8
28.1
130.41
132.59
g/l
9.89
2462
23824
2481
24207
1.12
1.72
39.6
27.9
243.00
241.72
e9/l
0.41
2448
23560
2238
21717
1.11
1.71
6.2
5.2
4.11
4.49
mmol/l
57.54
2122
19751
11
48
2.29
1.69
2.7
2.0
—
—
—
0
0
831
7705
1.10
1.68
4.8
5.0
22.94
22.15
%
0.69
396
4151
17
90
1.89
1.64
2.2
8.5
63.58
74.81
%
0.57
12
73
48
335
1.44
1.62
1.4
1.4
6.75
6.29
mmol/l
0.54
48
314
43
294
1.47
1.61
1.3
1.3
279.70
274.17
mosm/kgh2o
0.89
33
210
11
50
2.20
1.56
2.7
2.0
—
—
—
0
0
35
231
1.52
1.55
1.9
1.5
—
—
—
0
0
35
231
1.52
1.55
1.9
1.5
—
—
—
0
0
35
231
1.52
1.55
1.9
1.5
—
—
—
0
0
974
9141
1.09
1.51
2.0
1.9
1.36
1.31
mmol/l
0.58
862
7522
2254
21928
1.10
1.51
6.1
5.6
6.21
6.06
mmol/l
4.61
2078
19646
87
677
1.29
1.50
4.1
3.4
7.75
7.73
mmol/l
0.02
87
657
94
740
1.28
1.49
1.6
1.7
—
—
—
0
0
23
139
1.66
1.47
1.2
1.2
—
—
—
0
0
5
16
3.12
1.43
1.0
1.3
10.00
16.88
u/l
—
5
16
6
22
2.72
1.43
2.2
1.9
—
—
—
0
0
13
66
1.97
1.42
1.2
1.3
—
—
—
0
0
86
675
1.28
1.41
1.7
1.6
15793.85
17090.40
e6/l
0.08
62
476
23
141
1.63
1.40
2.9
2.0
—
—
—
0
0
23
141
1.63
1.40
1.2
1.2
—
—
—
0
0
90
712
1.27
1.39
1.5
1.4
—
—
—
0
0
22
134
1.64
1.38
1.5
1.7
315.69
296.79
mu/l
0.18
16
107
56
416
1.35
1.36
1.7
1.8
—
—
—
0
0
12
61
1.97
1.32
3.1
2.0
30.00
26.19
%
0.40
12
53
24
152
1.58
1.30
1.1
1.4
—
—
—
0
0
24
152
1.58
1.30
1.1
1.4
—
—
—
0
0
67
516
1.30
1.29
1.7
1.8
—
—
—
0
0
297
2641
1.14
1.28
1.7
1.4
—
—
—
0
0
88
704
1.25
1.26
1.7
1.5
—
—
—
0
0
29
194
1.50
1.25
1.5
2.2
8.74
8.14
mmol/l
0.32
29
194
41
294
1.40
1.25
1.1
1.1
—
—
—
0
0
32
220
1.46
1.22
1.6
1.5
27.81
25.84
%
0.14
23
137
22
140
1.57
1.19
2.8
1.9
19.68
17.48
%
0.29
22
132
18
110
1.64
1.14
3.8
7.0
3.46
179.37
ug/l
0.61
11
72
523
5611
0.92
1.08
3.0
3.5
0.79
0.83
ug/l
0.32
360
3973
47
610
0.77
1.04
1.4
1.7
4.32
5.08
mg/l
0.23
41
464
63
499
1.27
1.03
1.5
1.4
—
—
—
0
0
115
971
1.19
1.02
1.1
1.0
—
—
—
0
0
24
345
0.69
1.01
2.2
2.3
15.50
22.05
mg/l
—
6
122
14
83
1.69
1.00
1.1
1.1
—
—
—
0
0
53
412
1.29
1.00
1.6
1.8
4.69
4.69
mmol/24h
0.00
48
358
9
49
1.84
0.98
41.2
8.3
7.04
4.94
kpa
—
9
49
37
491
0.75
0.97
1.6
1.4
—
—
—
0
0
71
576
1.24
0.96
1.7
1.9
2.26
4.15
iu/l
3.67
26
233
6
27
2.22
0.93
1.7
1.9
22.73
15.98
umol/l
—
6
27
9
52
1.73
0.92
1.1
1.5
1.18
1.16
mmol/l
—
9
52
19
126
1.51
0.90
1.2
1.5
—
—
—
0
0
11
63
1.75
0.89
1.4
1.8
79.77
625.11
nmol/24h
0.64
11
63
76
627
1.21
0.89
1.6
1.5
—
—
—
0
0
6
29
2.07
0.89
1.0
1.1
—
—
—
0
0
10
168
0.59
0.87
2.3
3.8
—
—
—
0
0
17
111
1.53
0.87
1.1
1.2
—
—
—
0
0
145
1270
1.15
0.85
1.3
1.3
162.20
230.48
u/ml
1.11
125
1184
42
325
1.29
0.85
1.3
1.2
261.84
287.10
u/ml
0.22
25
174
62
504
1.23
0.85
1.4
1.5
29.41
31.09
g/l
0.51
56
461
11
65
1.69
0.81
1.3
1.2
1.38
1.51
mmol/l
—
6
43
336
3098
1.09
0.81
3.5
4.1
23.00
21.66
ug/l
0.03
284
2568
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
47
374
1.26
0.78
1.2
1.5
—
—
—
0
0
53
428
1.24
0.78
1.4
1.4
—
—
—
0
0
56
456
1.23
0.77
6.0
4.9
523.00
3929.79
iu/ml
0.47
11
62
54
438
1.23
0.77
1.4
1.4
853.42
3750.06
e6/l
0.84
36
308
21
148
1.42
0.77
2.7
2.3
—
—
—
0
0
44
349
1.26
0.76
1.3
1.2
—
143.96
—
0
5
49
603
0.81
0.76
3.5
3.6
29.91
29.44
mg/l
0.03
36
438
22
157
1.40
0.75
1.3
1.1
—
—
—
0
0
21
149
1.41
0.74
1.3
1.1
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
9
54
1.67
0.74
1.2
1.2
98.67
106.27
%
—
9
49
18
254
0.71
0.73
1.3
1.1
—
73.86
—
0
14
9
56
1.61
0.72
2.3
1.3
—
—
—
0
0
88
755
1.17
0.71
1.5
1.6
30.34
21.66
u/ml
0.38
11
140
74
626
1.18
0.71
1.3
1.2
7.03
7.89
u/ml
0.10
12
94
9
58
1.55
0.69
1.0
1.1
—
—
—
0
0
36
283
1.27
0.68
2.3
1.9
5049.89
4567.38
u/l
—
8
105
21
152
1.38
0.68
1.3
1.1
—
—
—
0
0
9
59
1.52
0.68
1.1
1.1
—
—
—
0
0
139
1242
1.12
0.65
2.1
2.1
0.00
0.72
estimate
0.50
57
349
23
172
1.34
0.63
3.2
5.2
282.70
43.71
u/ml
—
6
55
73
626
1.17
0.62
1.3
1.2
46.70
3.30
u/ml
—
5
55
32
401
0.79
0.61
1.2
1.1
0.55
0.67
ratio
—
6
57
5
30
1.66
0.61
1.2
1.0
48.60
41.99
iu/ml
—
5
30
64
544
1.18
0.61
1.4
1.2
27.18
37.01
u/l
0.58
58
462
18
130
1.38
0.60
1.3
1.3
—
—
—
0
0
18
130
1.38
0.60
1.3
1.3
—
—
—
0
0
9
138
0.65
0.60
1.0
1.7
38.49
39.47
g/l
—
9
138
21
157
1.34
0.58
1.3
1.1
—
—
—
0
0
12
173
0.69
0.58
1.1
1.0
—
—
—
0
0
303
2834
1.07
0.56
4.0
3.7
—
—
—
0
0
8
124
0.64
0.54
2.0
1.6
—
—
—
0
0
31
248
1.25
0.54
1.1
1.1
—
4.17
—
0
31
14
193
0.72
0.54
1.6
1.4
—
—
—
0
0
12
82
1.46
0.54
1.0
1.2
—
—
—
0
0
90
1012
0.88
0.53
4.8
4.0
24.67
24.84
mmol/l
0.20
81
922
128
1156
1.11
0.53
3.0
3.4
396.85
105.10
mg/l
0.45
115
995
128
1156
1.11
0.53
3.0
3.4
29.36
67.35
mg/l
2.09
116
998
15
108
1.39
0.52
1.2
1.2
—
—
—
0
0
44
368
1.20
0.52
1.4
1.5
—
—
—
0
0
46
388
1.19
0.50
1.5
1.4
108682.57
81295.10
e6/l
0.13
23
222
11
75
1.47
0.50
1.1
1.1
—
—
—
0
0
10
67
1.49
0.49
1.2
1.4
—
2190609.80
—
0
5
70
613
1.14
0.49
2.7
3.3
4035.42
1106.73
u/ml
0.41
63
557
120
1087
1.11
0.48
2.5
3.2
4893.79
1843.02
u/ml
0.36
99
934
31
375
0.82
0.47
1.1
1.1
—
—
—
0
0
5
83
0.60
0.45
1.0
1.3
—
—
—
0
0
5
85
0.59
0.45
1.8
1.5
95.79
52.57
ug/l
—
5
85
42
356
1.18
0.45
2.8
2.6
140.00
1558.55
u/ml
—
5
31
21
166
1.26
0.42
1.3
1.1
—
—
—
0
0
113
1030
1.10
0.42
2.9
3.3
11.49
5.30
ratio
0.33
68
626
702
6792
1.04
0.41
4.8
3.7
0.06
0.16
estimate
0.36
215
2166
8
58
1.38
0.41
5.8
2.0
1.37
2.44
ratio
—
8
52
13
96
1.35
0.41
3.0
2.4
5.14
4.78
kpa
0.79
13
96
13
96
1.35
0.41
3.0
2.4
9.29
10.04
kpa
0.47
13
96
8
59
1.35
0.40
1.0
2.4
320.38
542.75
ug/l
—
8
59
8
60
1.33
0.40
1.3
1.1
—
—
—
0
0
7
101
0.69
0.39
2.6
1.7
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
13
170
0.76
0.38
1.7
1.5
—
—
—
0
0
19
233
0.81
0.35
1.4
1.3
—
—
—
0
0
38
436
0.87
0.34
1.2
1.2
1.49
1.55
g/l
0.58
38
436
17
135
1.26
0.34
3.4
2.2
31.50
124.45
ug/min
—
8
33
15
188
0.80
0.33
1.3
1.5
—
—
—
0
0
6
46
1.30
0.33
1.0
1.3
—
—
—
0
0
13
165
0.79
0.32
1.7
1.5
—
—
—
0
0
35
303
1.15
0.32
4.8
3.7
—
—
—
0
0
23
192
1.20
0.31
1.3
1.2
—
—
—
0
0
7
52
1.34
0.31
2.1
1.6
163.91
113.49
ug/l
—
7
47
7
98
0.71
0.30
1.7
1.2
5.47
6.29
mmol/l
—
7
93
54
485
1.11
0.30
2.0
1.6
—
—
—
0
0
21
175
1.20
0.29
2.2
2.4
17.75
43.32
iu/ml
—
6
28
21
175
1.20
0.29
1.3
1.5
0.38
0.31
nmol/l
0.18
13
137
45
401
1.12
0.28
1.3
1.3
10.73
10.02
u/l
0.17
33
323
99
1059
0.93
0.27
2.0
1.8
—
—
—
0
0
178
1861
0.95
0.25
2.8
2.2
12.45
12.54
nmol/l
0.04
157
1628
148
1402
1.06
0.25
1.9
2.0
1.10
1.45
g/l
1.93
141
1261
29
254
1.14
0.24
1.1
1.2
52.41
61.40
u/l
0.78
24
229
26
226
1.15
0.24
2.3
1.7
4.55
4.64
mg/l
0.04
26
216
31
349
0.89
0.24
1.8
1.5
—
—
—
0
0
30
265
1.13
0.23
1.9
2.2
1.62
1.29
u/field
0.17
13
145
36
322
1.12
0.23
1.1
1.1
13.75
71.78
iu/ml
—
8
61
5
39
1.28
0.23
1.0
1.2
—
—
—
0
0
21
241
0.87
0.21
1.6
1.5
—
—
—
0
0
34
377
0.90
0.21
1.3
1.2
307.23
217.47
miu/ml
0.40
13
154
0
10
0.00
0.21
0.0
1.0
—
0.01
—
0
5
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
2.61
—
0
6
21
240
0.87
0.21
1.1
1.0
2.30
1.97
eliau/ml
—
9
82
80
749
1.07
0.20
1.3
1.6
—
—
—
0
0
217
2244
0.96
0.20
3.6
3.9
1.23
1.23
mmol/l
0.00
193
1903
0
14
0.00
0.20
0.0
1.9
—
28.00
—
0
14
24
211
1.14
0.20
2.3
2.1
724.89
627.89
ml
0.77
18
121
14
165
0.85
0.19
1.4
1.5
1.46
1.23
ratio
—
8
106
14
165
0.85
0.19
1.4
1.5
0.94
0.97
ratio
—
8
106
14
165
0.85
0.19
1.4
1.5
1.09
1.13
ratio
—
8
106
114
1082
1.05
0.19
2.2
1.8
—
—
—
0
0
198
1907
1.04
0.19
4.7
3.7
5.19
5.17
kpa
0.11
189
1811
14
164
0.85
0.18
1.4
1.5
—
—
—
0
0
170
1634
1.04
0.18
4.5
3.6
1.74
2.06
mmol/l
0.47
119
1201
38
348
1.09
0.17
2.3
2.2
5393.40
920.25
u/ml
0.39
38
342
55
587
0.93
0.17
1.3
1.2
—
—
—
0
0
37
340
1.09
0.16
1.6
1.3
—
—
—
0
0
143
1479
0.96
0.15
4.7
3.7
1.02
1.02
ratio
0.37
124
1355
21
188
1.12
0.14
1.5
1.9
94.16
123.20
ng/l
1.04
21
188
15
131
1.14
0.14
1.3
1.3
1.23
1.14
nmol/l
—
10
90
36
335
1.07
0.12
1.7
1.3
—
—
—
0
0
16
142
1.13
0.12
1.6
1.6
4.80
2.36
u/field
—
5
100
12
104
1.15
0.12
1.0
1.4
143.05
165.08
pmol/l
0.27
12
104
102
982
1.04
0.12
2.0
1.8
—
—
—
0
0
15
133
1.13
0.11
1.9
3.2
1.17
1.17
%
0.00
15
133
44
415
1.06
0.11
1.2
1.2
—
—
—
0
0
16
177
0.90
0.10
1.3
1.1
—
—
—
0
0
967
9573
1.01
0.10
5.3
6.2
2.77
4.15
ug/l
1.68
875
8525
36
338
1.06
0.10
1.7
1.3
—
—
—
0
0
12
135
0.89
0.10
3.7
1.5
—
—
—
0
0
12
135
0.89
0.10
3.7
1.5
—
—
—
0
0
12
135
0.89
0.10
3.7
1.5
—
—
—
0
0
12
135
0.89
0.10
3.7
1.5
—
—
—
0
0
5
45
1.11
0.09
1.0
1.1
—
—
—
0
0
17
154
1.10
0.09
1.4
1.5
9.44
6.69
u/l
0.34
12
130
5
47
1.06
0.09
1.2
1.4
—
—
—
0
0
111
1139
0.97
0.09
2.3
2.0
—
—
—
0
0
14
154
0.91
0.08
2.4
1.6
10.20
12.92
umol/l
—
5
102
7
65
1.07
0.08
2.6
1.3
11.09
8.92
ug/l
—
7
65
6
70
0.86
0.07
1.8
2.4
18.85
134.09
ug/l
—
6
63
37
387
0.95
0.07
2.5
1.9
18.09
25.12
ug/l
1.02
37
382
247
2434
1.01
0.06
1.4
1.4
—
—
—
0
0
34
327
1.04
0.04
1.7
1.3
—
—
—
0
0
26
271
0.96
0.04
1.2
1.1
2.21
1.46
u/ml
0.20
11
151
34
328
1.03
0.03
1.7
1.3
—
—
—
0
0
2157
21553
1.00
0.03
25.3
18.5
72.95
73.38
ml/min/173m2
0.40
2049
20112
34
329
1.03
0.03
1.7
1.3
—
—
—
0
0
19
197
0.96
0.01
1.2
1.1
0.42
1.11
u/ml
—
9
102
47
461
1.02
0.01
2.4
1.9
1.73
1.70
mmol/l
0.06
47
450
47
477
0.98
0.01
1.4
1.5
0.91
0.82
nmol/l
0.55
41
391
17
163
1.04
0.01
1.4
1.2
—
—
—
0
0
11
105
1.05
0.00
2.0
1.9
40.23
51.52
ug/l
0.75
11
100
21
214
0.98
0.00
1.2
1.2
102.29
101.92
pmol/l
0.01
21
214
10
96
1.04
0.00
4.2
1.6
—
—
—
0
0
10
96
1.04
0.00
4.2
1.6
—
—
—
0
0
21
211
0.99
0.00
1.8
1.5
—
—
—
0
0
15
155
0.97
0.00
1.3
1.6
78.93
86.66
umol/l
0.51
15
155
121
1207
1.00
0.00
1.2
1.2
83.79
135.83
u/ml
1.00
36
420
10
98
1.02
0.00
4.2
1.6
—
—
—
0
0
8
85
0.94
-0.00
1.6
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
2.44
—
0
9
0
6
0.00
-0.00
0.0
5.2
—
399.83
—
0
6
0
6
0.00
-0.00
0.0
1.2
—
7.57
—
0
6
0
8
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
0.01
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint I9_CEREBDOTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_CEREBDOTH | 1.804 [1.65, 1.98] | < 0.001 |
| Birth year | 0.993 [0.99, 1.0] | 0.089 |
During the follow-up period (1.1.1998 — 31.12.2019), 4689 out of 9333 females with I9_CEREBDOTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_CEREBDOTH | 1.745 [1.58, 1.93] | < 0.001 |
| Birth year | 0.983 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 4617 out of 9686 males with I9_CEREBDOTH died.
Mortality risk
Mortality risk for people of age
years, who have I9_CEREBDOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.154% | 0.319% |
| 5 | 0.957% | 1.904% |
| 10 | 2.44% | 4.433% |
| 15 | 4.835% | 8.401% |
| 20 | 8.489% | 14.215% |
Relationships between endpoints
↥Index endpoint: I9_CEREBDOTH – Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data